Golgi proteomics : Identification of a novel cartilage-specific Golgi protein GoPro49 by Takatalo, Maarit
Golgi proteomics: Identification of a novel 
cartilage-specific Golgi protein GoPro49 
Maarit Takatalo
Department of Biological and Environmental Sciences
Division of Biochemistry 
Faculty of Biosciences
and
Viikki Graduate School in Molecular Biosciences
University of Helsinki, Finland
ACADEMIC DISSERTATION
To be presented for public criticism, with the permission of 
the Faculty of Biosciences, University of Helsinki, 
in the auditorium 1041 at Viikki Biocenter 2, 
Viikinkaari 5, Helsinki, on 2nd April 2009, at 12 noon.
Helsinki 2009
Supervisor:  PhD Ragna Rönnholm
   Department of the Biological and Environmental Sciences
   Division of Biochemistry
   University of Helsinki
   Helsinki
   Finland
Reviewers:  Docent Marjo Salminen
   Faculty of Veterinary Medicine
   University of Helsinki
   Helsinki
   Finland
   Docent Jussi Jäntti
   Institute of Biotechnology
   University of Helsinki
   Helsinki
   Finland
   
Opponent:  Professor Elina Ikonen
Institute of Biomedicine/Anatomy
University of Helsinki
Helsinki
Finland
ISBN 978-952-92-5210-7
ISBN 978-952-10-5321-4 (PDF)
Helsinki University Printing House
Helsinki 2009

Table of conTenTs
lisT of original publicaTions .......................................................................................................5
abbreviaTions ..........................................................................................................................................6
summary ......................................................................................................................................................7
1 review of The liTeraTure ........................................................................................................8
1.1 introduction to the secretory pathway .........................................................................................8
1.2 structure and dynamics of the golgi complex ..........................................................................10
1.3 functions of the golgi complex ..................................................................................................12
1.3.1 Golgi resident proteins .............................................................................................................14
1.3.2 Transport proteins ....................................................................................................................20
1.4 proteomics.....................................................................................................................................23
1.4.1 The Golgi proteome .................................................................................................................24
1.5 sequence analysis and databases ................................................................................................25
1.6 skeleton and cartilage ..................................................................................................................26
1.6.1 Development and patterning of the limb .................................................................................27
1.6.2 Endochondral ossification ........................................................................................................29
1.6.3 Cartilage extracellular matrix ..................................................................................................31
1.7 Dental tissues and periodontium ................................................................................................33
1.7.1 Tooth formation .......................................................................................................................34
2 aims of The sTuDy .........................................................................................................................37
3 experimenTal proceDures .....................................................................................................38
3.1 methods used in articles i-iv ......................................................................................................38
3.2 sirna experiments .......................................................................................................................38
3.3 Zebrafish gene expression and morpholino injections .............................................................39
3.4 alcian blue staining......................................................................................................................39
4 resulTs ................................................................................................................................................40
4.1 The golgi proteome (i, ii) ...........................................................................................................40
4.2 in silico analysis of the protein, gopro49 (iii) ..........................................................................41
4.3 The gopro49 tissue expression pattern (iii, iv) .......................................................................42
4.4 gopro49 subcellular localisation (i, iii, iv) ..............................................................................45
4.5 Knockdown experiments (unpublished results) ........................................................................47
5 Discussion .........................................................................................................................................48
5.1 Diversity of the golgi proteome and the ‘proteinpedia’ database ...........................................48
5.2 restricted, developmentally regulated expression of gopro49 ...............................................50
5.3 gopro49 localisation in β-cop positive structures and possible function .............................53
5.4 potential regulation mechanisms of gopro49 expression ........................................................54
6 concluDing remarKs ................................................................................................................56
acKnowleDgemenTs ..........................................................................................................................57
references ...............................................................................................................................................58
5List of originaL pubLications
This thesis is based on the following original publications, which are referred in the text by their 
Roman numerals, and on unpublished results presented in the text. 
Takatalo MS, Kouvonen P, Corthals G, Nyman TA, Rönnholm RH.  I. 
Identification of new Golgi complex specific proteins by direct organelle proteomic analysis.
Proteomics. 2006, 6(12):3502-8.
Mathivanan S, Ahmed M, 157 coauthors including Rönnholm R and Takatalo MS, and Pandey II. 
A. 
 Human Proteinpedia enables sharing of human protein data. 
 Nature Biotechnology. 2008, 26(2):164-7.
Takatalo MS, Järvinen E, Laitinen S, Thesleff I, Rönnholm RH.III. 
Expression of the novel Golgi protein GoPro49 is developmentally regulated during
mesenchymal differentiation.
Developmental Dynamics. 2008, 237(8):2243-2255.
Takatalo MS, Tummers M, Thesleff I, Rönnholm RH.IV. 
GoPro49 is a novel, specific marker for the dental follicle. 
Journal of Dental Research, in press.
These articles are reproduced with the permission of their copyright holders.
6abbreviations
Abbreviations used only once are not included in this list.
ACBD3 acyl-Coenzyme A binding domain containing 3
AER apical ectodermal ridge
Agc aggrecan
Arf ADP-ribosylation factor
BMP bone morphogenetic protein 
bp base pair
Bsp1 bone sialoprotein 1
CASP CDP/cut alternatively spliced product
Col Collagen 
COPI Coat protein type I
COPII Coat protein type II
CtBP/BARS C-terminal binding protein 1, short form/brefeldin-A dependent ADP ribosylation substrate
dpn days postnatal
E embryonic day
ECM Extracellular matrix
En-1 Engrailed
ER Endoplasmic reticulum
ERGIC ER-Golgi-intermediate-compartment
EXT Exostoses (multiple)
FGF fibroblast growth factor 
GAP GTPase activating protein
GC Golgi complex
GEF Guanine nucleotide exchange factor
Gli glioma-associated oncogene homolog (zinc finger protein)
GlcNac N-acetylglucosamine
GM130 Golgi matrix protein, 130 kDa
GoPro49 Golgi protein 49 kDa, NP_775823
GRASP65 Golgi Reassembly Stacking Protein 65 kDa
HERS The Hertwig’s epithelial root sheath
Ihh Indian hedgehog
k.d. knockdown
LC liquid chromatography
MALDI matrix-assisted laser desorption/ionisation
MEF2C myocyte enhancer factor 2C
MMP matrix metalloproteinase
MS mass spectrometry
MSX msh homeobox 
Myt1 Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
Nir2 phosphatidylinositol transfer protein, membrane-associated 1
NMRI Naval medical research institute, an inbred mouse strain
Pax9 paired box gene 9
PCR polymerase chain reaction
PDL periodontal ligament
pf post fertilisation
PM plasma membrane
PTHrP Parathyroid hormone-related protein
qPCR quantitative PCR
Rab Ras-related protein
RT-PCR reverse transcriptase PCR
Runx2 runt related transcription factor 2, also known as Cbfa1
Shh Sonic hedgehog
Smad mothers against decapentaplegic homolog
SNAP soluble NSF attachment proteins
SNARE soluble NEM-sensitive factor attachment protein receptors
Sox SRY-box containing gene
Tbx T-box
Tbp TATA-box binding protein
Tcf/Lef T-cell factor/Lymphoid-enhancing factor transcription factor
TGFβ transforming growth factor beta
TGN Trans Golgi network
TOF time-of-flight
TM transmembrane 
TRAPP transport protein particle
VEGF vascular endothelial growth factor
VSV-G vesicular stomatitis virus G-protein
Wnt Wingless-related MMTV integration site
wt wild type
ZPA zone of polarising activity
7summary
The Golgi complex is a central organelle of the secretory pathway, responsible for a range of 
post-translational modifications, as well as for membrane traffic to the plasma membrane and 
to the endosomal-lysosomal pathway. In addition, this organelle has roles in cell migration, in 
the regulation of traffic, and as a mitotic check point. The structure of the Golgi complex is 
highly dynamic and able to respond to the amount of cargo being transported and the stage of 
the cell cycle. The Golgi proteome reflects the functions and structure of this organelle, and can 
be divided into three major groups: the Golgi resident proteins (e.g. modification enzymes), the 
Golgi matrix proteins (involved in structure and tethering events), and trafficking proteins (e.g. 
vesicle coat proteins and Rabs). The Golgi proteome has been studied on several occasions, 
from both rat liver and mammary gland Golgi membranes using proteomic approaches, but still 
little more than half of the estimated Golgi proteome is known. Nevertheless, methodological 
improvements and introduction of shotgun proteomics have increased the number of identified 
proteins, and especially the number of identified transmembrane proteins. 
Cartilage, even though not a typical tissue in which to study membrane traffic, secretes large 
amounts of extracellular matrix proteins that are extensively modified, especially by amino acid 
hydroxylation, glycosylation and sulfation. Furthermore, the cartilage ECM contains several, 
large oligomeric proteins (such as collagen II) that are difficult to assemble and transport. Indeed, 
cartilage has been shown to be susceptible to changes both in secretory pathway (e.g. the COPII 
coat assembly) and in post-translational modifications (e.g. heparan sulfate formation). Dental 
follicle, and the periodontal ligament (PDL) that it forms, are another type of connective tissue, 
and they have a role in anchoring teeth to bone. This anchorage is achieved by numerous matrix 
fibres that connect the bone matrix with the cementum. These tissues have in common the 
secretion of large matrix molecules.
In this study the Golgi proteome was analysed from purified, stacked Golgi membranes 
isolated from rat liver. The identified, extensive proteome included a protein similar to Ab2-095, 
or Golgi protein 49kDa (GoPro49), which was shown to localise to the Golgi complex as an 
EGFP fusion protein. Surprisingly, in situ hybridisation showed the GoPro49 expression to be 
highly restricted to different mesenchymal tissues, especially in cartilage, and this expression 
pattern was clearly developmentally regulated. In addition to cartilage, GoPro49 was also 
expressed in the dental follicle, but was not observed in the mature PDL. Importantly, GoPro49 
is the first specific marker for the dental follicle. Endogenous GoPro49 protein co-localised 
with β-COP in both chondrosarcoma and primary dental follicle cell lines. The COPI staining 
in these cells was highly dynamic, showing a number of tubules. This may reflect the type of 
secretory cargo they secrete. Currently GoPro49 is the only Golgi protein with such a restricted 
expression pattern.
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Introduction to the secretory pathway1.1 
Membrane trafficking within the cell occurs by two main pathways: endocytosis, where material is 
engulfed and transported from outside the cell into the cytoplasm, and exocytosis, where material 
produced inside the cell is transported towards the plasma membrane. The endoplasmic reticulum (ER) 
forms the starting point of the exocytotic pathway, where membrane-associated ribosomes translate 
and, together with the Sec61 translocon, translocate cargo proteins across the ER membrane (reviewed 
in Alder and Johnson, 2004). In the lumen of the ER, heat shock family proteins function as chaperones 
to guide the process of protein folding, and to recognise hydrophobic patches, immature N-glycans and 
exposed thiol residues. In addition, they can assist in disulfide bond formation and oligomerisation of 
protein complexes. Besides the common chaperones that facilitate folding of many different proteins, 
several tissue and substrate-specific chaperones are known that have a limited number of target proteins. 
One of these is Hsp47, which is involved in collagen biosynthesis (reviewed in Anelli and Sitia, 2008).
Translocated proteins undergo first post-translational modifications as they enter the ER lumen. 
Precursor N-glycan chains are transferred from dolichol-linked precursors by a multisubunit 
oligosaccharyltransferase complex to the asparagine residues on growing amino acid chain (Asn-X-
Ser/Thr, N-glycosylation) (Stanley et al., 2009). Glycosylation enzymes (α-glucosidases I and II, and 
α-mannosidase I) can then trim these nascent N-glycans, while UDP-Glc:glycoprotein glucosyltransferase 
adds new glycan moieties to misfolded proteins (reviewed in Anelli and Sitia, 2008). Trimming of 
N-glycan chains helps in monitoring the folding level of a protein; this process is called ‘ER quality 
control’ (Hurtley and Helenius, 1989). Other modifications that proteins may undergo in the ER are lipid 
modification (GPI anchors) and proline hydroxylation (Anelli and Sitia, 2008, Myllyharju, 2003).
As folded proteins leave the ER, they carry the core N-glycan chain, and lectins (such as ERGIC-53) 
can assist in forward transport of these glycosylated proteins (reviewed in Anelli and Sitia, 2008). From 
the ER, cargo is transported to the ER-Golgi-intermediate compartment (ERGIC) and onwards to the 
Golgi complex (GC) in coated vesicles (see Figure 1). In the GC, escaped ER resident proteins are 
captured and recycled back to the ER, leaving cargo proteins to traffic through the GC stack. Membrane 
traffic to and through the GC is discussed in more detail in Chapter 1.3, Functions of the Golgi complex. 
Different model proteins used to study anterograde membrane traffic to the plasma membrane (PM) 
include vesicular stomatitis virus G-protein (VSV-G) and procollagen type I. In particular, procollagen 
has been used to demonstrate the transport of large, soluble cargo (300nm bundles) not fitting into 
normal vesicles, and it has been suggested to traverse the GC without use of vesicles (Bonfanti et al., 
1998).
When a cargo molecule reaches the trans Golgi network (TGN), it is sorted and transported 
by clathrin coated vesicles to its final destination: the apical and basolateral PM or the endosomal-
lysosomal pathway. Sorting signals that are recognised in the basolateral PM cargo proteins include 
tyrosine, leucine, and dileucine-based motifs, while the apical PM targeting motifs include GPI-anchors, 
N- and O-glycans, lipid rafts, and proteinaceous targeting motifs (reviewed in Rodriguez-Boulan and 
Musch, 2005). Endosomal proteins can be sorted based on recognition of DXXLL motifs, or through 
interactions with the mannose-6-phosphate receptor (reviewed in Bonifacino and Traub, 2003). 
While exocytosis is responsible for membrane traffic towards the PM, endocytosis is important for 
regulation of the number and activity of membrane proteins, for the recycling of synaptic vesicles, and for 
9nutrient intake. The uptake can occur through receptor-mediated endocytosis (clathrin coated vesicles), 
or through phagocytosis and pinocytosis (without vesicle coat formation) (reviewed in Nichols and 
Lippincott-Schwartz, 2001). The endocytosed material is transported to the early endosomes that mature 
ﬁrst into late endosomes and then gradually into lysosomes, with transport of hydrolysing enzymes from 
the GC and lowering of the pH. From early and late endosomes, proteins can either be recycled back to 
the TGN or to the PM, or they can be directed to degradation in the lysosomes (reviewed in Bonifacino 
and Rojas, 2006). 
Along with proteins, lipids are central components of the endomembranes, the most abundant ones 
Figure 1. Electron 
micrograph of the GC, 
and a schematic view 
of the membrane trafﬁc 
machinery of a cell
A) An electron micrograph 
of the NRK cell GC. The 
structure of this diverse 
membrane-bound organelle is 
best described as ribbon-like in 
interphase cells. The cisternal 
stack has polarity from cis to 
trans both in protein and lipid 
composition and in pH. Image 
courtesy of Eija Jokitalo. Scale 
bar 1 m. 
B) A schematic image of 
the secretory pathway of a cell. 
Proteins translated in the ER 
are packed into COPII coated 
vesicles (orange with orange 
coat) for transport towards the 
ERGIC (yellow), from where 
COPI vesicles (pink with red 
coat) are needed for further 
transport to the GC. Rab 
GTPases, together with Golgins 
as tethers, mediate targeting 
of these vesicles. Cargo is 
then transported through the 
GC stack by vesicles (blue 
arrow), maturation, or cisternal 
membrane continuities (blue 
arrowhead). As cargo passes 
through the cisternae from 
cis to trans it undergoes 
further post-translational 
modiﬁcations. 
In the trans Golgi network, 
cargo is sorted and packed into 
a third set of vesicles: clathrin 
coated vesicles (light purple or 
light blue at the PM, with blue 
coat). Different recognition motifs are utilised (e.g. partition to rafts, red areas on the two trans-most cisternae). 
From the PM, escaped Golgi enzymes and PM receptors can be transported back to endosomes (green), from 
where they can be recycled to the TGN or to the PM, or directed to degradation in the lysosomes (red). Some 
proteins that participate in transport or that are required for Golgi structure are marked. The GC structure also 
includes closely associated vesicles (purple). Green arrows mark transport of cargo, black arrows transport and 
recycling of resident proteins, and the red arrow transport of proteins to lysosomes for degradation.
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being cholesterol, glycerophospholipids, sphingophospholipids and glycosphingolipids or ceramides. 
In mammalian cells, glycerophospholipids and sterols are produced in the ER, peroxisomes and 
mitochondria, while the majority of sphingolipids are produced in the GC (reviewed in van Meer et al., 
2008). The lipid composition forms a gradient between the ER and the PM, with the lowest amounts 
of cholesterol and glycolipids in the ER and the greatest in the PM. The lipid composition of the GC is 
between these two, as is its position in the secretory pathway (van Meer et al., 2008). 
Besides these changes in the total membrane lipid composition across the pathway, there are also 
differences in the composition of the inner (cytoplasmic) and outer (luminal) membrane leaflet. Membranes 
of the ER have a uniform composition, with comparable amounts of the different phospholipids in both 
leaflets, while the GC and the PM bilayers have phosphatidylcholine and glycolipids mainly in the 
outer leaflet, and phosphatidylserine and phosphatidylethanolamine in the inner leaflet (reviewed in 
Daleke, 2007). This organised lipid composition may affect the fluidity of the membrane, as well as 
the localisation of proteins, as is observed for lipid rafts (Harder et al., 1998). Lipid rafts, enriched 
in glycosphingolipids and cholesterol, are dynamic membrane domains that may sort and concentrate 
proteins into distinct domains (e.g. apical sorting).  
Structure and dynamics of the Golgi complex 1.2 
The GC is a central organelle of the secretory pathway and the intracellular membrane trafficking route. 
In interphase cells, the GC structure is ribbon-like, in juxtanuclear position, and it is composed of 
stacked flattened cisternae that have a polarisation from cis (input from the ER) to trans (export to the 
PM, Figure 1). The cis and trans Golgi networks form recycling compartments from which vesicles bud 
for both retrograde and anterograde transport. The enzyme composition of the cisternae is also polarised 
from cis to trans, with the transferase distribution roughly following the order of the glycosylation 
events (Rabouille et al., 1995). Moreover, the pH of the secretory compartments decreases gradually 
beginning from the ER (~7.4), towards the Golgi (~6.2), and the secretory granules (~5.5) (Wu et al., 
2001). In addition to the cisternae, the GC structure encompasses a number of closely associated small 
vesicles or tubules that have been observed in, for example 3D reconstruction electron tomography 
studies (Figure 1B, Marsh et al., 2001, Marsh et al., 2004, Trucco et al., 2004). 
To accomplish all its functions, the Golgi complex has to be a highly dynamic organelle. Depending 
on the cell type, the amount of secretory cargo and the stage of the cell cycle, it is able to change 
shape from the stacked morphology adjacent to the nucleus to vesicular-tubular structures (Kreis el 
al., 1997). Furthermore, the GC structure is intimately linked with the cytoskeleton, and thus is highly 
susceptible to changes in cytoskeleton organisation (Ho et al., 1989, Kreis el al., 1997). Indeed, the 
perinuclear GC localisation is dependent on a functional cytoskeleton and cytoskeletal motor proteins 
that interlink membranes with the cytoskeleton (Turner and Tartakoff, 1989, Xu et al., 2002). In addition 
to the cytoskeleton, several other factors contribute to the GC structure, including the Golgi matrix 
proteins, GTPases such as ADP-ribosylation factors (Arfs), kinases, and membrane input from the ER 
(Short et al., 2005, Gillingham and Munro, 2007, Feinstein and Linstedt, 2007, Shaul and Seger, 2006, 
Marra et al., 2007).
The morphology of the GC is linked to the cell cycle, and changes rapidly depending on the stage 
of the cell cycle. As a mammalian cell enters mitosis, the typical interphase cisternae organisation 
is progressively lost, and by metaphase numerous small punctuated dispersed structures of the GC 
fragments can be observed. In addition, traffic from the ER to the GC comes to a halt when cells are 
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near the end of the G2 phase, which is caused by the disruption of the ER exit sites (ERES) (Warren et 
al., 1983, Kano et al., 2004). These changes in the Golgi morphology may be linked to the need for even 
distribution of the GC between cells during cytokinesis. When the cell cycle reaches telophase, the GC 
is reassembled and membrane traffic resumes to provide the membranes required for the completion of 
cell division (Goss and Toomre, 2008). 
There are two different models that attempt to explain GC inheritance (reviewed in Colanzi and 
Corda, 2007). The first one regards the GC as dependent on, and in a dynamic equilibrium with the ER, 
and considers the Golgi as an inherited part of the ER. The key step in this model is the blockage of 
membrane transport from the ER, causing redistribution of Golgi proteins to the ER (Kano et al., 2004, 
Zaal et al., 1999). The second model considers the GC as an independent organelle, which requires 
the Golgi remnants for reassembly. In this model, the key step is disruption of membrane tethering 
complexes, followed by equal distribution of Golgi fragments between daughter cells (Seemann et al., 
2002, Pecot and Malhotra, 2004). 
Regardless of the model, fragmentation of the GC is a necessary step for the progression of the 
mammalian cell cycle, but it can be bypassed by artificial GC fragmentation (Feinstein and Linstedt, 
2007, Colanzi et al., 2007). The fragmentation is controlled by numerous phosphorylation events and 
several kinases, including Cell division cycle 2 kinase (Cdc2 or CDK1), the RAF/MEK1/ERKc1 
pathway, Polo-like kinase 1 (Plk1) and Plk3 (reviewed in Lowe and Barr, 2007). Furthermore, inhibition 
of phosphorylation by MEK1/ERKc1 significantly delays the G2/M transition (Feinstein and Linstedt, 
2007, Shaul and Seger, 2006). One of the phosphorylation targets is Golgi matrix protein Golgi reassembly 
stacking protein 65kDa (GRASP65), which is required, together with the fission protein CtBP1/BARS 
(C-terminal binding protein 1, short form/brefeldin-A dependent ADP ribosylation substrate), to sever 
non-compact zones during early GC fragmentation (Feinstein and Linstedt, 2007, Carcedo et al., 2004, 
Preisinger et al., 2005). The GC reassembly at telophase requires membrane-associated tyrosine- and 
threonine-specific cdc2-inhibitory kinase (Myt1), which phosphorylates Cdc2 and inhibits mitotic entry 
(Nakajima et al., 2008). However, Myt1 function is not required for maintenance of the interphase GC 
structure. 
In addition to the need for even distribution of the Golgi membranes between cells, the mitotic GC 
fragmentation has also been found to be associated with other aspects of cell duplication. Several proteins 
are released into the cytosol by the fragmentation, including clathrin, phosphatidylinositol transporter 
Nir2, and acyl-Coenzyme A binding domain-containing protein 3 (ACBD3). During mitosis, clathrin 
plays a role in the regulation of chromosome segregation, and in the stabilisation of the connections 
between chromosomes and the mitotic spindle (Royle et al., 2005, Okamoto et al., 2000). Phosphorylated 
Nir2 protein relocates during mitosis to the cleavage furrow, where it is required for Plk1 docking and 
normal cytokinesis (Litvak et al., 2004). The third released protein, ACBD3, regulates signalling of 
Numb in asymmetric cell division and is an essential Numb partner in cell-fate specification (e.g. in 
neural progenitor cells) (Zhou et al., 2007). 
In addition to mitosis, Golgi fragmentation is observed during apoptosis. However, the apoptotic 
GC fragmentation is not controlled by phosphorylation, but instead by irreversible caspase cleavage 
of Golgi matrix proteins, and is needed for the progression of apoptosis (Mancini et al., 2000, Lowe 
et al., 2004, Maag et al., 2005). This GC fragmentation occurs early in apoptosis, and is thought to be 
required for inhibition of membrane traffic (Lowe et al., 2004, Mukherjee et al., 2007). Furthermore, 
proapoptotic caspase-2 has been directly localised to the GC, where it can cleave golgin-160 and other 
substrates (Mancini et al., 2000). 
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Functions of the Golgi complex1.3 
The GC is responsible for a range of post-translational modifications of proteins and lipids on the secretory 
pathway, and for the transport and sorting of cargo proteins to their appropriate locations (Varki, 1998, 
Honke and Taniguchi, 2002, van Vliet et al., 2003). In addition, recent reports have described Golgi 
complex proteins instrumental in the process of cell migration and signalling cascades (e.g. mitotic 
Golgi check point, cell proliferation and regulation of traffic within the GC) (Preisinger et al., 2005, 
Preisinger et al., 2004, Sheen et al., 2004, Pulvirenti et al., 2008).
The main modifications for a protein in the lumen of the GC are glycosylation, modification of 
the glycans, and sulfation. While N-glycosylation is initiated in the ER during protein translocation, 
O-glycosylation can begin in the GC by addition of an N-acetylgalactosamine to serine or threonine 
residues by polypeptide-N-acetyl-galactosaminyltransferases (Figure 2, Elhammer and Kornfeld, 1986). 
Modification of both N- and O-glycans continues in the GC (Li et al., 1978, Brockhausen et al., 2009, 
Stanley et al., 2009). Several different O-glycan core structures can be formed, of which core 1 and 
core 2 types are the most common (Figure 2B, Brockhausen et al., 2009). O-glycan core structures 
can be further branched and elongated, and N-glycans can be trimmed and modified to obtain complex 
and hybrid-type structures. The oligo- or high-mannose type N-glycans, found in mature proteins (e.g. 
lysosomal proteins) of multicellular animals, result from incomplete trimming of the precursor glycan 
chain attached in the ER, as further mannose residues are not added to N-glycans in the GC (Stanley et 
al., 2009).
Enzymes that are needed to produce the complex and hybrid-type N-glycans include mannosidases 
(e.g. endo- and type II) that trim the nascent chain in the GC, and N-acetylglucosaminyltransferases 
that add N-acetylglucosamine (GlcNAc) residues to α3- and α6-mannose residues of the glycan core 
structure in the medial-Golgi (Figure 2A, Tabas and Kornfeld, 1978, Roth et al., 2003, Stanley et al., 
2009). Further glycan modifications take place in the trans-Golgi, where several monosaccharides, 
including fucose, N-acetylglucosamine, galactose, sialic acid, and N-acetylgalactosamine can be added 
to the core glycan chain (Stanley et al., 2009). Modified glycans such as phosphorylated GlcNac, can 
also be added to the terminal mannose on N-glycans of lysosomal proteins. This GlcNac is then trimmed 
away to yield mannose-6-phosphate, which is recognised by Man-6-P receptors (Reitman and Kornfeld, 
1981, Varki and Kornfeld, 1980).
Finally, a third type of glycosylation in the GC is attachment of glycosaminoglycan (repeated 
disaccharide units e.g. heparan sulfate) to core protein serine residues (reviewed in Gorsi and Stringer, 
2007). Enzymes needed for glycosaminoglycan formation include exostoses (multiple) 1 (EXT1) and 
EXT2, which are involved in heparan sulfate biosynthesis and chain elongation (Busse et al., 2007). 
Glycolipids are the second major structure bearing glycans in cells. The lipid moiety of glycosphingolipids 
is produced in the ER and it is transported to the GC, where it can be further glycosylated to obtain e.g. 
lactosylceramide or the more complex glycan structures of gangliosides (reviewed in Degroote et al., 
2004).
Each of these glycan types can be further modified by sulfate, phosphate, acetate or methyl groups. Of 
these, sulfate groups can be attached both to glycans (e.g. in heparan sulfate to GlcNac or glucuronic acid), 
and to tyrosine residues on proteins (reviewed in Gorsi and Stringer, 2007, Kehoe and Bertozzi, 2000). 
Even though sulfation is not as abundant a modification as glycosylation, it has been shown to be important 
for the development of many tissues, including cartilage, where sulfated glycosaminoglycans bind growth 
factors, and thus help to regulate and limit their diffusion (Kluppel et al., 2005, Chintala et al., 1995). 
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The major task of the GC is to mediate membrane traffic. Coat protein type I (COPI) and type II 
(COPII) on the ER-Golgi side, and clathrin on the TGN-PM side, constitute the three major coat types of 
the secretory pathway. The COPII coated membranes are filled with anterograde cargo and traffic from 
the ER to the ERGIC, a tubulovesicular membrane cluster (Barlowe et al., 1994, Aridor et al., 1995). 
Further transport from the ERGIC to the GC requires COPI membranes (Aridor et al., 1995, Scales et 
al., 1997, Styers et al., 2008). In addition, COPI vesicles participate in retrograde transport from the GC 
to the ER (Letourneur et al., 1994). The morphology of these transport membranes can range from small 
vesicles to larger tubules. The debate on the shape and size of the membrane transport compartments is 
connected to the controversy surrounding the different Golgi transport models in the field. 
As the protein reaches the GC in the exocytotic pathway, it needs to traverse the GC stack. Whether 
COPI vesicles move in a retrograde or anterograde direction, or in both directions, within the GC is still 
Figure 2. A schematic view of N- 
and O-glycosylation and glycan 
modification.
A) The precursor N-glycan chains are 
transferred from dolichol-linked precursors to 
a translocated protein (on asparagine residues) 
by a multisubunit oligosaccharyltransferase 
complex. In the ER these nascent N-glycans 
are further trimmed by removal of three 
glucose residues (grey circle) and a mannose 
residue (light gray circle). Trimming of 
N-glycan chains helps in monitoring the 
folding level of a protein and new glucose 
moieties can be added to misfolded proteins 
to assist further folding. Lectins can assist the 
transport of folded proteins to the GC.
In the GC the N-glycans undergo further 
trimming and modifications, and several 
of the mannose residues can be removed 
by specific mannosidases. The following 
branching of N-glycan begins by addition 
GlcNAc residues (grey square) to mannoses 
of the core structure. The glycan chains can 
be further modified and elongated by other 
glycan moieties, such as fucose (to core 
GlcNAc residue, triangle), or galactose 
(white circle) and N-acetylneuramic acid 
(light gray diamond) to the branches. 
The lysosomal proteins are differentially 
modified in the GC by addition of 
phosphorylated GlcNac to the terminal 
mannose. This GlcNac is then trimmed away 
in later compartments yielding mannose-6-
phosphate, which is recognised by Man-6-P 
receptors and sorted to endosomal-lysosomal 
pathway. 
B) The mucin type O-glycosylation begins in the GC by addition of an N-acetylgalactosamine (white square) to 
serine or threonine residues. There are eight different O-glycan core structures, of which core 1 and 2 structures are 
the most common. In core 1 structures galactose is added to N-acetylgalactosamine, and this core 1 structure can be 
further modified e.g. by addition of N-acetylneuramic acid or GlcNAc residues. The core 2 structure is formed from 
the core 1 structure by adding GlcNAc residue to the N-acetylgalactosamine. Both branches of core 2 structure can 
be further modified (e.g. as the one shown). 
Glucose grey circle, mannose light gray circle, GlcNAc grey square, galactose white circle, fucose triangle, 
N-acetylgalactosamine white square, N-acetylneuramic acid light gray diamond. Modified from Brockhausen et al. 
2009 and Stanley et al. 2009.
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under debate. Moreover, recent studies have suggested that besides the vesicular or tubular transport 
carriers, direct membrane continuities between adjacent cisternae may mediate intra-Golgi transport 
(Marsh et al., 2004, Trucco et al., 2004). There are four models that attempt to explain membrane traffic 
within the GC. The traditional models include the cisternal maturation model and the vesicular transport 
model, while more recent models include a hybrid of these two and a continuity-based or inter-cisternal 
connection model (reviewed in Elsner et al., 2003, Mironov et al., 2005). This debate on the correct 
model for transport has been going on for the past 50 years (reviewed in Elsner et al., 2003). Problems 
with these models are that the observed vesicles are small and unable to fit large cargo (e.g. procollagen), 
while tubules are not observed in many cell types and maturation of cisternae is a process too slow to 
explain rapid transport of cargo proteins (VSV-G). 
In the maturation model, the cisternae are dynamic and move or ‘mature’ with the cargo as new 
cisternae are formed at the cis side, while at the trans side cisternae are consumed for membrane 
transport (see Figure 3A). In this model, the modification enzymes are recycled back to the adjacent 
cisterna, causing it to ‘mature’. In yeast, direct maturation of cisternae has been observed supporting 
the maturation model (Matsuura-Tokita et al., 2006, Losev et al., 2006). However, the yeast cisternae 
are not stacked, and when COPI vesicle formation is defective, maturation is considerably slowed 
(Matsuura-Tokita et al., 2006). In the vesicle transport model, the cisternae form a stable compartment, 
and the cargo is transported through the GC in vesicles, from the cis cisternae to the medial and then to 
the trans side (Figure 3B). In support of this model some studies have identified anterograde cargo, such 
as proinsulin and VSV-G protein, enriched in vesicles (Orci et al., 1997). 
As neither of these models can explain all aspects of transport, a hybrid model has been proposed. 
According to this model, coated vesicles move in both directions, while the cisternae mature (Pelham 
and Rothman, 2000). The most recent model, the continuity-based model, incorporates the continuities 
observed between the cisternae in 3D tomography studies. In this model cisternae can either be viewed 
as stable, with cargo flowing through continuities (the modified ‘vesicle’ model), or they can undergo 
maturation with enzymes flowing backwards (the modified maturation model) (Marsh et al., 2004, 
Trucco et al., 2004). 
golgi resident proteins1.3.1 
All Golgi resident proteins are thought to be membrane proteins: either peripheral membrane proteins 
on the cytoplasmic leaflet (e.g. Golgi matrix proteins), or integral to the membrane (Altan-Bonnet et al., 
2004). The Golgi resident proteins use different methods to retain their localisation, including recycling 
(from the ER or PM), lipid modifications, and interactions or oligomerisation with other proteins 
(reviewed in van Vliet et al., 2003). Sequence features can also affect localisation, including GRIP 
domains and the length of the transmembrane domain, which is longer than in ER resident proteins and 
shorter than in PM proteins, reflecting the lipid composition of the GC  (Bretscher and Munro, 1993, 
Munro and Nichols, 1999). Proteins that are used as examples are listed in Table I.
The wide variety of Golgi resident modification enzymes or transferases reflects one of the main 
functions of the GC, which is to modify proteins and lipids. This group includes enzymes needed to form 
and modify both O- and N-glycans (Brockhausen et al., 2009, Stanley et al., 2009). Glycosyltransferases 
are highly specific and catalyse the transfer of only one specific glycan to a target position. Some of the 
enzymes may be shared between these pathways, while some belong to just one or the other. Unlike 
the ER enzyme oligosaccharyltransferase, these Golgi enzymes only transfer monosaccharides from 
15
nucleotide donors such as UDP-Gal, and thus several Golgi resident nucleotide-sugar transporters are 
also known (e.g. UDP-N-acetylglucosamine transporter) (Berninsone and Hirschberg, 2000, Guillen 
et al., 1998). Besides glycan modiﬁcations, other Golgi resident enzymes (e.g. sulfotransferases and 
phosphotransferases) can further modify the glycopeptide chain.
In addition to the modiﬁcation enzymes, Golgi resident proteins include proteins that are important 
for the regulation of lumenal pH and ion concentration (e.g. the Ca2+ and Cl- needed for normal protein 
trafﬁcking). These proteins include ion transporters (secretory-pathway Ca2+-transport ATPase 1, 
SPCA1) and proton pumps (Golgi pH regulator, GPHR) (Van Baelen et al., 2003, Maeda et al., 2008). 
Furthermore, several proteins required for signalling and regulation of membrane trafﬁc have been 
localised to the GC, including kinases Plk3 and Ysk1 (Preisinger et al., 2004, Bahassi el et al., 2002). 
Plk3 regulates apoptosis after stress responses and the GC fragmentation in mitosis (Bahassi el et al., 
2002, Ruan et al., 2004). The second Golgi kinase, Ysk1 through phosphorylation of 14-3-3, is involved 
in the orientation of the GC towards the leading edge in migrating cells together with ERK (through 
Figure 3. The Golgi transport models
Transport through the GC has been explained by two traditional models, the cisternal maturation model (A) and 
the vesicle transport model (B). COPII vesicles (striped vesicles) transport cargo from the ER to the ERGIC, from 
where COPI vesicles (shaded vesicles) are needed for further transport. The intra-Golgi transport is handled with 
COPI vesicles moving in as anterograde (vesicle transport model) or retrograde (maturation model) direction.
In the cisternal maturation model (A) cargo proteins transit the GC inside the cisternae, which move and ‘mature’ 
from the cis side to the medial and trans sides, pushed by formation of new cisternae on the cis side. Cisternae
maturation is caused in this model by the backwards transport of enzymes either in vesicles or in cisternal continuities 
(marked with white arrow in A). In the vesicle transport model (B), cisternae are a more stable compartment and 
cargo is transported through the stack, either in vesicles or through cisternal continuities (marked with white arrow in 
B), while enzymes maintain their distribution in the stack. In both models, once the cargo has reached the TGN, it is 
sorted and packed into clathrin coated vesicles (patterned vesicles) for transport to ﬁnal destinations.
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GRASP65) (Preisinger et al., 2004, Bisel et al., 2008). 
The second major class of resident Golgi proteins is the Golgi matrix proteins that are believed to 
have a role in the structure of the GC, and many of them also have a role in membrane trafficking events. 
These proteins are defined according to their behaviour in cells where ER-to-Golgi transport is blocked: 
they do not relocate to the ER like Golgi enzymes, instead they remain in the independent Golgi-like 
structures (reviewed in Short et al., 2005). These Golgi matrix proteins can be integral to the membrane, 
lipid anchored, or recruited to the membrane by adapter proteins (such as Ras-related proteins, Rabs) 
(Linstedt and Hauri, 1993, Barr et al., 1997, Matanis et al., 2002). 
A major part of this Golgi matrix is formed by a large protein family called Golgins that are 
characterised by their Golgi localisation and extensive coiled-coiled domains. The other feature shared 
by these Golgins is their interaction with small GTPases. These Golgins have distinct localisations within 
the Golgi stack. Golgins localising to the cis-Golgi side include Golgi matrix 130kDa (GM130), p115 
and Giantin, which participate in vesicle tethering events together with Rab1 (Figure 1B, Linstedt and 
Hauri, 1993, Waters et al., 1992, Nakamura et al., 1995). Giantin in COPI, and Rab1 in COPII vesicles are 
suggested to recruit p115 into these membranes (Sonnichsen et al., 1998, Moyer et al., 2001). GM130 in 
the GC could then tether these vesicles to the Golgi membrane for fusion (Nakamura et al., 1997, Moyer 
et al., 2001). Moreover, GM130 has been shown to regulate centrosome organisation during interphase 
(Kodani and Sutterlin, 2008). Another cis-Golgi localising protein is GMAP-210 (Infante et al., 1999). 
Earlier studies suggested GMAP-210 to be a Golgi microtubule-associated protein, while more recent 
studies have shown it to function as a membrane curvature sensor in vesicle tethering events (Drin et al., 
2008, and reviewed in Barr and Egerer, 2005).
A second tethering pair is formed by Golgin-84, which is localised throughout the Golgi stack, and 
CDP/cut alternatively spliced product (CASP) (Bascom et al., 1999, Gillingham et al., 2002). Golgin-84 
binds Rab1, and has a role in reassembly and maintenance of the Golgi structure, while CASP binds 
the Arf guanine nucleotide exchange factor (GEF) cytohesin and yeast soluble NEM-sensitive factor 
attachment protein receptor (SNARE) Gos1p (Gillingham et al., 2002, Satoh et al., 2003, Mansour et 
al., 2002). Together, Golgin-84 and CASP tether a subpopulation of COPI vesicles different from those 
bound by p115 (Malsam et al., 2005). 
Golgins localised to the the trans Golgi side include Golgin-245 and Bicaudals. Golgin-245 is required 
for tumor necrosis factor-α (TNF) secretion, while its shorter splice variant CrpF46 binds centrosomes 
(Figure 1, Fritzler et al., 1995, Lieu et al., 2008, Wei et al., 2008). Bicaudal-D1 and Bicaudal-D2 localise 
to the TGN by interacting with Rab6, as well as with dynein, thereby linking the microtubule network 
to the GC and tethering events (Matanis et al., 2002, Hoogenraad et al., 2001). 
A second important Golgi matrix protein family is the GRASP family. It is composed of two members: 
GRASP55 and GRASP65, both of which are required for formation and maintenance of the Golgi 
structure (Figure 1, Barr et al., 1997, Shorter et al., 1999, Feinstein and Linstedt, 2008, Puthenveedu 
et al., 2006). In addition, GRASP65 may have a role in spindle dynamics and as a mitotic check point 
(Preisinger et al., 2005, Sutterlin et al., 2005). Furthermore, GRASP65, together with GM130, has a role 
in the formation of lateral cisternal connections that mediate Golgi ribbon formation (Puthenveedu et 
al., 2006). 
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transport proteins1.3.2 
Throughout this thesis the term ‘transport proteins’ will refer to proteins with a function in any of the 
following processes: membrane traffic, membrane deformation and vesicle budding, recruitment of coat 
proteins, or recognition and tethering to target membranes. The majority of these proteins are located on 
the vesicles or tubules carrying proteins and lipids, at least during transport events. The coat complexes, 
together with adaptor proteins, form the oligomeric cage which deforms the membrane and recruits 
cargo. On clathrin coated vesicles, which function on both endocytic and exocytic pathways on the PM, 
these coats are composed of oligomers of three light and three heavy chains. Several adaptor proteins, 
including AP1 to AP4 participate in the cargo selection and recruitment, and others, such as dynamin, 
are required for pinching off the vesicle (reviewed in Benmerah and Lamaze, 2007). 
The COPII coats are composed of five major subunits: the small GTPase Sar1 (Secretion associated, 
ras related protein), Sec23 and Sec24, which form the ‘inner coat’, and the ‘outer coat’ subunits Sec13 
and Sec31 (Figure 4B and Table I). The Sec proteins were first characterised in yeast secretory mutants 
screens: Sec13, Sar1 and Sec23 were among the 23 mutants identified in the first screen (Novick et 
al., 1980). The Sec23/24-Sar1 complex participates in the cargo selection and ‘outer coat’ recruitment, 
while Sec13/31 forms the outer cage that drives membrane deformation (Aridor et al., 1998, Stagg et 
al., 2006). In addition, Sec23 functions as a GTPase activating protein (GAP) for Sar1, which results in 
vesicle coat depolymerisation after budding (Aridor et al., 1998, Yoshihisa et al., 1993). 
Membrane traffic is tightly regulated, and proteins of the COPII coat have been shown to be targets 
for post-translational modifications. Sec24 undergoes cytoplasmic O-GlcNAc modification during 
interphase and phosphorylation during mitosis. This phosphorylation blocks membrane transport, 
possibly by preventing association of the protein with the membrane (Dudognon et al., 2004). Besides 
its role in coat formation and membrane budding, the COPII coat has also been implicated in vesicle 
targeting and homeostasis. Several recent studies have shown that tethering, fusion and transport proteins, 
including transport protein particle I (TRAPPI) subunit Bet3, and Grh1p (yeast GRASP65 homologue), 
can bind directly to COPII coat proteins (Cai et al., 2007, Reilly et al., 2001). In addition, p150Glued, a 
component of the dynactin complex, has been shown to directly interact with Sec23A, and blockage of 
this interaction slows down ER export kinetics (Watson et al., 2005). 
Intact membrane traffic is highly important, as illustrated by a single amino acid change, F382L, 
in the COPII coat protein Sec23A that causes a rare genetic disorder called cranio-leticulo-sutural-
dysplasia (CLSD). CLSD is characterised by malformation of the craniofacial structure and abnormal 
collagen secretion, in addition to the development of cataracts (Boyadjiev et al., 2006). The defect 
caused by this mutation was shown to be due to the reduced affinity of Sec23A towards the outer coat 
complex Sec13/31, and subsequent reduced vesicle formation (Fromme et al., 2007). 
The functions of the COPI coat are not as well characterised as those of the COPII and clathrin 
coats, but the mode of action and regulation is thought to be similar. There are nine COPI coat protein 
subunits known: α-, β-, β’-, ε-, γ1-, δ- and ζ1-COP, with alternative isoforms γ2- and ζ2-COP. Together 
they form a variable heptameric protein complex (coatomer) containing a single copy of each subunit 
(Figure 4A, Lowe and Kreis, 1996, Wegmann et al., 2004). The different coatomer subunits have been 
shown to preferentially select cargo with different cytoplasmic signals. The KKXX motif is recognised 
by α-, β’-, or γ-COP, while the di-phenylalanine motif is recognised by γ-COP and WXXW/Y/F by 
δ-COP (reviewed in Bethune et al., 2006). In β-COP depleted HeLa cells, many ERGIC, Golgi and TGN 
markers co-localise in fragmented compartments. In addition, secretion of soluble cargo is inhibited 
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in these cells, suggesting that COPI vesicles are needed for both ERGIC-Golgi transport, and Golgi 
biogenesis (Styers et al., 2008). 
In addition to the coatomer, proteins needed for COPI vesicle formation are: Arf1, p23, p24, and 
ArfGAP (see Figure 4A). Arf1 is a small GTPase required for coatomer recruitment and binding, GTP 
hydrolysis and vesicle uncoating, while the p23/24 family proteins are needed for efﬁcient recruitment of 
Arf1 and the coatomer to the membrane (Palmer et al., 1993, Tanigawa et al., 1993, Gommel et al., 2001). 
ArfGAP might not be essential for vesicle assembly, but it is needed to activate Arf1 GTPase activity 
for vesicle uncoating, and may have a role in cargo selection (Lanoix et al., 2001, Reinhard et al., 2003). 
Figure 4. Schematic view of COPI and COPII vesicle coat formation
A) COPI vesicle coats are composed of coatomer (seven subunits -), Arf1, ArfGAP and p23/p24-family 
proteins. Coat formation begins from recruitment of Arf1 by p23/p24 proteins, and activation of Arf by nucleotide 
exchange (1). Both GTP-bound Arf1 and p23 will then participate in coatomer and ArfGAP recruitment (2). The 
coatomer, ArfGAP and KDEL receptor can then take part in cargo selection. After the membrane deformation is 
complete, the vesicle buds off. ArfGAP in free vesicles stimulates Arf1 GTPase activity, leading to GTP hydrolysis 
(3) and coat disassembly (4), leaving an uncoated vesicle to travel to the target membrane. The coat subunits are 
released to the cytoplasm and are then free to undergo further rounds of coat formation.
B) COPII vesicle coats include Sar1 GTPase, inner coat subunits Sec23 and Sec24, and outer coat subunits 
Sec13 and Sec31. COPII coat formation begins by recruitment of Sar1 to the membrane by Sec12, a Sar1 GEF (1). 
Sar1 then recruits the Sec23/Sec24 complex and cargo selection can begin (2). Sec24 binds cargo, while Sec23 and 
Sar1 recruit the outer coat subunits Sec13/Sec31 (3). The Sec13/Sec31 coat polymerisation drives the membrane 
deformation. Once the vesicle is formed, the GAP activity of Sec23 will stimulate the GTPase activity of Sar1, 
leading to coat disassembly and vesicle uncoating (4).
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Furthermore, the KDEL-receptor, a seven transmembrane helix protein, recognises KDEL-sequences of 
ER resident proteins in a pH dependent manner. The cargo-bound KDEL-receptor is incorporated into 
retrograde COPI vesicles for recycling back to the ER (Orci et al., 1997, Wilson et al., 1993). 
Deformation of the membrane is a necessary step for carrier formation: in COPI vesicles the coatomer 
and Arf1 perform this task (Ostermann et al., 1993, Spang et al., 1998). Furthermore, Arf1 is able to 
induce membrane deformation as a dimer, and this dimerisation is required for COPI vesicle formation 
(Beck et al., 2008). In addition, ArfGAP1 might function as a membrane curvature sensor, since its 
GAP activity can be stimulated by increased membrane curvature (Bigay et al., 2005). Moreover, lipids, 
including diacylglycerol and phosphatidic acid, are required for COPI vesicle budding and retrograde 
transport, and for fission and recruitment of ArfGAP and BARS (Fernandez-Ulibarri et al., 2007, Yang 
et al., 2008). 
After coat assembly and membrane deformation, the vesicle buds off from the membrane. CtBP1/
BARS is a membrane fission protein required for retrograde transport of the KDEL receptor in COPI 
vesicles, and for anterograde transport from the GC to the basolateral PM (Bonazzi et al., 2005, Yang 
et al., 2005). The vesicles formed by fission can then be moved to the target membranes along the 
microtubule tracks by cytoskeletal motor proteins like kinesins and dyneins (Xu et al., 2002, Watson et 
al., 2005, Gupta et al., 2008). 
Fusion to the target membrane is the last stage of membrane traffic. The current view on how vesicle 
fusion occurs involves three major steps: 1) recognition and tethering to the target membrane; 2) docking; 
and 3) fusion with the target membrane. There are several proteins and protein families involved in 
these steps, including SNAREs, soluble NSF attachment proteins (SNAPs), Golgins and Rab GTPases. 
Of these, SNAREs function in the recognition of and fusion with the target membrane (reviewed in 
Wickner and Schekman, 2008). Both the donor and acceptor membranes have a specific set of SNAREs, 
which upon vesicle docking form a four-helix coiled-coil structure that precedes membrane fusion. Of 
the Golgi specific SNAREs, ERS24, membrin and Bet1 are found mostly on the cis side, while GS15 
is found mostly on the trans side. Syntaxin5 and GOS28 are nearly equally distributed throughout the 
stack, while for Ykt6 the precise Golgi localisation has not been reported (Volchuk et al., 2004).
Rab small GTPases participate in multiple steps during vesicle budding, transport, and tethering, 
and they are essential for membrane fusion (reviewed in Wickner and Schekman, 2008). These proteins 
have highly restricted subcellular localisations and cooperate with specific effectors like Golgins, and 
it has been speculated that they regulate targeting (Moyer et al., 2001, Satoh et al., 2003, Valsdottir et 
al., 2001). GTP-bound Rabs can bind to tethering complexes on the target membrane and subsequently 
recruit other proteins and lipids needed for assembly of the fusion microdomain, including the SNARE 
complex. Over 60 different Rab proteins have been identified in mammalian cells to date, a few of which 
are Golgi specific, including Rab1, Rab2, Rab6 and Rab33b. Rab effectors are numerous, and they have 
roles in tethering (GM130, TRAPP), regulation of GEF and membrane fusion (Rabex-5 and rabaptin-5), 
and transport (Bicaudal-D) (Matanis et al., 2002, Moyer et al., 2001, Cai et al., 2007, Valsdottir et al., 
2001, Horiuchi et al., 1997). 
In addition to Rabs, another family of small G proteins has been identified in the Golgi membranes: 
the Arf and Arf-related GTPase (Arl) family. Many of these proteins have a role in the regulation of 
membrane traffic and the actin cytoskeleton (reviewed in Gillingham and Munro, 2007, Myers and 
Casanova, 2008). 
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Proteomics1.4 
Proteomics is the study of the proteome or ‘all proteins expressed in a given cell or tissue at specific 
conditions’ (Wasinger et al., 1995). The most popular proteomic method consists of mass spectrometry 
(MS) analysis of the proteome to obtain a list of protein identifications. Suitable MS methodology for 
identification of proteins has been available since early 1990, but completion of the human genome 
sequencing project made this technique fashionable (chromosome 11 in 2006) (Chen, 2008, Taylor et al., 
2006). Since then, proteomics and ‘transcriptomics’ have been a central area of biological research. The 
potential of proteomics is great, and in combination with other methods it allows for example dissection 
of cellular pathways or domains, and quantitative comparison of samples (such as proteins modified in 
cancer) (Dormeyer et al., 2008).  
MS identifies charged molecules by obtaining precise mass-to-charge ratios (m/z) and deconvoluted 
masses that can then be used to identify the ionised small molecules. This technique is very powerful, as 
it allows identification of numerous proteins at once, and through the use of semi-automated platforms 
can analyse large sample sets. In addition, recent technological advances both in methods and sensitivity 
have facilitated the analysis of protein modifications such as phosphorylation and glycosylation, although 
these analyses are still not straightforward (Chen, 2008). The two most common methods used to ionise 
protein and peptide samples are matrix-assisted laser desorption/ionisation (MALDI) and electro-spray 
ionisation (ESI) (Hillenkamp and Karas, 1990, Tanaka et al., 1988, Fenn et al., 1989). Both are soft 
ionisation methods suitable for biomolecules. These can be coupled to different MS analysis methods, of 
which ion trap, quadrupol, time-of-flight (TOF), Orbitrap and Fourier-transform ion-cyclotron resonance 
have been used in proteomic LC-MS/MS studies (Bachi and Bonaldi, 2008, Han et al., 2008). However, 
many proteins are too large to be identified as such using MS, as the mass/resolution ratio limits the 
identification of larger molecules even with MALDI-TOF (Chen, 2008). Therefore, the usual approach 
relies on protein digestion by trypsin or other proteases prior to MS analysis. 
By coupling two analysers (MS/MS) it is possible to first obtain the m/z value of the peptide, and 
then to sequence the peptide by gas-phase fragmentation. However, the proteomic samples are complex 
mixtures with varying amounts of each protein, and low abundance proteins may not be detected. In 
order to simplify this complex task, proteins or peptides can be separated by one or more methods prior 
to MS analysis (Chen and Pramanik, 2008). Traditional methods rely on the separation of proteins by 
gel electrophoresis based on size and/or pI (1D or 2D). ‘Shotgun’ proteomics, or multidimensional 
protein identification technology (MudPIT), was introduced in 2001 to eliminate gel electrophoresis 
as a separation method, and to minimise the loss of small, basic, and hydrophobic proteins (Wolters 
et al., 2001). In shotgun proteomics, proteins are digested and peptides are fractionated in one or two 
‘dimensions’ in different liquid chromatography (LC) conditions such as µ-scale cation-exchange or 
reverse-phase, prior to analysis either off-line or on-line with the LC. The LC separation of peptides, 
followed by direct analysis, also helps to prevent loss of TM-proteins, which is a frequent issue in gel-
based separation techniques (Tan et al., 2008, Lu et al., 2008a).
Since proteomic samples are usually complex mixtures that contain hundreds or thousands of different 
proteins, several types of software have been developed to assist in their identification. However, this 
raises other issues, as the different programmes use different methods to identify the proteome. There 
have been initiatives to standardise data for distribution and collection, and to aid comparison of the 
data from different laboratories, e.g. the Human Proteome Organisation (HUPO) Proteomics Standards 
Initiative (http://www.psidev.info/). Nevertheless, all these programmes are only as reliable as the 
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accuracy of the m/z data. Thus, in spite of the methodological advances, sample preparation is still a key 
issue, together with the purity of the sample and the extent of contamination. Furthermore, homologous 
proteins with highly similar sequences might not be distinguished reliably. Other factors to bear in mind 
are possible post-translational modifications, which can affect the mass and charge of the peptide and 
thus identification. Then again, the characteristic change in the peptide mass caused by the modification 
allows the detection of these modifications, e.g. glycomics, which studies glycans on proteins and lipids 
(Chen, 2008). 
The cell make-up has been addressed in several organelle proteomic approaches that attempt to 
obtain the proteome of the ER, plasma membrane, mitochondria, and the GC, and have identified a 
number of novel proteins in these organelles (most recently by Stevens et al., 2008, Dormeyer et al., 
2008, Zhang et al., 2008, Gilchrist et al., 2006). Each of these studies was performed using the shotgun 
proteomic approach, which makes the solubilisation of the sample less of an issue when compared to 
gel based approaches. Indeed, in each of these studies a significant fraction of membrane proteins could 
be identified (from 21% to 56%) (Stevens et al., 2008, Zhang et al., 2008). In addition to giving an 
insight into the total proteome, proteomic studies are used to compare samples of different cell types or 
conditions: for example, PM in healthy and cancerous cell lines, or mitochondria in diverse apoptotic 
conditions (Dormeyer et al., 2008, Miller et al., 2008). These studies can also provide spatial information 
on the relative distribution of the proteins in different compartments (Gilchrist et al., 2006). 
the golgi proteome1.4.1 
The Golgi proteome has been estimated to contain about 1000 proteins (Taylor et al., 2000). Less than 
2/3 of these proteins (641 in humans) have been identified to date, based on their subcellular localisation 
according to the UniProt protein database. The Golgi proteome reflects the functions and structure of 
this membrane-bound organelle. Indeed, 35% of the Golgi proteins annotated on UniProt are different 
transferases that modify proteins and lipids. The second major group of GC proteins is involved in 
membrane traffic (23%). The major types of Golgi proteins are described in Section 1.3 and Table I. 
That so many GC proteins have been identified is partially thanks to the several Golgi proteomic 
studies that have been performed. The Golgi proteome has been analysed from isolated Golgi membranes, 
from both rat liver and mammary gland, using both gel electrophoresis-based techniques (Taylor et al., 
2000, Breuza et al., 2004, Bell et al., 2001, Wu et al., 2000) and shotgun proteomics (Gilchrist et al., 
2006, Wu et al., 2004). The first study, by Taylor et al. (2000), identified 73 proteins using fractionation 
of the Golgi membranes and 2D gels, while Bell et al. (2001) used 1D gels and were able to identify 81 
proteins. Another study focused on differences in the GC proteome between the two functional states 
of mammary epithelial cells and identified 30 proteins that were upregulated in the lactating mammary 
gland (Wu et al., 2000). The latest gel-based study focussed on the ERGIC proteome and identified 24 
proteins (Breuza et al., 2004). 
Technical advances in proteomic methods as well as progress in the genome sequencing projects 
resulted in a dramatic increase in the number of identified proteins, from less than a hundred in gel-
based studies to several hundred using shotgun approaches. The first shotgun study of the GC reported 
identification of a total of 421 proteins, of which 110 were known Golgi specific proteins, and 41 were 
previously unknown (Wu et al., 2004). Furthermore, 64% of the Golgi specific proteins identified in 
this study were predicted to be integral membrane proteins. The most recent of these proteomic studies 
examined the whole secretory pathway and identified 1430 proteins, of which 345 were of unknown 
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function (Gilchrist et al., 2006). In this study, the reported distribution between organelles showed that 
the majority of the proteins were unique to the ER (832), and 193 unique proteins were found in the 
Golgi/COPI fraction.
Sequence analysis and databases1.5 
Advances in proteomics and genomics have also driven the development of bioinformatics, as the amount 
of data generated in a single experiment has increased greatly. Sequence analysis is a powerful method to 
rapidly analyse data, and automated analysis softwares can facilitate analysis of large data sets. Usually, 
analysis is based on sequence comparisons to identify similar domains such as transmembrane (TM) 
domains, or binding motifs and structures (Emanuelsson et al., 2007, Puntervoll et al., 2003). Thus, 
predicted patterns are based on known protein and gene sequence data. There are numerous different 
prediction programmes on-line for identification and characterisation of proteins (e.g. for the analysis 
of MS, or MS/MS data), for pattern searches (to detect specific motifs, domains or post-translational 
modification sites), as well as software for structure prediction (Puntervoll et al., 2003, Perkins et al., 
1999, Letunic et al., 2008). 
Besides prediction programmes, there is a vast amount of biological information available in on-
line databases. The human genome was completed in 2006 (Taylor et al., 2006), and since then, the 
number of sequenced species has rapidly increased as methods have improved. Currently 358 eukaryotic 
genomes are available as draft genomes or are being assembled (NCBI, 3.10.2008). The largest sequence 
databases are the Uniprot (protein database), the NCBI (network of databases including nucleotide, 
genome and protein), and the Ensembl databases (genome database by EMBL-EBI and the Sanger 
Institute) (UniProt Consortium, 2008, Birney et al., 2004). These databases include data from genome-
wide sequencing approaches, from single submissions and from automated sequence analysis. 
However, none of these databases include information about large data sets, such as those from yeast-
2-hybrid or proteomic approaches. Many of these large datasets are published as supplementary data 
that is not easily examined, if published in full at all. Some journals recommend or require deposition 
of full data sets for journal archives, but this data is not easily accessible and it is spread over multiple 
websites. The ‘Mouse Genome Informatics’ (MGI) database collects data on mouse phenotypes, gene 
targeted mice and gene expression, and the ‘Zebrafish Information Network’ (ZIN) collect analogous 
data on zebrafish (Eppig et al., 2007, Sprague et al., 2008). However, neither of these databases includes 
proteomic or interaction data sets. The database for yeast, ‘Saccharomyces Genome database’ (SGD) 
includes such data sets, but until now there has not been such a functional database available for 
vertebrates, where authors could submit large, searchable data sets of multiple techniques. 
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Skeleton and cartilage1.6 
Cartilage and chondrocytes are not traditional cell types used to study the secretory pathway, although 
they are highly active with regard to the secretion of extracellular matrix (ECM), and to the modification 
of matrix proteins. Furthermore, cartilage and bone are generally considered restricted to vertebrates, 
although invertebrates, like the purple sea urchin Strongylocentrotus purpuratus, may have mineralised 
tissues and may secrete collagen (Col) or collagen-like proteins (Livingston et al., 2006). 
The vertebrate skeleton has evolved to support the body and to facilitate motility. The skeleton consists 
of bones as well as cartilage, which in juveniles is still present in growth plates, while in adults it 
can be found in joints, airways and ears. In addition to cartilage and bone, the skeleton includes the 
bone marrow, which fills the central regions of the bone after endochondral ossification has formed 
the mineralised bone collar. The bone marrow harbours the progenitors of blood cells, and also some 
stromal or mesenchymal stem cells that can function as progenitors for cartilage and bone (Pittenger et 
al., 1999).
However, during development cartilage forms the anlagen of the future skeleton. As development 
proceeds, chondrocytes and the cartilage anlagen are replaced by osteoblasts and bone (reviewed in 
Kronenberg, 2003). Bones of the trunk are formed in this way in the process called ‘endochondral 
ossification’. In the craniofacial area, bone formation and ossification can occur without a cartilage 
template, and thus craniofacial skeleton development differs markedly from that of other skeletal 
elements (reviewed in Helms and Schneider, 2003). 
The types of vertebrate cartilage present in different parts of the body arise from different embryonic 
cell types. The cartilage of the body is formed by the mesoderm, while cranial cartilage and bone are 
derived from the cranial neural crest cells (Helms and Schneider, 2003, Goldring et al., 2006). The 
vertebral column and ribs develop from somites, and limb cartilage from the lateral plate mesoderm 
(Olsen et al., 2000). Development of all these cartilage types is tightly controlled. Furthermore, the 
chondroblast differentiation and proliferation rates determine the size of the future bones: cell division 
that occurs too rapidly can lead to gigantism, while if the process is too slow, it may lead to premature 
hypertrophy, terminal differentiation of chondroblast, and shorter bones (van der Eerden et al., 2003).
Cartilage-forming chondroblasts and chondrocytes, and bone-forming osteoblasts and osteocytes, 
are all of mesenchymal origin, while osteoclasts, which regulate bone formation by absorbing any 
excess bone matrix, originate from the macrophage lineage (reviewed in Olsen et al., 2000, Datta et 
al., 2008). The chondrocyte population can be further divided into five to seven different categories 
depending on the differentiation status (see Figure 5, reviewed in Goldring et al., 2006). Chondrogenic 
mesenchymal cells condense and commit to pre-chondroblasts, which then enter the early chondroblast 
stage and begin the secretion of cartilage-specific ECM. The proliferating, columnar chondroblasts are 
active in ECM secretion and these cells provide the main force for elongation of the cartilage anlagen. 
At prehypertrophy, chondroblasts exit the cell cycle and become chondrocytes. This transition is 
accompanied by changes in the ECM expression profile. By hypertrophy, the cell morphology changes, 
giving enlarged cells filled with cytoplasm. These chondrocytes will terminally differentiate, and will 
begin the mineralisation of the matrix. These cells are termed chondroblasts in the proliferating stages, 
and chondrocytes when they are fully committed and no longer divide. The early and late stages can be 
distinguished by differential expression of ECM proteins, while in the stages inbetween the differences 
in ECM are quantitative rather that qualitative.
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Development and patterning of the limb 1.6.1
As the skeleton is a hallmark of vertebrates, it is not surprising that the development and maintenance of 
this tissue is tightly regulated by growth factors and transcription factors. Limbs form in speciﬁc, pre-
patterned areas called ‘limb ﬁelds’. The position of these limb ﬁelds is determined, at least partially, by 
the expression of homeobox (Hox) genes that help to specify position along the anterior-posterior axis 
(reviewed in Hueber and Lohmann, 2008). However, ectopic expression of ﬁbroblast growth factor 8 
(FGF8) has demonstrated that the whole embryonic ﬂank contains potency to form a limb (Vogel et al., 
1996). Hindlimbs and forelimbs have different identities, and paired-like homeodomain transcription 
factor 1 (Pitx1) contributes to hindlimb determination, while T-box 4 (Tbx4, hindlimb) and Tbx5 
Figure 5. Schematic 
view of the growth 
plate of a long bone, 
the signalling zones 
of limb development 
and the network 
regulatory signals 
directing chondrocyte 
differentiation 
A) A schematic view 
of the embryonic long bone 
growth plate with different 
cartilage cell stages marked. 
The resting chondroblasts 
are at the epiphyseal 
end of the plate and 
hypertrophic chondrocytes 
and osteoblasts at the 
distal end. The differential 
expression of ECM genes 
at various times is indicated 
along with growth factors 
and transcription factors 
promoting (green arrows) 
or inhibiting (red bars) each 
stage. 
B) A schematic view 
of the different signalling 
zones during limb 
formation. The AER (red 
ridges) directs the proximal 
(Pr) – distal (D) patterning 
and mesenchyme proliferation. The ZPA (violet areas) directs the anterior (A) – posterior (P) patterning of more 
distal elements, and Wnt7a and En-1 of the non-ridge ectoderm direct the dorsal (Dr) – ventral (V) patterning. The 
three limb segments, the stylopod, zeugopod and autopod, are indicated on a schematic image of an upper limb.
C) Schematic view of the network of interactions that direct chondrocyte proliferation and differentiation. 
Signals are placed so as to reﬂect their roles in either differentiation or proliferation; signals affecting both are 
placed on the separating dotted line. Factors promoting each stage are marked with green, while factors inhibiting 
are marked with red. Green arrows mark upregulation or activation by a signalling molecule, while red bars signify 
downregulation or inhibition. Downstream genes and upstream regulators that have not been shown to be directly 
involved at that stage are marked in black. The same signals are shown multiple times, as they may have different 
effects at different stages.
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(forelimb) have roles in their respective limb initiation events, but not in determination (DeLaurier et 
al., 2006, Naiche and Papaioannou, 2007, Minguillon et al., 2005). The subsequent limb development is 
regulated by signals from three different regions of the limb bud: the zone of polarising activity (ZPA), 
the apical ectodermal ridge (AER), and the non-ridge ectoderm (see Figure 5B). These signalling centres 
direct the development of the limb proximal-distal (AER), dorsal-ventral (non-ridge) and anterior-
posterior (ZPA) axes in interconnected ways (reviewed in Mariani and Martin, 2003). 
Limb development begins as a limb bud, a thickening of lateral plate mesoderm mesenchyme 
surrounded by the surface ectoderm. To initiate the limb bud, a signal from the mesoderm (FGF10) is 
required for limb formation to proceed (Sekine et al., 1999). FGF10 signals to the surrounding ectoderm 
and initiates a cascade that leads to Fgf8 expression and AER induction (Sekine et al., 1999, Yonei-
Tamura et al., 1999). Wingless-related MMTV integration site 10a (Wnt10a) and Wnt3 are also involved 
in the Fgf8 upregulation, and in AER formation and maintenance (Barrow et al., 2003, Narita et al., 
2005). Furthermore, bone morphogenetic proteins (BMPs) are required, as inhibition of BMP signalling 
in ectoderm will disrupt AER formation (Ahn et al., 2001).
The AER runs along the anterior-posterior axis of the limb bud, and separates dorsal and ventral 
sides. It promotes mesenchymal cell proliferation and it directs the proximal-distal patterning of the 
limb (reviewed in Niswander, 2003). The AER is thought to time the generation of the progenitor cells 
and thus influence the number of cells available for condensation (Lu et al., 2008b). AER functions 
are mediated through four different FGFs: FGF4, -8, -9 and -17. FGF8 is required for normal limb 
development, for the maintenance of limb bud outgrowth, and for normal limb patterning (Moon and 
Capecchi, 2000, Lewandoski et al., 2000, Boulet et al., 2004). Moreover, FGF8 alone is enough to 
sustain normal limb formation, and FGF9/FGF17 functions, while FGF4 might be able to compensate 
for some of the functions of FGF8 in gene targeted mice (Boulet et al., 2004, Mariani et al., 2008). 
The anterior-posterior patterning is regulated by the ZPA. Sonic hedgehog (Shh) is expressed in the 
ZPA and is the morphogen directing the anterior-posterior patterning, and is required for the patterning 
of digits two to five (reviewed in Hill, 2007). However, the proximal limb patterning (humerus and 
femur) appears to be independent of Shh in ZPA (Chiang et al., 2001, Kraus et al., 2001). In addition, 
the patterning role of Shh is dependent on Gli3 activation and the subsequent activator:repressor ratio 
of Gli3 (te Welscher et al., 2002). An FGF signal from the AER is needed to induce Shh in the ZPA, 
which in turn maintains FGF4 expression in the AER by suppressing BMP signalling through Gremlin 
(Khokha et al., 2003). 
The dorsal-ventral polarity of the limbs is directed by the non-ridge ectoderm. Wnt7a is expressed in 
the dorsal ectoderm, and regulates the expression of LIM homeobox transcription factor 1 (Lmx-1) in the 
dorsal mesenchyme (Cygan et al., 1997). Engrailed (En-1), induced by BMPs in the ventral ectoderm, 
helps to restrict Wnt7a expression to the dorsal region (Ahn et al., 2001, Loomis et al., 1996). In addition, 
dorsal-ventral signalling is connected to the maintenance of the ZPA, as loss of Wnt7a expression in the 
dorsal ectoderm will reduce or abolish Shh expression in the ZPA (Parr and McMahon, 1995). 
Mesenchymal cells of the limb bud obtain the proximal-distal specification either from the AER in 
the progress zone model or from signals in the early limb bud (reviewed in Tickle, 2003). Either way, as 
these cells proliferate and exit the AER zone, they form prechondrogenic condensations if a sufficient 
number of cells is available, and they will then give rise to skeletal elements through endochondral 
ossification (reviewed in Mariani and Martin, 2003). Development of the three segments (stylopod, 
zeugopod and autopod; Figure 5B) is differentially controlled from the three signalling regions. The 
digit identity is additionally regulated by the interdigital mesenchyme (Dahn and Fallon, 2000).
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In species with free digits, after the cartilage anlagen are formed, the interdigital mesenchyme is 
removed by apoptosis (reviewed in Zuzarte-Luis and Hurle, 2005). The transforming growth factor 
beta (TGFβ) superfamily might play a role in determining the digital/interdigital fate, while BMPs 
have a role in promoting apoptosis in the interdigital zone (Ganan et al., 1996, Montero et al., 2008, 
Bandyopadhyay et al., 2006). TGFβs are expressed in the presumptive digit regions, and can induce 
formation of extra digits from the interdigital mesenchyme (Ganan et al., 1996). 
FGFs have been implicated in blockage of BMP activity and prevention of interdigital apoptosis 
(Macias et al., 1996). Consistent with this protective role for interdigital mesenchyme, FGF8 has been 
linked to maintaining the interdigital webs in bat (Weatherbee et al., 2006). The BMP signalling in the 
interdigital zone downregulates the FGF expression and thus allows the interdigital areas to be removed 
by programmed cell death (Pajni-Underwood et al., 2007). In mouse limbs, Fgf4 expression in the 
AER ceases by E11.5, while Fgf8 expression is first downregulated over the interdigital regions, and no 
expression is detected after E12.5 (Lewandoski et al., 2000, Salas-Vidal et al., 2001). 
Endochondral ossification1.6.2 
Endochondral ossification is the process by which most of the bones of the vertebrate skeleton are formed 
(with the exception of many craniofacial bones). It begins with the condensation of the mesenchyme 
and the formation of cartilage anlagen, which is replaced by bone and marrow as development proceeds 
(reviewed in Mariani and Martin, 2003). Long bones are considered the model organ for endochondral 
ossification. As the chondroblasts in cartilage anlagen divide, the cells in central areas (e.g. diaphysis in 
long bones) start to differentiate into hypertrophic chondrocytes and will eventually form the structure 
called the ‘growth plate’ (see Figure 5A). The growth plate is located between the epiphyseal and the 
metaphyseal bone at the distal end of long bones. The chondrocyte proliferation in the growth plate 
provides the driving force for bone elongation (reviewed in Horton, 2003). 
The growth plate consists of chondroblasts and chondrocytes at different developmental stages 
as well as osteoblasts. The growth plate is highly ordered: resting chondroblasts are located at the 
epiphyseal end, while hypertrophic chondrocytes and ossification of the matrix is observed at the distal 
end of the plate (reviewed in Horton, 2003). This highly organised structure is achieved by tight control 
of cell proliferation and differentiation. Chondroblasts undergo several stages of differentiation before 
entry into hypertrophy. The whole differentiation cascade and transition into hypertrophy is crucial 
for endochondral bone formation. As a consequence, several genetic factors, hormones, and growth 
factors, together with nutrition and environment, are known to affect bone growth and chondroblast 
proliferation.
The four major growth factor families involved in chondrogenesis are hedgehog (Hh), FGF, TGFβ-
related proteins (TGFβs, BMPs and activins), and Wnt. The FGF family has been shown to be important 
for cell survival, and many of the family members affect chondrocytes and bone growth. FGF1, -2, -17 and 
-19 have been found in human fetal cartilage at the protein level, and FGF-receptors 1-3 are expressed in 
mesenchyme and in chondrocytes (Krejci et al., 2007, Delezoide et al., 1998). The Wnt growth factors act 
through three distinct pathways, the canonical or β-catenin pathway, the non-canonical planar-cell polarity 
pathway and the calcium pathway (reviewed in Macsai et al., 2008). The canonical pathway leads to the 
activation of T-cell factor/Lymphoid enhancing factor (Tcf/Lef) transcription factor and transcription of 
target genes, while the non-canonical calcium pathway leads to an increase in the intracellular Ca2+ and to 
NF-AT activation and expression of e.g. retinoblastoma-like 2 protein (p130) (Yang et al., 2003). 
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The endochondral ossification begins with condensation of the mesenchymal cells (Figure 5C). 
These cells differentiate to form the chondroblasts, which start proliferation and secretion of the 
ECM (Lefebvre and Smits, 2005). Important transcription factors in the chondrogenic mesenchyme 
are Pax1 and Pax9, which together contribute to the maintenance of the chondrogenic fate of the 
mesenchymal progenitor cells (Peters et al., 1999). The p38 kinase pathway, an alternative pathway for 
the Smad signalling downstream of TGFβs, may also act as a positive regulator of the differentiation 
of mesenchymal progenitors to chondroblasts, and of the expression of collagen type II (Col II) and 
aggrecan (Agc) (Watanabe et al., 2001, Oh et al., 2000). However, the p38 pathway can additionally be 
regulated by other growth factors, including Wnt5a (Jin et al., 2006). 
Chondroblast proliferation requires SRY (sex determining region Y)-box transcription factors (Sox5, 
Sox6, and Sox9), which cooperatively activate Col II and Agc expression (Akiyama et al., 2002, Smits 
et al., 2001). TGFβ/BMP, Rac1/N-cadherin and Wnts may regulate expression and activation of these 
Sox proteins (Woods et al., 2007, Dong et al., 2006, Yoon et al., 2005). Furthermore, BMP signalling is 
required for promoting the expression of cartilage-specific ECM components, e.g. Col II, Agc and link 
protein (Yoon et al., 2005).
Gli3, the Indian hedgehog (Ihh) effector in cartilage, has an inhibitory role in early chondroblast 
differentiation into columnar chondroblasts, which is independent of parathyroid hormone-related 
protein (PTHrP) (Koziel et al., 2005). Moreover, canonical Wnt signalling inhibits chondrogenesis, 
and expression of active β-catenin in early chondroblast blocks chondrocyte differentiation and matrix 
mineralisation (Tamamura et al., 2005, Akiyama et al., 2004). Nevertheless, the non-canonical Wnt 
pathway promotes chondroblast proliferation and differentiation, and gene targeting of non-canonical 
Wnt5a in mice leads to a severe skeletal phenotype with shorter limbs and missing digits (Yang et al., 
2003, Topol et al., 2003). 
The columnar, proliferative chondroblasts are highly active with respect to the secretion of ECM. 
However, changes in the gene expression profile during chondroblast differentiation are quantitative, 
rather than qualitative, and the majority of these cartilage ECM genes are expressed until the cells enter 
hypertrophy (Vornehm et al., 1996). Ihh is the main Hh controlling chondrocyte differentiation and 
hypertrophy, and it coordinates the ossification process (reviewed in Ehlen et al., 2006). Ihh signalling 
from the prehypertrophic chondrocytes up-regulates the expression of PTHrP in perichondrium. 
PTHrP in turn promotes columnar chondroblast proliferation, and suppresses chondroblast entry into 
hypertrophy thus establishing the distance between PTHrP and Ihh expressing cells. However, Ihh can 
also regulate chondroblast proliferation and columnar cell mass independently of PTHrP (Kobayashi et 
al., 2005). 
When chondroblasts enter prehypertrophy and form chondrocytes, they exit the cell cycle. By the 
time the cells enter terminal differentiation, they have increased their volume up to twenty fold, and the 
surrounding ECM has a high degree of mineralisation. These cells will eventually undergo apoptosis 
and make space for the arriving osteoblasts and bone marrow (reviewed in Kronenberg, 2003). In the 
absence of PTHrP, Ihh can drive the chondroblast differentiation into prehypertrophic chondrocytes, as 
in postnatal and adult cartilages, possibly through canonical Wnt or BMP signalling (Mak et al., 2008). 
This Ihh/PTHrP feedback loop ensures the correct balance and speed for cell proliferation and entrance 
into prehypertrophy. Furthermore, FGF2 can downregulate Ihh expression in tissue culture and regulate 
the onset of hypertrophic differentiation (Minina et al., 2002).
In addition to Ihh, BMPs and Wnts have a role in controlling hypertrophy. BMP regulates the transition 
from proliferating, columnar chondroblasts to hypertrophic chondrocytes and induces collagen X (Col X) 
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expression and alkaline phosphatase activity (reviewed in Adams et al., 2007). Expression of active 
β-catenin (Wnt pathway) in mature chondrocytes also stimulates hypertrophy and mineralisation, and 
gene targeting or inhibition of β-catenin at this stage causes a severe delay in chondrocyte hypertrophy 
(Tamamura et al., 2005, Akiyama et al., 2004, Chen et al., 2008). 
Transcription factors that induce chondrocyte hypertrophy and Col X expression include Runx2 (runt 
related transcription factor 2), and myocyte enhancer factor 2C (MEF2C) (Enomoto et al., 2000, Arnold 
et al., 2007). Runx2 can be regulated at the expression level by BMP2 and Wnt/β-catenin (upregulation), 
and by PTHrP (downregulation), while FGF2 (via the ERK1/2 pathway) causes phosphorylation and 
activation of Runx2 at the protein level (Dong et al., 2006, Franceschi and Xiao, 2003, Li et al., 2004). 
In addition, Sox9 regulates Runx2 expression and inhibits chondrocyte hypertrophy (Zhou et al., 2006). 
Furthermore, Runx2 provides epigenetic control by maintaining its association with chromosomes 
in cells undergoing mitosis, and thus influences the cell lineage fate (Young et al., 2007). MEF2C is 
required for the activation of Col X and vascular endothelial growth factor (VEGF) expression, and it 
may act upstream of Runx2 (Arnold et al., 2007).
In the very last phase of endochondral ossification, the calcified growth plate cartilage is invaded 
by blood vessels. Angiogenesis is necessary for osteoblast infiltration and bone formation. VEGF plays 
an important role as an endothelial cell chemoattractant, expressed by the hypertrophic chondrocytes, 
and Runx2 and hypoxia-induced factor α induce the VEGF expression in growth plate hypertrophic 
chondrocytes (Zelzer et al., 2001, Schipani et al., 2001). Furthermore, hypoxia induced factor α has been 
implicated as a survival factor for the hypertrophic chondrocytes, and may act as a negative regulator of 
cell proliferation (Schipani et al., 2001). 
cartilage extracellular matrix1.6.3 
For cartilage and bone the ECM is essential, as robustness and function of these tissues depend on an 
ECM that is hardened by mineralisation. Indeed, major functions of chondrocytes are secretion of the 
different ECM proteins like collagens, as well as calcification of the matrix (Lefebvre and Smits, 2005). 
Col II is the most abundant protein secreted by chondroblasts. The gene encodes two splice variants 
that have different expression patterns during development. These alpha (A) and beta (B) types can 
be distinguished by differences in exon 2, which encodes a cysteine-rich von Willebrand factor C-like 
domain, which is missing in collagen type IIB (McAlinden et al., 2005). 
For cartilage tissues, the capacity of the ECM to bind water is crucial, as it influences the ability 
to resist pressure and to be elastic at the same time. The water binding capacity is highly dependent on 
the glycosylation level of the ECM proteins, and indeed a high degree of glycosylation is typical for 
the cartilage extracellular matrix. The GC, along with the ER, is the major site for the generation and 
modification of glycosyl groups. Therefore, defects in glycosylation or sulfation of ECM proteins can 
disturb cartilage formation (Kluppel et al., 2005, Chintala et al., 1995) and defects in Golgi modification 
enzymes can cause cartilage diseases. As an example, human EXT1 and EXT2 genes are linked to 
cartilage and bone formation, and mutations in these genes were identified as a cause of the ‘Hereditary 
multiple exostoses’ (HME) disease characterised by benign bone tumors (Stickens et al., 2000, Koziel 
et al., 2004, and reviewed in Duncan et al., 2001). 
The HME mutations have been linked to three different loci, EXT1, EXT2 and EXT3. Of these, 
the EXT1 and EXT2 genes encode two different glycosyltransferases located in the GC as a dimer, 
and involved in heparan sulfate biosynthesis and chain elongation (Busse et al., 2007). The function 
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of the EXT3 locus is not known. Gene targeting of either Ext1 or Ext2 in mice is embryonic lethal. 
In heterozygote Ext1 embryos there is an increase in the area of Ihh diffusion and in chondroblast 
proliferation, while chondrocyte hypertrophy is delayed (Hilton et al., 2005). Ext2 heterozygote embryos 
have impaired heparan sulfate synthesis and develop exostoses (Stickens et al., 2005). In addition, the 
typical columnar organisation of proliferating chondroblasts is slightly disturbed.
Chodrocytes are known to secrete multiple ECM proteins at different stages (Figure 5A, reviewed 
in Lefebvre and Smits, 2005). While Col I is only secreted by mesenchymal progenitor cells and 
pre-chondroblasts, Col II synthesis occurs during most of the stages of chondroblast differentiation. 
Col IIA is expressed during mesenchymal cells condensation and proliferation (Sandell et al., 1994, 
Sandell et al., 1991). A splice variant, type IIB, along with proteoglycans such as Agc, and Col IX and 
XI, are secreted by early chondroblasts (Vornehm et al., 1996, Mallein-Gerin et al., 1988). Columnar 
chondroblasts upregulate the expression of, for example, Agc and cartilage oligomeric protein (Comp). 
During prehypertrophy, cells secrete high levels of Col IIB, Agc, and most other early cartilage matrix 
proteins, and they initiate expression of Col Xa1. Col X expression continues as cells progress to 
hypertrophy, while expression of other early matrix proteins stops (Lefebvre and Smits, 2005). During 
terminal differentiation, cells secrete matrix metalloproteinase-13 (MMP-13), osteopontin and alkaline 
phosphatase, which regulate the extracellular matrix mineralisation (Inada et al., 2004, and reviewed in 
Gerstenfeld and Shapiro, 1996). 
The non-cartilage mesenchymal tissues also display active secretion of ECM proteins, if not as 
abundantly as cartilaginous tissues. At least N-CAM, N-cadherin and Col I are expressed in non-
differentiated mesenchymal cells (Lefebvre and Smits, 2005). In contrast, osteoblasts and osteocytes do 
not secrete Col II, despite the fact that they display active secretion. Nevertheless they retain expression 
of Col I, which is the major protein found in the bone ECM. Other glycoproteins, including osteopontin, 
osteocalcin and alkaline phosphatase, which are thought to regulate mineralisation of the bone, are also 
expressed (Gehron Robey, 1996).
The ECM needs to be remodelled as endochondral ossification proceeds. Several proteases with substrate 
specificity for collagens have been identified. Probably the best known family of proteases are the matrix 
metalloproteinases (MMPs), of which MMP-9, MT1-MMP and MMP-13 are critical for normal bone 
formation (Inada et al., 2004, Vu et al., 1998, Holmbeck et al., 1999). In addition, the ECM is rich in 
different growth factors that bind to the ECM (e.g. heparan sulphates) and are released when proteases 
process the matrix. This growth factor binding capacity of the ECM is used to control the amount, the 
diffusion, and the rate of release of different growth factors, and thus regulate the rate of signalling 
(Kluppel et al., 2005, Chintala et al., 1995). 
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Dental tissues and periodontium1.7 
In mammals, four types of teeth can be observed: incisors, canines, premolars, and molar teeth. The 
number of molars and premolars varies, as well as the number and shape of the incisors. Mice and 
other rodents only develop one set of teeth which are permanent, while most other mammals have 
two sets of teeth, deciduous or ‘milk teeth’, and permanent teeth, which replace the deciduous teeth 
as an animal reaches a larger body size. There is much variation in the vertebrate incisors. Rodent 
incisors grow continuously, and while human incisors are covered with enamel on the whole crown 
area, rodent incisors are covered with enamel only on their labial side. Furthermore, the rodent incisor 
labial side is considered to be reminiscent of the molar crown, while the lingual side may follow root 
patterning (Figure 6B). This asymmetry requires inhibition of BMP on the lingual side (by follistatin), 
and proliferation of ameloblasts and odontoblasts in the posterior end of the incisor (Wang et al., 2004b, 
Harada et al., 1999). 
Teeth are composed of four markedly different layers with different functions for each layer (Figure 
6A). Dental pulp is soft tissue, while enamel, dentin, and cementum are hard mineralised tissues that 
have a high mineral to protein ratio (reviewed in Fong et al., 2005). The function of these hard tooth 
layers is to withstand the forces of mastication, and to protect the vulnerable dental pulp. The enamel 
is secreted by ameloblasts, which are derived from the dental epithelium. Once formed, the enamel can 
no longer be remodelled. The three other dental layers are derived from the dental mesenchyme (see 
Figures 6A and C). Dentin is secreted by the odontoblasts at the surface of the dental pulp, and helps to 
prevent enamel fractures from the forces of mastication. Cementum covers the roots of teeth, but unlike 
enamel, cementum can be deposited and remodelled throughout the life of the tooth. Dental pulp has a 
role as a pain sensor for the tooth, and in dentin repair after damage. In addition, dental pulp harbours 
the dentin-forming odontoblast cells, and it contains most of the precursor cells that regenerate dentin 
and cementum (Fong et al., 2005). 
Periodontium is defined as tissues supporting and investing the tooth, and it consists of cementum, 
periodontal ligament (PDL), bone lining alveolus (socket), and the gingiva facing the tooth (Ten Cate, 
1997). The dental mesenchyme also contributes to the formation of the PDL. PDL is not strictly speaking 
one of the dental tissues, but it has an important role in anchoring teeth to the bone. It is a soft, specialised 
connective tissue which is situated between the cementum and the bone of the socket wall. The main 
constituents of the PDL matrix are collagen fibres that protrude into the cementum and the bone socket, 
and crosslink these tissues (Nanci and Somerman, 2003). The PDL has many functions: it supports the 
tooth and allows the slight movement of teeth during mastication, and it also has a role as the sensory 
organelle for the jaws.
Another important feature of the PDL is its ability to regulate the level of mineralisation and to 
prevent ankylosis (fusion of bone and tooth). Periodontal ligament-associated protein-1 (PLAP-1) 
has been suggested to suppress mineralisation and to bind directly to BMP2 (Yamada et al., 2007). In 
addition, msh homeobox 2 protein (Msx2) has been found in PDL fibroblasts, and it can repress Runx2 
activity and mineralisation (Yoshizawa et al., 2004).
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tooth formation1.7.1 
Tooth development has been considered a model for epithelial-mesenchymal organ development. Teeth 
develop from the oral ectoderm and the neural crest cell derived ectomesenchyme (Figure 6C, reviewed 
in Miletich and Sharpe, 2003, Thesleff et al., 2001). This whole process is highly organised and tightly 
regulated. Hox genes are important for determining tooth identity, with BarH-like homeobox 1 (Barx1) 
expression marking the future molar region, and Msx1 the incisor region (Tucker et al., 1998b, Tucker et 
al., 1998a). The timing and combination of the different signals is crucial for correct patterning. Many of 
the signalling molecules (BMP, FGF, Hh, and Wnt) and transcription factors important for cartilage and 
bone development are also important for tooth development. These molecules are used during several 
stages, and their expression may fluctuate between ectoderm and mesenchyme (reviewed in Thesleff, 
2006). Fine tuning of the signals by additional inhibitory signals (e.g. follistatin and Ectodin) is necessary 
for normal tooth formation (Wang et al., 2004a, Kassai et al., 2005). 
Tooth morphogenesis begins by formation of the dental placode, a thickening of oral ectoderm 
(Figure 6C). The dental epithelium forms a bud and mesenchymal cells condense around it. The bud 
develops into a dental cap, and the ectomesenchyme beneath the epithelial cap forms the dental papilla, 
while the surrounding ectomesenchyme will form the dental follicle. The bell stage marks shaping of the 
tooth crown, and differentiation of ameloblasts and odontoblasts begins. In the differentiation stage the 
dental lamina that has connected the tooth to the oral epithelium breaks up, separating the developing 
tooth from the oral epithelium (Miletich and Sharpe, 2003, Thesleff et al., 2001). 
The primary enamel knot (Figure 6C, cap state) functions as a signalling centre and directs tooth 
growth and shape, while secondary enamel knots direct the formation of future cusps in molars. 
Formation of the primary enamel knot requires Msx1 and BMP4, followed by Wnt/Lef1 to induce FGF4 
expression, leading to stimulation of enamel epithelium and dental papilla proliferation (Bei et al., 2000, 
Kratochwil et al., 2002). At the end of crown formation, secretion of the enamel and dentin by terminally 
differentiated ameloblasts and odontoblasts begins. Incisors have primary, but not secondary, enamel 
knots, and the signalling involved has not been studied in detail (Thesleff et al., 2001).
The root formation begins when the crown formation is almost complete. However, this process 
is not understood as well as crown formation, but similar principles may apply to the formation of 
single-rooted and multi-rooted teeth. Cessation of FGF10 signalling at the end of crown formation may 
regulate the transition from crown to root formation in mouse molars, while continuous expression is 
important for survival and maintenance of stem cell populations in mouse incisors (Yokohama-Tamaki 
et al., 2006, Harada et al., 2002). In addition, nuclear factor I/C (Nfic) transcription factor is essential for 
root formation, while BMP4 is important for root formation through regulation of Hertwig’s epithelial 
root sheath (HERS) (Steele-Perkins et al., 2003, Hosoya et al., 2008).
At the beginning of root formation, a bilayer of cells from inner and outer dental epithelium of 
HERS extends apically, outlining the shape of the future root, and leaving only the basal portion of the 
dental papilla unenclosed (Figure 6A, reviewed in Luan et al., 2006). HERS separates the periodontal 
ligament from odontoblasts and dental papilla, and is thought to signal to the dental papilla to induce 
odontoblast differentiation. As the HERS subsequently fragments to epithelial cell rests of Malassez, the 
dental follicle cells come in contact with the predentin. The future cementoblasts begin differentiation 
and start the deposition of cementum matrix (reviewed in Nanci and Bosshardt, 2006). The precursors 
of cementoblasts are believed to arise either from the dental follicle cells along with precursors for 
periodontal ligament fibroblasts and osteoblasts, or from HERS cells undergoing epithelial-mesenchymal 
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Figure 6. View of a molar tooth and the different cell types, schematic view of rodent incisor 
and stages of tooth development
A) Schematic view of a molar tooth, and the different cell types that can be observed in the root follicle at 
the root forming stage (hematoxyline-eosin staining). PDL and dental follicle cells, cementum and dentin layers, 
odontoblasts, bone, Hertwig’s epithelial root sheath (HERS) and dental pulp are marked in the hematoxyline-eosin 
image.
B) Schematic view of a rodent incisor. The lingual side is reminiscent of molar roots while the labial side is 
comparable with the molar crown. Mesenchyme of the dental papilla is marked with pink, enamel with white, 
ameloblasts with orange, dentin with light rose, dental follicle with cyan and dental epithelium cells with ochre. 
Lingual and labial sides are indicated. 
C) The main stages of tooth development. The dental epithelium thickens, forming a placode (initiation), 
followed by budding of the epithelium and condensation of the dental mesenchymal cells around the bud (bud 
stage). The future dental follicle and dental papilla are a morphologically homogenous population of mesenchymal 
cells at this stage. The enamel knot forms, and the bud develops into the cap stage. Mesenchymal cells beneath the 
dental epithelium will form the dental papilla, while the peripheral dental mesenchymal cells will give rise to the 
dental follicle. At the bell stage the crown shape is formed, and ameloblasts and odontoblasts differentiate. By the 
differentiation stage, the tooth is separated from the oral epithelium. Secretion of enamel and dentin begins from 
cusp sites and continues in the cervical direction. Root formation begins when the enamel front reaches the base of 
the crown. Epithelial cells proliferate and form the HERS, which extends and outlines the future root. 
Oral epithelium is marked with dark ochre, dental epithelium with light ochre, dental mesenchyme with 
lilac, dental follicle with cyan, dental papilla with pink, enamel knot with green, ameloblasts with orange, and 
odontoblasts with purple.
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transformation (Grzesik and Narayanan, 2002). 
The cementum, which will cover the root in the same way as the enamel covers the crown, is 
deposited on top of a layer of dentin. In human teeth, dentin mineralisation starts internally, permitting 
intermingling of cementum matrix collagen fibrils with un-mineralised dentin fibrils (Nanci and 
Bosshardt, 2006). As mineralisation continues, it spreads to the cementum matrix and creates the dentin 
enamel junction. In rodents, dentin mineralisation happens initially, and the cementum is laid down on 
mineralised dentin, making the connection between dentin and cementum weaker than it is in humans 
(Nanci and Bosshardt, 2006). As the cementum layer reaches its final thickness, periodontal ligament 
fibrils become imbedded in it. Bone sialoprotein 1 (Bsp1) is a marker for these terminally differentiated 
mineralised cells (cementoblasts lining the root surface, and osteoblasts lining the bone surface), while 
Activinβ is a marker for the dental follicle during early stages of tooth formation (Wang et al., 2004a, 
Yamashiro et al., 2003).
PDL is thought to be formed by the dental follicle cells, but its formation has not been characterised 
in detail. The mature PDL is composed of a heterogeneous population of mesenchymal cells. The 
principal cells of PDL are fibroblasts, which are responsible for the PDL matrix secretion that anchors 
teeth to the bone. Other differentiated cells identified in the PDL include osteoblasts and osteoclasts, 
monocytes, macrophages, cementoblasts and odontoclast. Moreover, an important class of PDL cells 
are the undifferentiated mesenchymal, or progenitor cells, needed for tissue repair and regeneration 
(reviewed in Nanci and Bosshardt, 2006). PDL is a connective tissue, and the major part of it is composed 
of the long fibre bundles that crosslink bone to the cementum. Collagen is a major component of this 
fibre network, and dental follicle cells are known to secrete at least type I, III and XII collagens (the 
same as in the cementum) (MacNeil et al., 1998, Hou et al., 1999, Berkovitz, 2004). 
In addition to its role in PDL formation, the dental follicle is required for tooth eruption (Marks, 
1995, Marks and Cahill, 1987). It has been suggested that the crown follicle regulates the resorption of 
bone that is needed for tooth eruption, while the root follicle may regulate the deposition of new bone 
at the tip of the root.
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aims of the stuDy2 
When this study was started, several hundred of the estimated 1000 Golgi proteins (Taylor et al., 2000) 
were still unknown or uncharacterised. There was also an increasing amount of data indicating that the 
GC has additional functions besides the traditional transport, sorting and modification of cargo. 
The specific aims of this study were:
To identify the Golgi proteome by an organelle proteomic approach.1. 
To verify the localisation of some of the novel proteins.2. 
To further characterise a novel, interesting Golgi protein.3. 
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experimentaL proceDures3 
Methods used in articles I-IV3.1 
Detailed descriptions of the materials and methods are found in the original publications.
Materials and methods Original publications
antibody production I III
bioinformatic methods
    ms/ms data analysis I
    In silico searches I III
cell culture I III IV
cloning I III
golgi membrane isolation I
imaging and confocal microscopy I II III IV
Immunofluorescence I II III IV
In situ hybridisation
    radioactive III IV
    whole mount III
lc I
mass spectrometry I
primary cell culture IV
protein isolation III
qpcr III
rna isolation III
sDs-page I
subcellular fractionation I
Tissue culture III
Transfection I II
siRNA experiments3.2 
Chondrosarcoma cells were transfected with small interfering RNAs (siRNAs) by electroporation. 
Both self-designed siRNAs (sense sequence for duplex 1: CGAACUGACCGACCGGCGCTT; duplex 
2: GAACGUGUACUUCGCGCAGTT; duplex 3: GCGCUAUGGCAGAUUCCAGTT; and control 
duplex: AGCUUCAUAAGGCGCAUGCTT), and predesigned SMARTpool siRNAs from Dharmacon 
were used. Briefly, cells were trypsinised and suspended to a cell density of 2x106 /ml in phosphate 
buffered saline. 2x105 cells were mixed with 10 µl of siRNA (20 μM), CaCl
2
 was added to a final 
concentration of 1 mM, and cells were preincubated in electroporation cuvettes on ice for 10 min. After 
incubation, cells were electroporated once with a BTX Electro cell manipulator 630 (300V, 100Ω, 25μF) 
and cooled on ice for further 10 min. Cells were then suspended into 3 ml of growth medium, and plated 
and grown for 72 to 96 h, after which cells were fixed and stained for GoPro49, β-COP, GM130, or other 
markers. 
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Zebrafish gene expression and morpholino injections3.3 
To obtain the time scale of gene expression in zebrafish (Danio rerio), the RNA was isolated from 
embryos at 0.5 h, 6 h, 24 h, 48 h and 72 h post fertilisation (pf), and gene expression was studied 
using reverse transcriptase polymerase chain reaction (RT-PCR) and gene specific primers for 
zgc:101666 (CGATGCGGCAAGTTCCTCTT and GGAACCCAAGCGTTTGAGCA, product 300 
bp), LOC571492 (CTGCGCTTCCTCCCTCTCAA and TTCACGAGGCTCCCCGTACT, 300 bp), and 
β-actin (TGTGGCCCTTGACTTTGAGCAG and TAGAAGCATTTGCGGTGGACGA, 474 bp). 
Translation blocking morpholino oligos were designed for the 5’ UTR sequence, for both zebrafish 
genes (Gene-Tools, LLC, for zgc:101666 ATTTAAGCGACAATATCCGCAG[CAT] and for LOC571492 
AAGCGCAG[CAT]GTTCGTGCACTAGC), and the corresponding five mismatch oligos were used as 
controls. Oligos were dissolved in sterile water to a concentration of 10 mg/ml and stored in aliquots at 
-70°C. For injection, oligos were further diluted in sterile water and ~30% phenol red to obtain injection 
dilutions. 
Zebrafish embryos were collected 30 minutes pf and injected at the one-to-four cell stage with 4 nl of 
0.5-2 ng/nl morpholino to the yolk sac. Fifty embryos were injected for each oligo, in each experiment. 
Injected and non-injected control embryos were further grown for 24 to 144 hours at the standard 28.5°C 
temperature, in T3-buffer supplemented with phenylthiourea to prevent pigmentation. Any changes in 
phenotypes were monitored daily, and samples collected at 3d (72 h) and 6d (144 h), cooled on ice for 
15 min, and fixed with either 4% paraformaldehyde or methanol according to the protocol approved by 
the University of Helsinki Review Board for Animal Experiments.
Alcian blue staining 3.4 
To analyse any cartilage phenotypes in morpholino injected zebrafish, Alcian blue staining was performed 
on paraformaldehyde fixed zebrafish embryos according to Schilling et al. (1996) and modifications 
therein. Briefly, paraformaldehyde fixed embryos were incubated overnight at +4°C in 0.1% Alcian 
blue in 80% ethanol/20% glacial acetic acid. Embryos were rinsed with ethanol and rehydrated stepwise 
in phosphate buffered saline. Tissues were cleared with 0.05% trypsin in saturated sodium tetraborate 
for 1-3 h, and bleached in 3% hydrogen peroxide/1% potassium hydroxide to remove pigmentation. 
Samples were transferred to 70% glycerol in phosphate buffered saline for imaging.
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resuLts4 
A brief description of the main results is given, together with some unpublished data. 
The Golgi proteome (I, II)4.1 
Despite the several Golgi proteomic studies performed, the Golgi proteome is still not complete (Gilchrist 
et al., 2006, Taylor et al., 2000, Breuza et al., 2004, Bell et al., 2001, Wu et al., 2000, Wu et al., 2004, 
Publ. I). Of these studies three were done using LC-based fractionation of peptides coupled to direct 
analysis by MS/MS (Gilchrist et al., 2006, Wu et al., 2004, Publ. I). The study conducted by Wu et al. 
used isolated stacked Golgi membranes, using an approach which is similar to our own study. The most 
recent of these studies (Gilchrist et al.) involved a quantitative study of the whole secretory pathway.
Publication I describes our LC-ESI-MS/MS approach to identifying the Golgi proteome from 
highly purified (130-fold enrichment) stacked rat liver Golgi membranes (verified by EM), and lists 
the identification of 1125 proteins, of which 1031 were identified with two or more peptides. All 
identified proteins were grouped into 16 different categories based on Swiss-Prot database information 
on subcellular localisation or function (Publ. I, Fig. 2 and Supplementary table 1). The main categories 
were: Golgi and membrane transport, ER, cargo, cytosolic, and localisation undetermined. 201 (17.5%) 
of these identified proteins were previously known Golgi and transport proteins, 101 (8.8%) were known 
ER proteins, and 89 (7.7%) were previously unknown or uncharacterised. Counting the number of 
peptides in each category showed that 29.9% were from different Golgi (20.2%) and transport proteins, 
13.3% were from ER proteins, and 4.6% of proteins from contaminating organelles (PM, endosomes, 
lysysomes, mitochondria, nucleus and peroxisomes). 22.8% of the peptides were from different cargo 
proteins, while cytosolic proteins and those with undetermined localisation accounted for 18.1%. This 
is well in line with what Gilchrist et al. also reported in their study.
Comparison of our data with the previous Golgi proteomic studies showed that overlap between 
the studies, especially of novel proteins, was relatively small. Wu et al. used similar rat liver Golgi 
membranes and thus should be the most alike. Of the 421 protein identified by Wu et al. (2004), 399 
could be identified in our study. However, of the 42 unknown proteins identified in their study, only 24 
were identified in our study, and of our 89 unknown proteins only 11 were found in theirs. The Gilchrist 
et al. study (2006) found only 122 of the Golgi, ERGIC and transport proteins identified in our study 
(59% overlap). Thus, to obtain a comprehensive list of all Golgi proteins, data from multiple studies 
need to be combined and verified. 
Two of the unknown proteins identified in our study were selected for initial characterisation: the 
human homologue for RIKEN cDNA 2510039O18 (later called KIAA2013) and the protein similar 
to Ab2-095 (later called GoPro49). Both of these proteins were shown to localise to the GC as EGFP-
fusion proteins in HeLa cells, with clear co-localisation with the Golgi marker, GM130. For KIAA2013, 
co-localisation of the endogenous protein with GM130 was also seen (Publ. I, Fig.2). KIAA2013 was 
one of the unknown proteins shared between Wu et al. (2004) and our study, but GoPro49 could not be 
identified in their data, while both of these proteins were found in the data from Gilchrist et al. (2006).
Some of the unknown proteins identified in Publication I, including the protein similar to Ab2-095, 
were also included in a novel protein database, Human Proteinpedia (Publ. II). This database is the first 
attempt to collect interaction and functional data on human proteins into one database which contains 
full analysis datasets that can be cross-searched. This database is open to all researchers, and after 
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registration everyone can contribute their datasets on proteomic, yeast-2-hybrid, and localisation studies, 
as well as data on post-translational modifications. In addition, the contributors’ names and contact 
details will stay in the entry, and only the contributor can change the deposited data.
In silico analysis of the protein, GoPro49 (III)4.2 
The protein similar to Ab2-095/hypothetical protein LOC205428/c3orf58/DIA1, or from here on Golgi 
protein 49kDa (GoPro49), was selected for further study. Based on the in silico data, the gene is predicted 
to code for a 49kDa protein containing a signal peptide. However, the prediction programmes were not 
unanimous in this prediction and all gave a very low score to the cleavage site. Furthermore, these 
prediction programmes (such as SignalP, Emanuelsson et al., 2007) may not reliably distinguish signal 
peptide from signal anchors. Indeed, of the 226 different Golgi localising transferases (annotated in 
UniProt) that are all supposedly signal anchored, 51% were predicted not to contain a signal anchor (with 
over 50% probability), and 22% did not even score a 10% probability, demonstrating how unreliable 
this type of prediction is. Thus in vitro analysis is required to determine whether GoPro49 has a signal 
peptide or a signal anchor.
The further in silico analysis of GoPro49 did not reveal any known functional domains or homology 
to known proteins, but it did suggest a few short binding motifs that might either be related to the 
function or to the regulation of the protein. One of these motifs is the potential binding sites for 14-
3-3 proteins. The GoPro49 sequence showed no potential N- or O-glycosylation or lipid modification 
sites, but two potential glycosaminoglycan attachment sites (Puntervoll et al., 2003) were identified. In 
addition, the sequence contained numerous potential phosphorylation sites (Figure 7A). 
The orthologous GoPro49 proteins are highly homologous and the sequence alignment of twelve 
different species shows the middle third to be especially conserved (Publ. III, Fig. 1). Of the analysed 
species, zebrafish was the only one where two, highly homologous sequences could be identified. This 
was not unexpected, as the zebrafish genome has undergone a recent genome duplication (Woods et 
al., 2000). Based on the current sequence data, the human gene for GoPro49 is predicted to code for 
two different splice variants: a large one used in this study (isoform A, Q8NDZ4 or NP_775823), and 
a smaller one that has alternative exon 1 (isoform B) that was not in the databases when this study was 
conducted (unpublished data). Isoform B encodes a protein (NP_001127942) that contains amino acids 
220-430 of the longer isoform A and eleven unique amino acids in the N-terminus. Unlike isoform A, 
isoform B is not predicted to have a signal sequence or a transmembrane domain, and thus it is predicted 
to be cytoplasmic. Both isoforms are depicted in Figure 7A. Whether the corresponding mouse gene also 
encodes two similar isoforms is unclear at the moment, but it is likely that, as for some other species 
(e.g. dog and horse), only the corresponding shorter isoform can be found in databases. The peptides 
that were used to identify the protein similar to Ab2-095 in Publication I, cover 23% of the GoPro49 
sequence and both N- and C-terminal halves, indicating that rat liver expressed the longer isoform.
The EST data for the gene suggested that the highest expression levels are found in leukocytes and 
blood vessels. However, as the EST data seldom includes samples of cartilage and bone, these tissues are 
easily missed in this kind of data (Figure 7B). The in silico analysis of the 2kb sequence 5’ upstream of the 
GoPro49 coding sequence showed a number of potential transcription factor binding sites. Several sites for 
Tcf/Lef (Wnt pathway), Runx2 (BMP-2, TGFβ and FGF pathways), a homeobox gene Msx2, Smads and 
Sox5 (BMP pathways) and Pax9 were among the hits conserved between human and mouse (with rVista 
2.0: Tcf/Lef, Runx2, Smad and Sox5; and with MatInspector: all the previous, plus Msx2 and Pax9). 
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The GoPro49 tissue expression pattern (III, IV)4.3
To identify the tissues where the GoPro49 gene was expressed during development, the expression was 
studied using both quantitative PCR (qPCR) and in situ hybridisation. The expression was shown to increase 
from embryonic day 7 (E7) towards E15, after which the expression leveled off (Publ. III, and Figure 8B). 
The probe (680nt) used for the in situ hybridisation was designed for the longer isoform A, but overlaps 
Figure 7. Schematic view of the two GoPro49 isoforms and selected transcription factor binding 
sites identiﬁed, using rVista, in 5kb sequence 5’ upstream of the GoPro49 long isoform coding 
sequence
A) Schematic view of the gene structure and the two protein isoforms coded by the GoPro49 gene. Isoforms
differ in the alternative exon 1. Exon 1A is 1192 bp, while exon 1B is 239 bp long. The untranslated regions of both 
transcripts are marked in yellow, and the coding regions in blue. The binding site of probe used in Publications 
III and IV is indicated with light blue bar under the isoform A (not including the intronic sequence marked with 
dashed line), and the qPCR amplicon (108 bp) is marked with magenta. 
Potential modiﬁcation sites on the encoded proteins: glycosaminoglycan attachment and 14-3-3 binding sites 
(ELM), globular domains (green), and potential phosphorylation sites (NetPhos2.0) are shown for both isoforms. 
Amino acid 220 marked in the isoform A is the ﬁrst homologous amino acid shared by these isoforms.
B) Schematic view of the selected potential transcription factor binding sites that are conserved between 
human and mouse (identiﬁed by rVista 2.0). Sites for Tcf/Lef (Lef1, Lef1B, Lef1Tcf1), Runx2 (Cbf and Osf2), 
Smads, Sox5, and En1 are among the ones identiﬁed in the sequence from the 3 kb marker to the beginning of the 
coding sequence, marked by the blue bar. The untranslated region is marked by yellow bar. 
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the first 160nt of the human isoform B sequence, which was not in the databases at the time. Thus, the 
probe may also recognise the shorter isoform B. Moreover, the qPCR primers used were designed for a 
site that overlaps in the two sequences, and thus they do not distinguish between the possible two mouse 
isoforms.
In situ hybridisation analysis of GoPro49 expression during mouse embryogenesis clearly showed 
the highest expression levels in different mesenchymal tissues that give rise to the skeletal elements 
later at life (Figure 8A). Furthermore, the GoPro49 expression pattern was both restricted and 
developmentally regulated in the mesenchymal and cartilaginous tissues during development. Intense 
expression was observed in vertebrae, ribs and limbs, and, in the craniofacial area, in the nasal septum 
and dental follicle. In the vertebrae and snout region, clear co-expression with Col II was detected. In 
paws, additional expression was detected in the interdigital area at E12 and E14. Expression levels in 
the trunk area were decreasing from E14, while in the craniofacial cartilages, expression continued to 
be strong in the postnatal tissues (Publ. III, Fig. 2-6). The highest expression levels were detected in 
the proliferating and columnar chondroblasts, but no expression was observed in the hypertrophic or 
terminal chondrocytes.
To compare the GoPro49 expression levels in different stages of the limb development, the 
expression was analysed in E10.5-E18.5 limb bud RNA using qPCR, and the results were normalised 
against TATA box binding protein (Tbp), a housekeeping gene with a relatively low expression level that 
was comparable to the level of GoPro49 expression (unpublished data, Figure 8B). Expression was seen 
already in E10.5 RNA, at which stage the limb buds have formed. By E12.5, even more distal elements 
(autopod condensations) have formed and Col II expression can be observed in in situ hybridisation. 
The GoPro49 expression level increased throughout the examined period, and E18.5 had the highest 
expression, with 40% more expression than at E10.5 (Figure 8B, unpublished data). The bones at E18.5 
have well-formed growth plates, and mineralisation of the matrix has begun at the diaphysis. 
In addition to the cartilage, clear and restricted expression of GoPro49 was observed during embryonic 
and postnatal tooth development. The expression was restricted mainly to the dental follicle from E12 to 
12 d postnatal (dpn), in both molars and incisors (Publ. III, Fig. 6 and Publ. IV). No significant expression 
was observed in other tooth tissues at any of the time points examined. Noticeably, while GoPro49 was 
expressed intensely in most of the condensed mesenchyme surrounding the bud stage tooth germ, it was 
absent from the presumptive dental papilla mesenchyme. During embryonic stages, the expression was 
detected in the whole dental follicle, while in the postnatal molars only a little expression was observed 
in the crown follicle of non-erupted teeth.
GoPro49 expression in the dental follicle was clearly complementary to Bsp1 in bone and 
cementoblasts, and strongly restricted to the loosely located fibroblast-like cells that later become 
embedded in the matrix. ActivinβA was co-expressed with GoPro49 in the incisor dental follicle during 
embryonic and postnatal tooth development, but expression appeared more intense in the peripheral 
cells of the follicle bordering the area of bone formation. In addition, strong ActivinβA expression was 
seen in the dental papilla, in the osteogenic mesenchyme and in ameloblasts and it was downregulated 
in the root follicle earlier than GoPro49 (Publ. IV).
The GoPro49 expression levels in the different craniofacial tissues were also analysed using qPCR 
(Figure 8B). As expected, the highest expression levels in the craniofacial area were detected in the nasal 
septum. Surprisingly, the expression levels in the molars did not follow the staining intensity observed 
in the in situ hybridisation, with higher expression levels detected in E16.5 rather than in 4 dpn molars. 
Unfortunately, on western blot the antibodies we raised were only able to detect transfected fusion 
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Figure 8. Pattens of GoPro49 expression 
A) The schematic view of the GoPro49 expression pattern from in situ hybridisation. The ﬁgure shows all the 
different mesenchymal tissues where expression was detected during the embryonic period. GoPro49 expression 
(brown) was observed in mouse embryos using in situ hybridisation, in the nasal septum (from E12 to 4 dpn), in the 
dental follicle (from E12 to 12 dpn), in the spine and ribs (from E12 to E16), in long bones (from E12 to E16) and 
between the digits (blue, at E12 and E14). GoPro49 expression observed in the dental follicle is also shown in the 
different stages of tooth development.
B) A comparison of the expression levels using qPCR. The GoPro49 expression levels were analysed in whole 
embryo cDNA (from E7-E17), in limbs (from E10.5 to E18.5), in nasal septum (from E14.5 to 4 dpn) and in molars 
(at E16.5 and 4 dpn). The qPCR data was normalised against Tbp and compared to the reference sample (E12.5 nasal 
septum), which was set as 1. For the whole embryo cDNA samples the GoPro49 expression levels increased from 
E7 to E15, but were considerably lower than in e.g. E14.5 limbs or nasal septum. The expression levels in limbs 
increased from E10.5 to E18.5, with 40% more expression in E18.5 than in E10.5 which suggests that expression in 
limbs increases with formation of more and larger cartilaginous elements. In the craniofacial samples there was less 
variation in the expression levels between stages. Of the tissues examined, the E18.5 limbs had the highest expression 
levels, suggesting that the protein function is linked to the level of cartilage differentiation. 
C) Expression in the zebraﬁsh embryonal RNA. The expression levels of the homologous zebraﬁsh genes 
zgc:101666 (300 bp) and LOC571492 (300 bp), as well as β-actin (474 bp) from embryos at 0.5 h to 72 h post 
fertilisation were analysed using RT-PCR. The expression levels of both zebraﬁsh GoPro49 orthologs stayed 
relatively constant throughout the period and β-actin intensity shows that the RNA levels in the different samples 
are comparable. The strong expression that is observed at the 0.5 h time point indicates that both gene products are 
already present in maternal RNA. It also suggests that the gene products are required in zebraﬁsh before formation of 
cartilaginous elements around 3d pf. The speciﬁcity of the primers was tested in a cDNA sample of zgc:1010666. 
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protein, but not the endogenous protein. Thus the expression could not be analysed at the protein level. 
To check whether FGF, BMP or TGFβ pathways could regulate the GoPro49 expression, tissue 
culture experiments were performed. Shh and BSA, were used as negative controls, as no Gli sites 
were identified in the 5’ upstream sequence. Bead implantation experiments were tested first, but the 
results were inconclusive as a very weak signal was observed; thus the role of FGF was further tested 
using a qPCR-based approach. The qPCR results (in Publication III as RT-PCR) indicated that the 
GoPro49 expression was not affected by FGF4 in these samples or that the expression was even slightly 
downregulated (Figure 8D). 
GoPro49 subcellular localisation (I, III, IV)4.4 
To gain insight into the role of GoPro49, its subcellular localisation was studied. The EGFP-fusion 
protein showed clear co-localisation with the Golgi protein GM130 in HeLa cells (Publ. I, Fig. 2). 
However, the endogenous protein levels in HeLa cells were too low to be detected using the antibodies 
we raised against GoPro49. Thus, endogenous localisation was studied in the chondrosarcoma cell line 
HTB-94 (Publ. III), and also in primary dental follicle cells isolated from E18.5 mouse molars (Publ. 
IV). A clear co-localisation with β-COP was detected in both cell lines (Publ. III, Fig. 7 and Publ. IV, 
Fig. 3). However, the endogenous protein did not co-localise with the GM130 staining as was expected 
based on the EGFP-fusion protein localisation in HeLa cells (Publ. I, Fig. 2). 
Furthermore, GM130 staining in chondrocytes showed a markedly different Golgi morphology, 
from that of hamster kidney (BHK) or HeLa cells, which are often used in membrane traffic studies. The 
more reticular appearance of the GC observed in both chondrosarcoma and dental follicle cells could 
suggest higher amounts of secretory cargo in these cells, as the GC size is known to be indicative of 
the membrane traffic load. Cycloheximine treatment for 3 h did not change the GoPro49 co-localisation 
with β-COP in chondrosarcoma cells, but it did reduce the number of tubules seen in these cells (Publ. 
III, Fig. 7G-I). In addition to β-COP, GoPro49 also co-localised partially with Col II (unpublished data, 
Figure 9F and F’). 
However, the antibodies used to study protein localisation could not distinguish between the isoforms 
A and B, as the peptide antibody was made against the C-terminus, which is identical in the isoforms, and 
the epitope used to raise the antibody against the full length protein also covers the whole of isoform B. 
However, an EGFP-tagged deletion mutant [covering amino acids 236-430 (∆1-235, 88% of the isoform B 
Representative images of alcian blue stained, morpholino-injected zebrafish at 3d and 6d. No major differences 
could be observed between uninjected, specific, and mismatch morpholino injected embryos. The lack of a strong 
phenotype might be related to the duplication of the zebrafish genome, and possible functional compensation by the 
homologous protein; however the presence of maternal RNA makes the success of k.d. less likely. 
D) Downregulation of GoPro49 expression by FGF4 in tissue culture. FGF4 added to the growth medium in 
E11.5 forelimb and hind limb tissue culture experiments caused a slight downregulation of GoPro49 expression. This 
effect was more pronounced in forelimb than in hind limb. These results suggest that FGF4 could regulate GoPro49 
expression in limbs during limb development and perhaps help to determine its expression domain. The error bars 
present standard deviation, significant differences (t-test, p<0.01 *, p<0.001 **) are indicated.
E) Caspase-3 activity in transfected HeLa cells. Caspase-3 activity was measured from HeLa cell lysates of 
GoPro49-EGFP and control transfected cells, and the activity of GoPro49-EGFP samples was compared with the 
non-transfected and EGFP-transfected samples. A clear increase in the caspase-3 activity (1.6 fold) was seen from 
24h onwards in the GoPro49-EGFP transfected samples in comparison with EGFP-transfected control sample, where 
no significant increase was observed. This activity was most pronounced at the 30 h time point where 2.5 fold 
increase in caspase-3 activity was observed. Error bars present standard deviations, significant differences (p<0.01, 
t-test) are indicated by asterisk, ns means non-significant difference.
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sequence)] of GoPro49 localises to punctuated structures, that have no co-localisation with GM130 (Figure 
9L) or with β-COP (unpublished results), suggesting that the β-COP co-localisation of the endogenous 
protein is specific to isoform A.
Figure 9. 
Localisation of 
GoPro49, β-COP, 
Col  II, and GM130 
in HTB-94 cells 
and localisation of 
∆1-235 GoPro49-
EGFP in HeLa 
cells
The GoPro49 
(A, D, G) subcellular 
localisation was 
compared with that 
of β-COP (B), Col II 
(E) and GM130 (H) 
in a chondrosarcoma 
cell line using 
confocal micro-
scopy (C, F and I 
are merged images). 
The endogenous 
protein clearly co-
localised with both 
β-COP (C’) and 
Col II (F’), but not 
with GM130 in the 
cis-Golgi (I’). The 
β - C O P - p o s i t i v e 
structures observed 
in these cells were 
more widespread 
than those showing 
GM130 staining, 
perhaps indicating 
more active memb-
rane traffic in these 
cells. 
The localisation 
of the deletion 
mutant ∆1-235 
G o P r o 4 9 - E G F P 
in HeLa cells (J) 
was compared 
with GM130 
(K, fluorescence 
microscopy). The 
mutant localised to 
punctuated struc-
tures that did not 
co-localise with 
GM130 (L). Scale 
bars A-L 25 μm, C’, 
F’ and I’ 10 μm.
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Knockdown experiments (unpublished results)4.5 
Our early observation for GoPro49-EGFP transfected HeLa cells was that more cells were dying within 
24-48 h after transfection than control cells transfected with EGFP plasmid only. This increased cell 
death resulted from 2.5 times higher apoptotic caspase-3 activity (detected from cell lysate with a 
luminescent substrate peptide) than was seen in the control HeLa cells transfected with EGFP only 
(unpublished data, Figure 8E). One possibile explanation for this apoptotic activation is that GoPro49 
somehow influences the cell cycle or division, as many Golgi proteins have been shown to be important 
as mitotic regulators. However, this is unlikely, as GoPro49 was not identified in a large screen for genes 
affecting the cell cycle performed in Drosophila (M. Björklund, personal communication). 
To gain insight into the protein’s function, several different siRNAs were tested in a chondrosarcoma 
cell line. The knock down (k.d.) efficiency of each experiment was verified using indirect 
immunofluorescence. Unfortunately, these cells are extremely difficult to transfect, and a lentivirus vector 
or microinjection of siRNA would be required to perform siRNA experiments. With electroporation, 
k.d. efficiency varied greatly between experiments. The slight tubulation of COPI vesicles could be 
a significant phenomenon (seen in experiments with better GoPro49 k.d. efficacy), but more efficient 
transfer of siRNA is needed to verify this observation. From these experiments it can be concluded that 
the k.d. of GoPro49 is not lethal for chondrosarcoma cells. 
Zebrafish (Danio rerio) expresses both homologous GoPro49 genes from the beginning of fertilisation, 
and the expression levels stay relatively stable between 0.5 h and 72 h, indicating that both genes are 
already present early in the maternal RNA pool (see Figure 8C, unpublished data). Therefore, to analyse 
the role of GoPro49 in zebrafish, a morpholino k.d. approach was tested. Morpholinos were designed 
against both zebrafish genes, zgc:101666 and LOC571492, and were used in subsequent experiments 
both one at a time and in combination. However, no significant change in the phenotype was observed 
when injecting 8 ng of a single morpholino or a mixture of morpholinos against both genes (4+4 ng). 
K.d. embryos fixed at 3d and 6d were also stained with Alcian blue, in order to study possible defects 
in the cartilage (Figure 8C). However, no major differences could be observed between uninjected, 
specific, and control morpholino injected embryos. As translation blocking morpholinos function at the 
level of translation and may not cause k.d. of mRNA, their functionality cannot be verified using PCR on 
the RNA level, and since our antibody cannot detect the endogenous zebrafish protein in western blots, 
the k.d. level could not be verified. 
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Discussion 5 
Diversity of the Golgi proteome and the ‘proteinpedia’ database5.1 
When this project was started, the Golgi proteome (estimated at 1000 proteins, Taylor et al., 2000) was 
far from complete. Furthermore, it had become apparent that the GC had additional functions besides 
the traditional roles in post-translational modifications and membrane traffic, including cell migration 
and signalling (Preisinger et al., 2005, Preisinger et al., 2004, Sheen et al., 2004, Bivona et al., 2003). 
Our aim was to discover new proteins from isolated rat liver Golgi membranes that might contribute to 
novel GC functions. Because proteomics is a highly powerful method to identify proteins, this approach 
was selected to study the Golgi proteome. Furthermore, introduction of shotgun proteomics a few years 
earlier had made this method better suited for the study of membranous organelles such as the GC 
(Wolters et al., 2001). This approach led to a significant improvement in the identification of integral 
membrane proteins compared to traditional approaches such as 2D gels. Indeed, 35% of the proteins 
identified in our study were integral to the membrane based on TM prediction (Publ. I). 
The identified proteome was very extensive and the known Golgi and membrane transport proteins 
formed a major fraction (17.5%, 201). 89 previously unknown proteins were also identified, of which 
GoPro49 was selected for further study. Our study is the most extensive Golgi proteomics study 
performed to date and the number of novel proteins found was greater that in previous Golgi proteomic 
studies (Taylor et al., 2000, Breuza et al., 2004, Bell et al., 2001, Wu et al., 2000, Wu et al., 2004). 
The study by Gilchrist et al. did not focus on the GC, but instead it studied the proteome of the whole 
secretory pathway (Gilchrist et al., 2006).
One aspect of the GC is its dynamic morphology, which is related to its functions in membrane traffic. 
Indeed, the GC membranes and proteins are in constant flux with both the ER and the PM. On the one 
hand, newly synthesised Golgi proteins are transported from the ER, and escaped, Golgi resident proteins 
are returned from the PM (Bonifacino and Rojas, 2006, Barlowe et al., 1994, Aridor et al., 1995). On 
the other hand, escaped ER resident proteins are recycled from the GC in COPI vesicles, while proteins 
and receptors on the PM can be internalised in clathrin coated vesicles, transported through endosomes 
to the TGN, and re-inserted into the PM (Nichols and Lippincott-Schwartz, 2001, Bonifacino and Rojas, 
2006, Orci et al., 1997, Benmerah and Lamaze, 2007, Wilson et al., 1993). Because of all this trafficking, 
the recycling ER and PM proteins might, at least partially, reflect proteins in transit such as the KDEL-
proteins. 
Furthermore, it is a matter of definition whether proteins like microtubule motors, which are required 
for transport and GC morphology and which function in multiple locations, should also be considered 
part of the Golgi proteome (Gupta et al., 2008, Lippincott-Schwartz et al., 1995, Kreis el al., 1997). 
Thus, are the estimated 1000 proteins the whole Golgi proteome? In my opinion the Golgi proteome 
cannot be considered to be a totally separate entity from the ER, the PM and the numerous cytosolic 
factors, and thus the number of proteins needed to ‘make’ the GC is likely to be greater than 1000.
In addition to the traditional Golgi proteome, the GC also includes proteins with ‘double identity’ or 
splice variants with different functions and localisations. Proteins with one isoform in the GC include, 
for example, BARS/Ctbp1 and Golgin-245/CrpF46 (Carcedo et al., 2004, Fritzler et al., 1995, Lieu et 
al., 2008, Wei et al., 2008). For these proteins, the two different isoforms have clearly separate functions. 
BARS is involved in fission events, while Ctbp1 acts as a transcription factor. For the second pair, 
Golgin-245 has a role in transport events from the TGN while CrpF46 binds centrosomes, and may 
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participate in their duplication (Carcedo et al., 2004, Lieu et al., 2008, Wei et al., 2008, Bonazzi et al., 
2005, Yang et al., 2005). Such splice variants might explain some controversial results, such as staining 
in multiple subcellular locations e.g. in the GC and centrosomes, or interactions with nuclear proteins.
The human gene for GoPro49 is also predicted to produce two splice variants that have different 
N-termini, according to the current databases. Our proteomic study clearly identified the longer isoform 
with matching peptides covering the whole sequence, while the shorter isoform is supported by similar 
protein isoforms identified in other species including dog and horse (Publ. I and unpublished data). 
Distinguishing between two or more isoforms with large identical domains might not be possible on the 
protein level. However, on the RNA level these genes are likely to have different 3’ or 5’ sequences and 
thus differences in expression could be studied. Furthermore, different isoforms might have different 
tissue expression patterns or differential expression during development as, for example, with collagen 
type 2 isoforms A and B (Sandell et al., 1994, Sandell et al., 1991).
Do the two GoPro49 isoforms have similar subcellular localisation and tissue expression patterns? 
As the shorter isoform is predicted not to be an integral membrane protein, these two proteins cannot 
localise to the same compartment, at the same side of the membrane. In addition to differences in the 
subcellular localisation, the in situ probe used in this study (Publ. III and Publ. IV) might recognise these 
two isoforms with different affinities. Thus they could also have different tissue expression patterns and 
the shorter isoform B might even be more ubiquitously expressed. Moreover they might have differential 
expression in tissues where our probe detected expression, e.g. isoform A mainly in cartilage and isoform 
B in the interdigital area. Based on these divergences, their functions are likely to be diverse. Thus, in my 
opinion, these two proteins should be considered different yet homologous proteins.
Sequence analysis of GoPro49 isoform A would indicate a cleavable signal peptide, but no 
transmembrane domain (SignalP, Emanuelsson et al., 2007). Based on the current view, if the signal 
sequence was cleaved the protein should be secreted to the ECM. However, this is not in line with the 
subcellular localisation of the endogenous protein in β-COP positive structures (Publ. III), or of the 
EGFP fusion protein in the GC (Publ. I). In addition, treatment of cells for 3h with cycloheximide did 
not change the co-localisation of endogenous protein with β-COP indicating that this localisation is not 
dependent on newly synthesised protein (Publ. III). Thus, the signal peptide prediction requires further 
validation. 
In the proteomics study of Gilchrist et al., the protein similar to Ab2-095, or GoPro49, was identified 
in the COPI/Golgi fraction, and was clearly enriched in the COPI population (Gilchrist et al., 2006) 
supporting our notion that GoPro49 does indeed localise to COPI vesicles. Thus, the interpretation of 
these results is that the signal peptide is not cleaved and it rather behaves as a signal anchor retaining 
GoPro49 in the β-COP-positive structures. Furthermore, if the software prediction were correct and this 
type of signal is cleaved, then several Golgi transferases should also be secreted, as they give similar 
prediction results. One possibility could be that the GC and COPI vesicles also contain soluble resident 
proteins, but this does not agree with the current view of different types of Golgi resident proteins 
(Altan-Bonnet et al., 2004). 
What could be the retention mechanism if GoPro49 were soluble? There appear to be no lipid 
modification sites in the sequence, nor KDEL or other ER recycling signals. The protein is also unlikely 
to undergo N- or O-glycosylation, but it may be a target for glycosaminoglycan attachment (two potential 
sites) (Puntervoll et al., 2003). On the one hand, lectin-based interactions are possible, but on the other 
hand, this seems unlikely as glycosaminoglycan modifications are mostly found on extracellular proteins. 
The few predicted peptide motifs (e.g. 14-3-3 binding) are all for cytoplasmic interactions, and if the 
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membrane orientation prediction of the C-terminus being in the lumen is correct, these sites are not 
accessible in the longer isoform. Therefore, there are no accessible interaction motifs identified so far 
in GoPro49 isoform A. This leaves interactions with unknown proteins, or oligomerisation (van Vliet et 
al., 2003) as possible mechanisms for retention in the COPI vesicles/GC.
The Golgi membranes have typically been isolated from rat liver, but could these membranes 
be isolated from cartilage? Unlike the liver, a major constituent of cartilage is the ECM, which is 
additionally mineralised in later stages. Furthermore, cartilage forms a major part of the skeleton only 
during embryogenesis. In adults, the amount of cartilage is greatest in the craniofacial area, which is 
not an abundant source. The number of cells could thus limit the material available, and critical mass 
for isolation might be hard to reach. However, based on our results for GoPro49 expression, it would 
be beneficial to isolate the Golgi membranes also from other sources besides liver, and to compare the 
Golgi proteomes, since Golgi proteins clearly can have restricted expression patterns. 
The limiting factor for proteomics and other high throughput methods is the subsequent characterisation 
of the identified proteins. The high sensitivity can also give false positive results. Thus, even though 
systems biology approaches may help to dissect connections and pathways that might not otherwise 
be detected, it also requires that most of the data is further analysed and validated in vivo and in vitro, 
for example to confirm expression or protein function. The wealth of data generated by the different 
‘–omics’ is difficult to keep up with. Thus databases are needed in which data from different approaches 
are integrated. The novel protein database Human Proteinpedia (http://www.humanproteinpedia.org/ 
Publ. II) is one such attempt to collect data on human proteins and interactions, and so far it is the 
only one for vertebrates where proteomic, yeast-2-hybrid interaction, localisation and modification data 
are all collected in the same database that can be easily explored and updated by contributors. As this 
database incorporates data from multiple sources and links the data to each protein, it makes the several 
levels of data easily accessible. The protein GoPro49 has also been included in this database.
Restricted, developmentally regulated expression of GoPro49 5.2 
As the secretory pathway is essential for all cells it is not surprising that ubiquitous expression has 
been reported for most Golgi proteins, with perhaps increased expression levels in secretory tissues. 
Unexpectedly, GoPro49 expression was observed in a clearly restricted pattern during mouse 
embryogenesis, with highest levels detected in developing cartilage, i.e. in columnar, proliferating 
chondroblasts (Publ. III). 
The differences in expression levels in developing limbs were analysed using qPCR. Expression 
was detected already in the E10.5 limb bud, and it increased as development proceeded. This is well 
in line with the observed expression in columnar chondroblasts, as increased expression corresponds 
to the formation of more cartilaginous elements at later stages. In the E18.5 limb, where the strongest 
expression was detected, the diaphysis is already ossified, but cartilage is still forming in the growth 
plates, and chondroblasts proliferation is rapid (Lefebvre and Smits, 2005). 
This expression pattern was surprising, as cartilage is not one of the ‘traditional’ tissues used to 
study the GC and secretory pathways. Liver and brain, in which many currently known membrane traffic 
components have been identified, are much more commonly used. What role could a Golgi protein have 
in this ‘non-typical’ secretory tissue? The cargo secreted by cartilage is very different from the cargo 
of liver and brain. Nevertheless, chondroblast and chondrocytes do secrete large quantities of ECM 
with Col II as a major component (Lefebvre and Smits, 2005). Furthermore, the membrane traffic is 
51
clearly vital for these cells, since defects in COPII vesicle formation cause severe cartilage phenotypes 
(Boyadjiev et al., 2006, Lang et al., 2006, Townley et al., 2008). In addition, the extent of different post-
translational modifications in the cartilage ECM is remarkable (Myllyharju, 2003, Kluppel et al., 2005, 
Chintala et al., 1995). The cartilage matrix modifications begin in the ER with numerous hydroxylysine 
and hydroxyproline modifications that are especially frequent in collagen chains (Myllyharju and 
Kivirikko, 2004). The extensive glycosylation and especially glycosaminoglycan modification of the 
matrix has been shown to be important for the regulation of chondrogenesis and for growth factor 
signalling (Kluppel et al., 2005, Chintala et al., 1995, Koziel et al., 2004, Stickens et al., 2005). In this 
respect, cartilage can indeed be viewed as a tissue where the secretory pathway has a central role. 
In addition to expression in the cartilage anlagen, GoPro49 expression was also detected in the 
interdigital zones that are removed by apoptosis in species with free digits (Zuzarte-Luis and Hurle, 
2005). Surprisingly, at E12.5 GoPro49 expression was limited to these interdigital areas with little 
expression observed in the digit condensations marked by Col II. At E14.5, expression could be seen in 
both the interdigital zones and digit cartilage. This change in expression domain from the interdigital 
zones (undifferentiated mesenchyme) to the digit chondroblasts could be connected with the stage of 
chondroblast differentiation. At E12.5, majority of the digit chondroblasts are at early chondroblasts 
stage, while in E14.5 digits columnar chondroblasts form a major fraction. Congruent with this the 
GoPro49 expression in long bones was mainly seen in the proliferating and columnar chondroblasts, 
with little expression in the resting chondroblasts. 
BMP has been shown to be a major growth factor that regulates apoptosis in the interdigital zone, and 
the changes that it directs in these zones include downregulation of FGF signalling (Ganan et al., 1996, 
Montero et al., 2008, Bandyopadhyay et al., 2006, Pajni-Underwood et al., 2007). The Fgf8 expression 
is first downregulated in the interdigital areas, then in the digit condensations. Notably, neither Fgf8 nor 
Fgf4 expression has been observed in mouse limbs after E12.5 (Lewandoski et al., 2000, Salas-Vidal et 
al., 2001). These interdigital areas correspond to the areas where GoPro49 expression is observed first 
(at E12). GoPro49 expression in the digit chondroblasts follows a few days later (E14). The timing of 
Fgf downregulation coincides with upregulation of GoPro49 expression from interdigital areas to digits 
and could be significant in determining the areas where GoPro49 is expressed. Consistent with this, 
FGF4 caused a slight downregulation of GoPro49 expression in the tissue culture experiments. 
This interdigital expression of GoPro49 is interesting, as overexpression of the GoPro49 fusion 
protein in HeLa cells caused an increase in the number of apoptotic cells and caspase-3 activity compared 
to vector transfected cells (Figure 8E). On one hand this could suggest that GoPro49 has some role in the 
apoptotic cascade in these interdigital cells. The GC itself has been implicated in the ER stress-induced 
apoptosis, and several Golgi matrix proteins are known to be caspase targets during early apoptotic 
events, which functions to stop membrane traffic (Lowe et al., 2004, Maag et al., 2005). In addition, the 
GC can regulate intra-Golgi transport in cells with transport loads (Pulvirenti et al., 2008). Thus, it would 
be interesting to see what role GoPro49 has in these cells, and if it is a target for caspase cleavage. 
On the other hand, cells of the interdigital zone are undifferentiated mesenchyme capable of forming 
cartilage elements and ectopic digits (Ganan et al., 1996). This could suggest that GoPro49 already has a 
role in mesenchyme before formation of the cartilage condensations, even though expression increases 
in later stage chondroblasts. In line with this hypothesis, GoPro49 expression could also be detected 
in E10.5 limb bud RNA, where mesenchyme is still largely undifferentiated. The interdigital cells do 
not express Col II and the amount of secreted ECM is not nearly as high as in cartilage. Furthermore, 
in several species like bats, and in BMP2-BMP4 double conditional mice, these areas are retained 
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(Bandyopadhyay et al., 2006, Weatherbee et al., 2006). If GoPro49 is expressed in these areas in bats or 
in BMP2-BMP4 double conditional mice, this would indicate that the role of GoPro49 is not related to 
interdigital apoptosis.
In teeth GoPro49 was expressed most intensely in the condensed mesenchyme surrounding the tooth 
germ, but it was absent from the dental papilla mesenchyme (Publ. III and Publ. IV). The expression 
was limited to the dental follicle area at all the stages examined. At the bud stage the condensed dental 
mesenchyme is a morphologically homogenous cell population. The fact that GoPro49 is already 
differentially expressed in the presumptive dental follicle and papilla cells at the bud stage shows its 
usefulness as a marker for the dental follicle cells. However, at later stages the dental follicle consists 
of a heterogeneous population of cells that can differentiate into cementoblasts, osteoblasts and PDL 
fibroblasts (Nanci and Bosshardt, 2006). It could well be that GoPro49 is only expressed in a subset of 
these cells. 
GoPro49 expression was observed in the dental follicle of both incisors and molars, and during 
postnatal stages it was mainly expressed in the root follicle, but not in the crown follicle (Publ. IV). 
At least in dogs, the crown and root follicle appear to have different functions during tooth eruption 
(Marks, 1995, Marks and Cahill, 1987). The bone resorption that allows eruption of the tooth through 
the bone is regulated by the crown follicle, while the root follicle stimulates bone formation at the tip 
of the root, and this is necessary for tooth movement towards the oral cavity (Marks and Cahill, 1987). 
This could indicate a specific function for GoPro49 in the root follicle, perhaps related to the eruption 
and movement of the tooth. How GoPro49 might participate in this process remains to be seen.
During postnatal tooth development, strong GoPro49 expression was observed in the dental follicle, 
but not in the mature periodontal ligament (Publ. IV). This is well in line with observation that it is 
expressed in columnar chondroblasts, but not in the terminally differentiated hypertrophic chondrocytes 
(Publ. III). However, while dental follicle cells may form several cell types, the columnar chondroblast 
are already committed to the chondrocyte linage and they show as almost synchronised stage of 
differentiation with neighbouring cells (Lefebvre and Smits, 2005). Whether protein function is linked 
to the differentiation level of cells requires further study. Cartilage and dental follicle have in common 
the formation of connective tissue, and the secretion of extensive fibrous ECM. Perhaps trafficking 
of specific cargo (such as Col II), or a change in the membrane transport load could trigger GoPro49 
expression.
In addition to the mesenchymal tissues where GoPro49 expression was detected on the RNA level, 
our proteomic study showed GoPro49 to be expressed in liver. However, little expression was observed 
in embryonic liver using in situ hybridisation, but expression levels in adult tissues could be different. 
Some expression was detected in the floor plate at E13, and in the brain. As the probe used may also 
detect the shorter isoform, it will be interesting to study which isoform is expressed in neurons. It could 
be that the isoform B expression could explain some of these differences in expression in different 
tissues. 
Besides the large scale genome sequencing approaches and our studies there is only one other 
publication about GoPro49, in which GoPro49 is mapped to an autism locus (Morrow et al., 2008). 
These authors describe a large, 886-kbp homozygous deletion in 3q24 [including the whole coding 
region for GoPro49/DIA1 (deleted in autism 1)] as a possible cause for autism in one patient affected by 
autism and epilepsy (Morrow et al., 2008). This human deletion indicates that GoPro49 functions can 
be compensated for by other proteins during development; but whether it is a cause of autism remains 
to be seen, as the large deletion also included several other genes. Furthermore, as no growth phenotype 
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was reported in this patient, the role of GoPro49 in cartilage development can not be indispensable. 
Nevertheless, as this deletion was only detected in one patient, subtle phenotypes in growth can not be 
excluded. In addition, whether the longer or shorter isoform is the one expressed in the human postnatal 
brain was not addressed in that study.
Morrow et al. also suggest that the gene is a downstream target of the MEF2 transcription factor, as 
MEF2A and MEF2D lentivirus RNAi vectors caused downregulation of GoPro49 gene expression in 
cultured, activated rat hippocampal neurons. In addition, after depolarisation with KCl the GoPro49/
DIA1 gene expression increased (~1.4x) in rat hippocampal cultures, as detected by using an Affymetrix 
microarray, which recognises the longer isoform. Based on GoPro49 downregulation by MEF2 RNAi, 
it would be interesting to study whether the third MEF2 transcription factor (MEF2C), which activates 
Col X and VEGF expression (Arnold et al., 2007), could also regulate GoPro49 expression. 
GoPro49 localisation in 5.3 β-COP positive structures and possible 
function
GoPro49 was shown to localise to the GC as an EGFP-fusion protein and to co-localise with GM130 in 
HeLa cells (Publ. I). However, the endogenous protein co-localised with β-COP in chondrosarcoma cells, 
but only slightly with the cis-Golgi marker GM130 (Publ. III and Publ. IV). The observed difference in 
the localisation of the endogenous GoPro49 and the EGFP-fusion protein could be due to various factors. 
Firstly, chondrosarcoma cells have a higher amount of secretory cargo than HeLa cells. Secondly, the 
tag could interfere with some protein interactions required for correct cellular localisation. Thirdly, 
overexpression might alter the localisation. The latter hypothesis is not surprising if we consider that the 
protein is in the secretory pathway. Membrane trafficking is a very sensitive system, and overexpression 
of any of its components might disturb the natural balance and alter the localisation (Cosson et al., 
2005). 
The endogenous protein localisation suggests that the protein might have a role in the secretory 
pathway, maybe in membrane transport events between the ER and the GC. The β-COP staining observed 
in the chondrosarcoma cells was broader and more tubular than GM130 in the cis-Golgi, and it could 
indicate COPI vesicles in the ERGIC. Furthermore, the atypically long vesicles/tubules seen in these 
cells could reflect the differential requirements of cartilage matrix transport (such as Col II). Indeed, 
when the amount of newly synthesised proteins transported from the ER was reduced by treatment with 
cycloheximine, both GoPro49 and β-COP were observed in more juxtanuclear structures (Publ. III, Fig 
7). In addition, the vesicular/tubular morphology of these β-COP positive structures was considerably 
reduced. However, cycloheximine treatment might also affect the cytoskeleton and thus reduce tubule 
formation from the GC.
What role could GoPro49 have in the β-COP positive membranes, especially in cartilage? The co-
localisation of GoPro49 and Col II in these β-COP-positive structures could suggest a role in ECM 
secretion, for example as a specific chaperone for ECM protein or as a receptor in recycling or transport 
of Col II. Proteins that have been identified in COPI vesicles include proteins needed for recruitment and 
formation of the coat: p23/24, coatomer subunits, Arf and ArfGAP; and cargo receptors like the KDEL-
receptor and cargo (Lowe and Kreis, 1996, Palmer et al., 1993, Tanigawa et al., 1993, Gommel et al., 
2001, Lanoix et al., 2001, Reinhard et al., 2003). In addition, proteins that participate in the tethering 
event, such as Giantin and p115, have been found in these vesicles (Sonnichsen et al., 1998). 
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Whether these potential COPI vesicles are retrograde or possible anterograde transport vesicles was 
not addressed in this study. However, if these membranes participate in retrograde transport towards 
the ER, what could be the role of GoPro49? Could it behave as a specific chaperone for Col II and 
assist in its folding? Or could it act as a receptor that detects unfolded or unassembled collagen and 
relocates it to the ER? The GoPro49 sequence does not contain any typical heat shock protein domains, 
but this is also true for the collagen-specific chaperon Hsp47 (SMART domains, Letunic et al., 2008). 
Furthermore, Hsp47 and GoPro49 proteins are roughly the same size, and both are predicted to have two 
large globular domains separated by a short linker (Puntervoll et al., 2003). 
If these membranes are moving in an anterograde direction, they are probably involved in transport 
from the ERGIC to the GC. According to the current view, procollagen I is too large to be accommodated 
in small vesicles and is transported through the GC without leaving the lumen (Bonfanti et al., 1998), 
which is also likely the case for Col II. Thus if collagen does not utilise vesicles for intra-Golgi transport, 
it should not cause such tubulation in the morphology of the β-COP positive structure, unless the pre-
Golgi stage is the one affected. 
Orthologous genes for GoPro49 have been identified in several species, and the sequence identity is 
high. However, as orthologous sequences were also found in non-vertebrate species, it is unlikely that 
the protein has a role only in cartilage ECM or collagen secretion. Perhaps GoPro49 activity is related 
to the transport of large or difficult cargo. Nevertheless, some non-vertebrates do express collagen-like 
proteins (Livingston et al., 2006), so there could be some similarities in their cargo too. While there 
was a clear increase in GoPro49 expression levels from E7 to E15 in mice (Publ. III and Figure 8B), 
the orthologous zebrafish genes were detected already in the maternal RNA pool, and with relatively 
constant levels from 0.5 h to 72 h pf. During this time (by 72 h post fertilisation) the first cartilaginous 
elements of the zebrafish craniofacial area have already formed (Kimmel et al., 1995). This suggests that 
in zebrafish these genes may be required at an earlier stage than the corresponding gene is in mouse.
The only siRNA phenotype that was observed was characterised by a slight tubulation of β-COP-
stained structures. This suggests that GoPro49 might have a role in the assembly or packing of these 
membranes. Whether the lack of phenotype in morpholino k.d. zebrafish was due to inefficient k.d. by 
morpholinos or to paralogous gene functions is unclear. Unfortunately, the dose of morpholinos in the 
double k.d. experiments could not be increased as the concentration used was close to that reported for 
non-sequence specific effects. In addition, the early presence of maternal RNA makes the morpholino 
k.d. less efficient. Regardless, the gene deletion in the autism patient would suggest that GoPro49 
functions can be compensated for during development and formation of cartilage (Morrow et al., 2008). 
However, as this deletion has been found in only a single patient, the presence of a subtle phenotype in 
cartilage might be possible. 
Potential regulation mechanisms of GoPro49 expression5.4 
Based on the GoPro49 expression in columnar chondroblasts and dental follicle, and known signalling in 
these tissues, what growth factors could regulate GoPro49 expression? Which of them should be studied 
further? FGF did not upregulate GoPro49 in our tissue culture experiment; instead it seemed to slightly 
downregulate its expression. The role of FGFs is to promote proliferation of chondroblast progenitors, 
and to inhibit differentiation during limb bud formation (Lu et al., 2008b, Moon and Capecchi, 2000, 
Lewandoski et al., 2000). Furthermore, the expression of Fgfs in AER is reduced by E11.5-12.5, when 
GoPro49 expression is still prominent (Lewandoski et al., 2000, Salas-Vidal et al., 2001). Thus, the 
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role of FGF might be to downregulate GoPro49 expression at earlier stages. The FGF receptors are 
expressed throughout the limb mesenchyme at early stages, but then become restricted to condensations 
and cartilage (Delezoide et al., 1998). Thus FGF signalling is active in these cells. 
The Wnt pathway is a good candidate to be a regulatory pathway for GoPro49 expression, because 
several Tcf/Lef sites (Wnt/β-catenin) were identified in the 5’ upstream sequence. However, canonical 
Wnt signalling inhibits chondrogenesis, and expression of active β-catenin in early chondrocytes blocks 
differentiation and mineralisation (Tamamura et al., 2005, Akiyama et al., 2004), which is the opposite 
of the GoPro49 expression pattern in columnar chondroblasts. In contrast, non-canonical Wnt signalling 
promotes proliferation and differentiation of chondroblasts, but in this regulation it does not use the Tcf/
Lef transcription factors (Yang et al., 2003, Topol et al., 2003).
BMPs (Smads and Sox5 sites) are expressed between digits and have a role in interdigital apoptosis 
(Ganan et al., 1996, Montero et al., 2008, Bandyopadhyay et al., 2006). BMPs also regulate the 
transition from proliferating, columnar chondroblasts to hypertrophic chondrocytes (Adams et al., 
2007). Furthermore, the balance between FGF and BMP signalling is believed to determine the pace of 
proliferation versus differentiation (Minina et al., 2002). All these correlate well with GoPro49 expression 
in columnar chondroblasts, and thus BMP is a good candidate to mediate regulation. In addition, TGFβ 
family signalling positively regulates chondroblast differentiation from progenitor mesenchyme via p38 
kinase pathway (Watanabe et al., 2001, Oh et al., 2000). Thus TGFβs could also be likely candidates for 
regulation. The reason why the bead induction assay did not reveal these pathways could be related to 
the fact that the probe for GoPro49 was not suited to whole mount in situ hybridisation, and therefore 
other methods of detection such as RT-PCR should be tested. Furthermore, the fact that at the time point 
studied (E11.5 to E12.5) BMP promotes apoptosis in limb mesenchyme, which decreases the number of 
cells possibly especially those where GoPro49 is expressed, could make the detection more difficult. 
The fourth major regulator of chondrogenesis, Ihh, promotes chondrocyte hypertrophy and 
chondroblast differentiation in a regulatory loop with PTHrP and also independently (Kobayashi 
et al., 2005, Lanske et al., 1996, Vortkamp et al., 1996). This does not coincide well with GoPro49 
expression in columnar chondroblasts. In addition, no Gli sites were observed in the 2kb upstream 
sequence. However, the other half of this regulatory loop, PTHrP, could be a possible regulator. PTHrP 
promotes columnar chondroblast proliferation and it suppresses entry into hypertrophy (Lanske et al., 
1996, Vortkamp et al., 1996). The target cells for PTHrP signalling match exactly with the cells where 
GoPro49 expression was observed. 
Growth factors that regulate dental follicle and root formation are not as well characterised as 
those for cartilage. Enamel knot is known to signal to the dental papilla and to promote proliferation. 
Downregulation of FGF10 is important for root formation, and BMP4 regulates formation of HERS 
(Thesleff, 2006, Yokohama-Tamaki et al., 2006, Hosoya et al., 2008). However, none of these growth 
factors have been directly linked to dental follicle development, which might or might not be regulated 
in a manner similar to the dental papilla. In conclusion, at present there is not sufficient information to 
provide rationalisation for the regulation of GoPro49 in the dental follicle.  
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concLuDing remarks6 
Although much is known about transport and cell biological aspects of the Golgi complex, the difference 
in the secretory pathway between different tissues has not been thoroughly explored, with the focus being 
on the cellular level (and on a few cell lines). However, different tissues have different requirements and 
cargo, and many aspects of transport may depend on the cell type, organism or developmental stage. 
This thesis describes identification and characterisation of a novel protein, GoPro49 that localises to 
the β-COP positive structures based on immunofluorescence, and is expressed mainly in cartilage during 
embryogenesis. GoPro49 expression levels seem to be linked with the differentiation stage of cartilage 
and dental follicle cells, and may be connected to transport of specific types of cargo, such as Col II. 
This restricted expression pattern also raises the question of whether there are other Golgi proteins with 
tissue specific expression patterns. Based on the localisation in the β-COP positive structures, GoPro49 
is likely to have a role in membrane traffic. However, what exact role this protein or its shorter isoform 
has will require further study. Furthermore, whether the two splice variants have similar expression 
patterns remains to be seen. 
Retrospectively, it is surprising how few studies there are on cell biological aspects of both cartilage 
and dental follicle. Both of these connective tissues have a large impact on the individual if their 
functions, including secretion of the matrix, are impaired. The morphology and ECM are well known, 
but molecular mechanisms, for example of Col transport, are still not known in detail. The differential, 
large cargo of chondroblasts, mainly Col II, might also explain why these cells would require a different 
set of Golgi proteins, especially during development.
57
acknowLeDgements
This study has been carried out at the Department of Biological and Environmental Sciences, in the 
Division of Biochemistry, University of Helsinki, under the supervision of Ragna Rönnholm during the 
years 2002-2009. The work has been financially supported by the Magnus Ehrnrooth foundation, the 
Viikki Graduate School in Molecular Biosciences, The Finnish Society of Science and Letters, and The 
Academy of Finland.
I want to thank Professor Carl G. Gahmberg for providing excellent facilities for this work and for 
his support during the years. 
I also wish to thank my supervisor Ragna Rönnholm for her advice and support during this long 
project. 
I am grateful for Docents Marjo Salminen and Jussi Jäntti for careful reviewing of my thesis and for 
their constructive comments. 
I want to express my gratitude to all the co-authors for excellent collaboration: Petri, Garry, and Tuula 
for the proteomic study, and Elina, Saara, Mark and Irma for the developmental studies on GoPro49. I 
also want to thank Riikka, Merja and Raija for their technical assistance. 
Docents Jussi Jäntti and Tuomas Haltia are also acknowledged for their supportive role in the follow-
up group. 
To all the past and present colleagues in the Biochemistry division, thanks for the time working 
together, and for all the help given during these years. In particullar, I want to acknowledge Leena 
and Maria for their technical assistance. Anne, Maria, Pauli, Silvia, Suski, Susanna, Tiina, and Terhi, 
thanks for all the nice times in the coffee-room and after work, and Silvia also for the help with English 
grammar. 
To my friends, Kirsi, Kaisa, Päivi, Hanna, Laura, and Satu thanks for understanding what it is like 
to make a PhD, and to Anna, Anu, and Fils for taking my mind off from it. Thanks for your friendship, 
it made this journey bearable. From now on, I will have more time for all of you.
I want to thank my family, mum, dad and Taimi, Mervi for all your support: I would not be here 
today without it. And last but not least, I want to thank Ari, especially for coping with me during the last 
stage of this project. Without you, this would have been so much more difficult. 
Maarit
58
references
adams, s.l., A.J. Cohen, and L. Lassova. 2007. Integration of signaling pathways regulating chondrocyte 
differentiation during endochondral bone formation. J.Cell.Physiol. 213:635-641.
ahn, K., Y. Mishina, M.C. Hanks, R.R. Behringer, and E.B. Crenshaw 3rd. 2001. BMPR-IA signaling is required for 
the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development. 128:4449-
4461.
akiyama, h., M.C. Chaboissier, J.F. Martin, A. Schedl, and B. de Crombrugghe. 2002. The transcription factor Sox9 
has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression 
of Sox5 and Sox6. Genes Dev. 16:2813-2828.
akiyama, h., J.P. Lyons, Y. Mori-Akiyama, X. Yang, R. Zhang, Z. Zhang, J.M. Deng, M.M. Taketo, T. Nakamura, 
R.R. Behringer, P.D. McCrea, and B. de Crombrugghe. 2004. Interactions between Sox9 and beta-catenin 
control chondrocyte differentiation. Genes Dev. 18:1072-1087.
alder, n.n., and A.E. Johnson. 2004. Cotranslational membrane protein biogenesis at the endoplasmic reticulum. 
J.Biol.Chem. 279:22787-22790.
altan-bonnet, n., R. Sougrat, and J. Lippincott-Schwartz. 2004. Molecular basis for Golgi maintenance and 
biogenesis. Curr.Opin.Cell Biol. 16:364-372.
anelli, T., and R. Sitia. 2008. Protein quality control in the early secretory pathway. EMBO J. 27:315-327.
aridor, m., S.I. Bannykh, T. Rowe, and W.E. Balch. 1995. Sequential coupling between COPII and COPI vesicle 
coats in endoplasmic reticulum to Golgi transport. J.Cell Biol. 131:875-893.
aridor, m., J. Weissman, S. Bannykh, C. Nuoffer, and W.E. Balch. 1998. Cargo selection by the COPII budding 
machinery during export from the ER. J.Cell Biol. 141:61-70.
arnold, m.a., Y. Kim, M.P. Czubryt, D. Phan, J. McAnally, X. Qi, J.M. Shelton, J.A. Richardson, R. Bassel-Duby, 
and E.N. Olson. 2007. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. 
Dev.Cell. 12:377-389.
bachi, a., and T. Bonaldi. 2008. Quantitative proteomics as a new piece of the systems biology puzzle. J.Proteomics. 
71:357-367.
bahassi el, m., C.W. Conn, D.L. Myer, R.F. Hennigan, C.H. McGowan, Y. Sanchez, and P.J. Stambrook. 2002. 
Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. 
Oncogene. 21:6633-6640.
bandyopadhyay, a., K. Tsuji, K. Cox, B.D. Harfe, V. Rosen, and C.J. Tabin. 2006. Genetic Analysis of the Roles of 
BMP2, BMP4, and BMP7 in Limb Patterning and Skeletogenesis. PLoS Genet. 2:e216.
barlowe, c., L. Orci, T. Yeung, M. Hosobuchi, S. Hamamoto, N. Salama, M.F. Rexach, M. Ravazzola, M. Amherdt, 
and R. Schekman. 1994. COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the 
endoplasmic reticulum. Cell. 77:895-907.
barr, f.a., and J. Egerer. 2005. Golgi positioning: are we looking at the right MAP? J.Cell Biol. 168:993-998.
barr, f.a., M. Puype, J. Vandekerckhove, and G. Warren. 1997. GRASP65, a protein involved in the stacking of 
Golgi cisternae. Cell. 91:253-262.
barrow, J.r., K.R. Thomas, O. Boussadia-Zahui, R. Moore, R. Kemler, M.R. Capecchi, and A.P. McMahon. 
2003. Ectodermal Wnt3/beta-catenin signaling is required for the establishment and maintenance of the apical 
ectodermal ridge. Genes Dev. 17:394-409.
bascom, r.a., S. Srinivasan, and R.L. Nussbaum. 1999. Identification and characterization of golgin-84, a novel 
Golgi integral membrane protein with a cytoplasmic coiled-coil domain. J.Biol.Chem. 274:2953-2962.
beck, r., Z. Sun, F. Adolf, C. Rutz, J. Bassler, K. Wild, I. Sinning, E. Hurt, B. Brugger, J. Bethune, and F. Wieland. 
2008. Membrane curvature induced by Arf1-GTP is essential for vesicle formation. Proc.Natl.Acad.Sci.U.S.A. 
105:11731-11736.
bei, m., K. Kratochwil, and R.L. Maas. 2000. BMP4 rescues a non-cell-autonomous function of Msx1 in tooth 
development. Development. 127:4711-4718.
bell, a.w., M.A. Ward, W.P. Blackstock, H.N. Freeman, J.S. Choudhary, A.P. Lewis, D. Chotai, A. Fazel, J.N. Gushue, 
J. Paiement, S. Palcy, E. Chevet, M. Lafreniere-Roula, R. Solari, D.Y. Thomas, A. Rowley, and J.J. Bergeron. 
2001. Proteomics characterization of abundant Golgi membrane proteins. J.Biol.Chem. 276:5152-5165.
benmerah, a., and C. Lamaze. 2007. Clathrin-coated pits: vive la difference? Traffic. 8:970-982.
berkovitz, b.K. 2004. Periodontal ligament: structural and clinical correlates. Dent.Update. 31:46-50, 52, 54.
berninsone, p.m., and C.B. Hirschberg. 2000. Nucleotide sugar transporters of the Golgi apparatus. Curr.Opin.
Struct.Biol. 10:542-547.
bethune, J., F. Wieland, and J. Moelleken. 2006. COPI-mediated transport. J.Membr.Biol. 211:65-79.
bigay, J., J.F. Casella, G. Drin, B. Mesmin, and B. Antonny. 2005. ArfGAP1 responds to membrane curvature through 
the folding of a lipid packing sensor motif. EMBO J. 24:2244-2253.
birney, e., T.D. Andrews, P. Bevan, M. Caccamo, Y. Chen, L. Clarke, G. Coates, J. Cuff, V. Curwen, T. Cutts, T. 
Down, E. Eyras, X.M. Fernandez-Suarez, P. Gane, B. Gibbins, J. Gilbert, M. Hammond, H.R. Hotz, V. Iyer, K. 
Jekosch, A. Kahari, A. Kasprzyk, D. Keefe, S. Keenan, H. Lehvaslaiho, G. McVicker, C. Melsopp, P. Meidl, 
E. Mongin, R. Pettett, S. Potter, G. Proctor, M. Rae, S. Searle, G. Slater, D. Smedley, J. Smith, W. Spooner, A. 
Stabenau, J. Stalker, R. Storey, A. Ureta-Vidal, K.C. Woodwark, G. Cameron, R. Durbin, A. Cox, T. Hubbard, 
and M. Clamp. 2004. An overview of Ensembl. Genome Res. 14:925-928.
bisel, b., Y. Wang, J.H. Wei, Y. Xiang, D. Tang, M. Miron-Mendoza, S. Yoshimura, N. Nakamura, and J. Seemann. 
2008. ERK regulates Golgi and centrosome orientation towards the leading edge through GRASP65. J.Cell 
Biol. 182:837-843.
bivona, T.g., I. Perez De Castro, I.M. Ahearn, T.M. Grana, V.K. Chiu, P.J. Lockyer, P.J. Cullen, A. Pellicer, A.D. Cox, 
and M.R. Philips. 2003. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. 
Nature. 424:694-698.
59
bonazzi, m., S. Spano, G. Turacchio, C. Cericola, C. Valente, A. Colanzi, H.S. Kweon, V.W. Hsu, E.V. Polishchuck, 
R.S. Polishchuck, M. Sallese, T. Pulvirenti, D. Corda, and A. Luini. 2005. CtBP3/BARS drives membrane 
fission in dynamin-independent transport pathways. Nat.Cell Biol. 7:570-580.
bonfanti, l., A.A. Mironov Jr, J.A. Martinez-Menarguez, O. Martella, A. Fusella, M. Baldassarre, R. Buccione, H.J. 
Geuze, A.A. Mironov, and A. Luini. 1998. Procollagen traverses the Golgi stack without leaving the lumen of 
cisternae: evidence for cisternal maturation. Cell. 95:993-1003.
bonifacino, J.s., and R. Rojas. 2006. Retrograde transport from endosomes to the trans-Golgi network. Nat.Rev.Mol.
Cell Biol. 7:568-579.
bonifacino, J.s., and L.M. Traub. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. 
Annu.Rev.Biochem. 72:395-447.
boulet, a.m., A.M. Moon, B.R. Arenkiel, and M.R. Capecchi. 2004. The roles of Fgf4 and Fgf8 in limb bud initiation 
and outgrowth. Dev.Biol. 273:361-372.
Boyadjiev, S.A., J.C. Fromme, J. Ben, S.S. Chong, C. Nauta, D.J. Hur, G. Zhang, S. Hamamoto, R. Schekman, M. 
Ravazzola, L. Orci, and W. Eyaid. 2006. Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation 
leading to abnormal endoplasmic-reticulum-to-Golgi trafficking. Nat.Genet. 38:1192-1197.
bretscher, m.s., and S. Munro. 1993. Cholesterol and the Golgi apparatus. Science. 261:1280-1281.
breuza, l., R. Halbeisen, P. Jeno, S. Otte, C. Barlowe, W. Hong, and H.P. Hauri. 2004. Proteomics of endoplasmic 
reticulum-Golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies 
ERGIC-32, a new cycling protein that interacts with human Erv46. J.Biol.Chem. 279:47242-47253.
brockhausen i, Schachter H, Stanley P. 2009. Structure and Biosynthesis of O-GalNAc Glycans. In: Essentials of 
Glycobiology, 2nd edition. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, 
Etzler ME, ed. Cold Spring Harbor Laboratory Press.
busse, m., A. Feta, J. Presto, M. Wilen, M. Gronning, L. Kjellen, and M. Kusche-Gullberg. 2007. Contribution of 
EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J.Biol.Chem. 282:32802-32810.
cai, h., S. Yu, S. Menon, Y. Cai, D. Lazarova, C. Fu, K. Reinisch, J.C. Hay, and S. Ferro-Novick. 2007. TRAPPI 
tethers COPII vesicles by binding the coat subunit Sec23. Nature. 445:941-944.
carcedo, c.h., M. Bonazzi, S. Spano, G. Turacchio, A. Colanzi, A. Luini, and D. Corda. 2004. Mitotic Golgi 
partitioning is driven by the membrane-fissioning protein CtBP3/BARS. Science. 305:93-96.
chen, c.h. 2008. Review of a current role of mass spectrometry for proteome research. Anal.Chim.Acta. 624:16-
36.
chen, g., and B.N. Pramanik. 2008. LC-MS for protein characterization: current capabilities and future trends. 
Expert Rev.Proteomics. 5:435-444.
chen, m., M. Zhu, H. Awad, T.F. Li, T.J. Sheu, B.F. Boyce, D. Chen, and R.J. O’Keefe. 2008. Inhibition of beta-
catenin signaling causes defects in postnatal cartilage development. J.Cell.Sci. 121:1455-1465.
chiang, C., Y. Litingtung, M.P. Harris, B.K. Simandl, Y. Li, P.A. Beachy, and J.F. Fallon. 2001. Manifestation of the 
limb prepattern: limb development in the absence of sonic hedgehog function. Dev.Biol. 236:421-435.
chintala, s.K., R.R. Miller, and C.A. McDevitt. 1995. Role of heparan sulfate in the terminal differentiation of 
growth plate chondrocytes. Arch.Biochem.Biophys. 316:227-234.
colanzi, a., and D. Corda. 2007. Mitosis controls the Golgi and the Golgi controls mitosis. Curr.Opin.Cell Biol. 
19:386-393.
colanzi, a., C. Hidalgo Carcedo, A. Persico, C. Cericola, G. Turacchio, M. Bonazzi, A. Luini, and D. Corda. 2007. 
The Golgi mitotic checkpoint is controlled by BARS-dependent fission of the Golgi ribbon into separate stacks 
in G2. EMBO J. 26:2465-2476.
cosson, p., M. Ravazzola, O. Varlamov, T.H. Sollner, M. Di Liberto, A. Volchuk, J.E. Rothman, and L. Orci. 2005. 
Dynamic transport of SNARE proteins in the Golgi apparatus. Proc.Natl.Acad.Sci.U.S.A. 102:14647-14652.
cygan, J.a., R.L. Johnson, and A.P. McMahon. 1997. Novel regulatory interactions revealed by studies of murine 
limb pattern in Wnt-7a and En-1 mutants. Development. 124:5021-5032.
Dahn, r.D., and J.F. Fallon. 2000. Interdigital regulation of digit identity and homeotic transformation by modulated 
BMP signaling. Science. 289:438-441.
Daleke, D.l. 2007. Phospholipid flippases. J.Biol.Chem. 282:821-825.
Datta, h.K., W.F. Ng, J.A. Walker, S.P. Tuck, and S.S. Varanasi. 2008. The cell biology of bone metabolism. J.Clin.
Pathol. 61:577-587.
Degroote, s., J. Wolthoorn, and G. van Meer. 2004. The cell biology of glycosphingolipids. Semin.Cell Dev.Biol. 
15:375-387.
Delaurier, a., R. Schweitzer, and M. Logan. 2006. Pitx1 determines the morphology of muscle, tendon, and bones 
of the hindlimb. Dev.Biol. 299:22-34.
Delezoide, a.l., C. Benoist-Lasselin, L. Legeai-Mallet, M. Le Merrer, A. Munnich, M. Vekemans, and J. Bonaventure. 
1998. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech.Dev. 
77:19-30.
Dong, y.f., Y. Soung do, E.M. Schwarz, R.J. O’Keefe, and H. Drissi. 2006. Wnt induction of chondrocyte hypertrophy 
through the Runx2 transcription factor. J.Cell.Physiol. 208:77-86.
Dormeyer, w., D. van Hoof, S.R. Braam, A.J. Heck, C.L. Mummery, and J. Krijgsveld. 2008. Plasma membrane 
proteomics of human embryonic stem cells and human embryonal carcinoma cells. J.Proteome Res. 7:2936-
2951.
Drin, g., V. Morello, J.F. Casella, P. Gounon, and B. Antonny. 2008. Asymmetric tethering of flat and curved lipid 
membranes by a golgin. Science. 320:670-673.
Dudognon, p., C. Maeder-Garavaglia, J.L. Carpentier, and J.P. Paccaud. 2004. Regulation of a COPII component by 
cytosolic O-glycosylation during mitosis. FEBS Lett. 561:44-50.
Duncan, g., C. McCormick, and F. Tufaro. 2001. The link between heparan sulfate and hereditary bone disease: 
finding a function for the EXT family of putative tumor suppressor proteins. J.Clin.Invest. 108:511-516.
60
ehlen, h.w., L.A. Buelens, and A. Vortkamp. 2006. Hedgehog signaling in skeletal development. Birth Defects 
Res.C.Embryo.Today. 78:267-279.
elhammer, a., and S. Kornfeld. 1986. Purification and characterization of UDP-N-acetylgalactosamine: polypeptide 
N-acetylgalactosaminyltransferase from bovine colostrum and murine lymphoma BW5147 cells. J.Biol.Chem. 
261:5249-5255.
elsner, m., H. Hashimoto, and T. Nilsson. 2003. Cisternal maturation and vesicle transport: join the band wagon! 
(Review). Mol.Membr.Biol. 20:221-229.
emanuelsson, o., S. Brunak, G. von Heijne, and H. Nielsen. 2007. Locating proteins in the cell using TargetP, 
SignalP and related tools. Nat.Protoc. 2:953-971.
enomoto, H., M. Enomoto-Iwamoto, M. Iwamoto, S. Nomura, M. Himeno, Y. Kitamura, T. Kishimoto, and T. 
Komori. 2000. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J.Biol.Chem. 275:8695-8702.
eppig, J.T., J.A. Blake, C.J. Bult, J.E. Richardson, J.A. Kadin, M. Ringwald, and The MGI staff. 2007. Mouse 
genome informatics (MGI) resources for pathology and toxicology. Toxicol.Pathol. 35:456-457.
feinstein, T.n., and A.D. Linstedt. 2008. GRASP55 Regulates Golgi Ribbon Formation. Mol.Biol.Cell. 19:2696-
2707.
feinstein, T.n., and A.D. Linstedt. 2007. Mitogen-activated protein kinase kinase 1-dependent Golgi unlinking 
occurs in G2 phase and promotes the G2/M cell cycle transition. Mol.Biol.Cell. 18:594-604.
fenn, J.b., M. Mann, C.K. Meng, S.F. Wong, and C.M. Whitehouse. 1989. Electrospray ionization for mass 
spectrometry of large biomolecules. Science. 246:64-71.
fernandez-ulibarri, i., M. Vilella, F. Lazaro-Dieguez, E. Sarri, S.E. Martinez, N. Jimenez, E. Claro, I. Merida, K.N. 
Burger, and G. Egea. 2007. Diacylglycerol is required for the formation of COPI vesicles in the Golgi-to-ER 
transport pathway. Mol.Biol.Cell. 18:3250-3263.
fong, h.K., B.L. Foster, T.E. Popowics, and M.J. Somerman. 2005. The crowning achievement: getting to the root 
of the problem. J.Dent.Educ. 69:555-570.
franceschi, r.T., and G. Xiao. 2003. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness 
to multiple signal transduction pathways. J.Cell.Biochem. 88:446-454.
fritzler, m.J., C.C. Lung, J.C. Hamel, K.J. Griffith, and E.K. Chan. 1995. Molecular characterization of Golgin-245, 
a novel Golgi complex protein containing a granin signature. J.Biol.Chem. 270:31262-31268.
fromme, J.c., M. Ravazzola, S. Hamamoto, M. Al-Balwi, W. Eyaid, S.A. Boyadjiev, P. Cosson, R. Schekman, and 
L. Orci. 2007. The genetic basis of a craniofacial disease provides insight into COPII coat assembly. Dev.Cell. 
13:623-634.
ganan, y., D. Macias, M. Duterque-Coquillaud, M.A. Ros, and J.M. Hurle. 1996. Role of TGF beta s and BMPs as 
signals controlling the position of the digits and the areas of interdigital cell death in the developing chick limb 
autopod. Development. 122:2349-2357.
gehron robey, p. 1996. Bone matrix proteoglycans and glycoproteins. In: Principles of bone biology. Bilezikian JP, 
Raisz LG, Rodan GA. Ed., San Diego: Academic Press. 155–165. 
gerstenfeld, l.c., and F.D. Shapiro. 1996. Expression of bone-specific genes by hypertrophic chondrocytes: 
implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. 
J.Cell.Biochem. 62:1-9.
gilchrist, a., C.E. Au, J. Hiding, A.W. Bell, J. Fernandez-Rodriguez, S. Lesimple, H. Nagaya, L. Roy, S.J. Gosline, 
M. Hallett, J. Paiement, R.E. Kearney, T. Nilsson, and J.J. Bergeron. 2006. Quantitative proteomics analysis of 
the secretory pathway. Cell. 127:1265-1281.
gillingham, a.K., and S. Munro. 2007. The small G proteins of the Arf family and their regulators. Annu.Rev.Cell 
Dev.Biol. 23:579-611.
gillingham, a.K., A.C. Pfeifer, and S. Munro. 2002. CASP, the alternatively spliced product of the gene encoding 
the CCAAT-displacement protein transcription factor, is a Golgi membrane protein related to giantin. Mol.Biol.
Cell. 13:3761-3774.
goldring, m.B., K. Tsuchimochi, and K. Ijiri. 2006. The control of chondrogenesis. J.Cell.Biochem. 97:33-44.
gommel, D.u., A.R. Memon, A. Heiss, F. Lottspeich, J. Pfannstiel, J. Lechner, C. Reinhard, J.B. Helms, W. Nickel, 
and F.T. Wieland. 2001. Recruitment to Golgi membranes of ADP-ribosylation factor 1 is mediated by the 
cytoplasmic domain of p23. EMBO J. 20:6751-6760.
gorsi, b., and S.E. Stringer. 2007. Tinkering with heparan sulfate sulfation to steer development. Trends Cell Biol. 
17:173-177.
goss, J.w., and D.K. Toomre. 2008. Both daughter cells traffic and exocytose membrane at the cleavage furrow 
during mammalian cytokinesis. J.Cell Biol. 181:1047-1054.
grzesik, w.J., and A.S. Narayanan. 2002. Cementum and periodontal wound healing and regeneration. Crit.Rev.
Oral Biol.Med. 13:474-484.
guillen, e., C. Abeijon, and C.B. Hirschberg. 1998. Mammalian Golgi apparatus UDP-N-acetylglucosamine 
transporter: molecular cloning by phenotypic correction of a yeast mutant. Proc.Natl.Acad.Sci.U.S.A. 95:7888-
7892.
gupta, v., K.J. Palmer, P. Spence, A. Hudson, and D.J. Stephens. 2008. Kinesin-1 (uKHC/KIF5B) is required for 
bidirectional motility of ER exit sites and efficient ER-to-Golgi transport. Traffic. 9:1850-1866.
han, x., A. Aslanian, and J.R. Yates 3rd. 2008. Mass spectrometry for proteomics. Curr.Opin.Chem.Biol. 
harada, h., P. Kettunen, H.S. Jung, T. Mustonen, Y.A. Wang, and I. Thesleff. 1999. Localization of putative stem 
cells in dental epithelium and their association with Notch and FGF signaling. J.Cell Biol. 147:105-120.
harada, h., T. Toyono, K. Toyoshima, and H. Ohuchi. 2002. FGF10 maintains stem cell population during mouse 
incisor development. Connect.Tissue Res. 43:201-204.
harder, T., P. Scheiffele, P. Verkade, and K. Simons. 1998. Lipid domain structure of the plasma membrane revealed 
by patching of membrane components. J.Cell Biol. 141:929-942.
helms, J.a., and R.A. Schneider. 2003. Cranial skeletal biology. Nature. 423:326-331.
61
hill, r.e. 2007. How to make a zone of polarizing activity: insights into limb development via the abnormality 
preaxial polydactyly. Dev.Growth Differ. 49:439-448.
hillenkamp, f., and M. Karas. 1990. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser 
desorption/ionization. Methods Enzymol. 193:280-295.
hilton, m.J., L. Gutierrez, D.A. Martinez, and D.E. Wells. 2005. EXT1 regulates chondrocyte proliferation and 
differentiation during endochondral bone development. Bone. 36:379-386.
ho, w.c., V.J. Allan, G. van Meer, E.G. Berger, and T.E. Kreis. 1989. Reclustering of scattered Golgi elements 
occurs along microtubules. Eur.J.Cell Biol. 48:250-263.
holmbeck, K., P. Bianco, J. Caterina, S. Yamada, M. Kromer, S.A. Kuznetsov, M. Mankani, P.G. Robey, A.R. Poole, 
I. Pidoux, J.M. Ward, and H. Birkedal-Hansen. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, 
arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99:81-92.
honke, K., and N. Taniguchi. 2002. Sulfotransferases and sulfated oligosaccharides. Med.Res.Rev. 22:637-654.
hoogenraad, c.c., A. Akhmanova, S.A. Howell, B.R. Dortland, C.I. De Zeeuw, R. Willemsen, P. Visser, F. Grosveld, 
and N. Galjart. 2001. Mammalian Golgi-associated Bicaudal-D2 functions in the dynein-dynactin pathway by 
interacting with these complexes. EMBO J. 20:4041-4054.
horiuchi, h., R. Lippe, H.M. McBride, M. Rubino, P. Woodman, H. Stenmark, V. Rybin, M. Wilm, K. Ashman, M. 
Mann, and M. Zerial. 1997. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide 
exchange to effector recruitment and function. Cell. 90:1149-1159.
horton, w.a. 2003. Skeletal development: insights from targeting the mouse genome. Lancet. 362:560-569.
hosoya, a., J.Y. Kim, S.W. Cho, and H.S. Jung. 2008. BMP4 signaling regulates formation of Hertwig’s epithelial 
root sheath during tooth root development. Cell Tissue Res. 333:503-509.
hou, l.T., C.M. Liu, Y.J. Chen, M.Y. Wong, K.C. Chen, J. Chen, and H.F. Thomas. 1999. Characterization of dental 
follicle cells in developing mouse molar. Arch.Oral Biol. 44:759-770.
hueber, s.D., and I. Lohmann. 2008. Shaping segments: Hox gene function in the genomic age. Bioessays. 30:965-
979.
hurtley, s.m., and A. Helenius. 1989. Protein oligomerization in the endoplasmic reticulum. Annu.Rev.Cell Biol. 
5:277-307.
inada, m., Y. Wang, M.H. Byrne, M.U. Rahman, C. Miyaura, C. Lopez-Otin, and S.M. Krane. 2004. Critical roles 
for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc.
Natl.Acad.Sci.U.S.A. 101:17192-17197.
infante, c., F. Ramos-Morales, C. Fedriani, M. Bornens, and R.M. Rios. 1999. GMAP-210, A cis-Golgi network-
associated protein, is a minus end microtubule-binding protein. J.Cell Biol. 145:83-98.
Jin, e.J., J.H. Park, S.Y. Lee, J.S. Chun, O.S. Bang, and S.S. Kang. 2006. Wnt-5a is involved in TGF-beta3-stimulated 
chondrogenic differentiation of chick wing bud mesenchymal cells. Int.J.Biochem.Cell Biol. 38:183-195.
Kano, f., A.R. Tanaka, S. Yamauchi, H. Kondo, and M. Murata. 2004. Cdc2 kinase-dependent disassembly of 
endoplasmic reticulum (ER) exit sites inhibits ER-to-Golgi vesicular transport during mitosis. Mol.Biol.Cell. 
15:4289-4298.
Kassai, y., P. Munne, Y. Hotta, E. Penttila, K. Kavanagh, N. Ohbayashi, S. Takada, I. Thesleff, J. Jernvall, and N. 
Itoh. 2005. Regulation of mammalian tooth cusp patterning by ectodin. Science. 309:2067-2070.
Kehoe, J.w., and C.R. Bertozzi. 2000. Tyrosine sulfation: a modulator of extracellular protein-protein interactions. 
Chem.Biol. 7:R57-61.
Khokha, m.K., D. Hsu, L.J. Brunet, M.S. Dionne, and R.M. Harland. 2003. Gremlin is the BMP antagonist required 
for maintenance of Shh and Fgf signals during limb patterning. Nat.Genet. 34:303-307.
Kimmel, c.b., W.W. Ballard, S.R. Kimmel, B. Ullmann, and T.F. Schilling. 1995. Stages of embryonic development 
of the zebrafish. Dev.Dyn. 203:253-310.
Kluppel, m., T.N. Wight, C. Chan, A. Hinek, and J.L. Wrana. 2005. Maintenance of chondroitin sulfation balance by 
chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during 
cartilage morphogenesis. Development. 132:3989-4003.
Kobayashi, T., D.W. Soegiarto, Y. Yang, B. Lanske, E. Schipani, A.P. McMahon, and H.M. Kronenberg. 2005. Indian 
hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of 
PTHrP. J.Clin.Invest. 115:1734-1742.
Kodani, a., and C. Sutterlin. 2008. The Golgi protein GM130 regulates centrosome morphology and function. Mol.
Biol.Cell. 19:745-753.
Koziel, l., M. Kunath, O.G. Kelly, and A. Vortkamp. 2004. Ext1-dependent heparan sulfate regulates the range of Ihh 
signaling during endochondral ossification. Dev.Cell. 6:801-813.
Koziel, l., M. Wuelling, S. Schneider, and A. Vortkamp. 2005. Gli3 acts as a repressor downstream of Ihh in regulating 
two distinct steps of chondrocyte differentiation. Development. 132:5249-5260.
Kratochwil, K., J. Galceran, S. Tontsch, W. Roth, and R. Grosschedl. 2002. FGF4, a direct target of LEF1 and Wnt 
signaling, can rescue the arrest of tooth organogenesis in Lef1(-/-) mice. Genes Dev. 16:3173-3185.
Kraus, p., D. Fraidenraich, and C.A. Loomis. 2001. Some distal limb structures develop in mice lacking Sonic 
hedgehog signaling. Mech.Dev. 100:45-58.
Kreis, Te, Goodson, HV, Perez, F, and Rönnholm, R. 1997. Golgi apparatus-cytoskeleton interactions. In: The Golgi 
apparatus, ed. E.G. Berger and J. Roth, Basel: Birkhäuser Verlag/Switzerland, 179–193.
Krejci, P., D. Krakow, P.B. Mekikian, and W.R. Wilcox. 2007. Fibroblast growth factors 1, 2, 17, and 19 are the 
predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatr.Res. 61:267-272.
Kronenberg, h.m. 2003. Developmental regulation of the growth plate. Nature. 423:332-336.
62
lang, m.r., L.A. Lapierre, M. Frotscher, J.R. Goldenring, and E.W. Knapik. 2006. Secretory COPII coat component 
Sec23a is essential for craniofacial chondrocyte maturation. Nat.Genet. 38:1198-1203.
lanoix, J., J. Ouwendijk, A. Stark, E. Szafer, D. Cassel, K. Dejgaard, M. Weiss, and T. Nilsson. 2001. Sorting 
of Golgi resident proteins into different subpopulations of COPI vesicles: a role for ArfGAP1. J.Cell Biol. 
155:1199-1212.
lanske, b., A.C. Karaplis, K. Lee, A. Luz, A. Vortkamp, A. Pirro, M. Karperien, L.H. Defize, C. Ho, R.C. Mulligan, 
A.B. Abou-Samra, H. Juppner, G.V. Segre, and H.M. Kronenberg. 1996. PTH/PTHrP receptor in early 
development and Indian hedgehog-regulated bone growth. Science. 273:663-666.
lefebvre, V., and P. Smits. 2005. Transcriptional control of chondrocyte fate and differentiation. Birth Defects 
Res.C.Embryo.Today. 75:200-212.
letourneur, f., E.C. Gaynor, S. Hennecke, C. Demolliere, R. Duden, S.D. Emr, H. Riezman, and P. Cosson. 1994. 
Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell. 79:1199-
1207.
letunic, i., T. Doerks, and P. Bork. 2008. SMART 6: recent updates and new developments. Nucleic Acids Res. 
lewandoski, m., X. Sun, and G.R. Martin. 2000. Fgf8 signalling from the AER is essential for normal limb 
development. Nat.Genet. 26:460-463.
li, e., I. Tabas, and S. Kornfeld. 1978. The synthesis of complex-type oligosaccharides. I. Structure of the lipid-
linked oligosaccharide precursor of the complex-type oligosaccharides of the vesicular stomatitis virus G 
protein. J.Biol.Chem. 253:7762-7770.
li, T.f., Y. Dong, A.M. Ionescu, R.N. Rosier, M.J. Zuscik, E.M. Schwarz, R.J. O’Keefe, and H. Drissi. 2004. 
Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. 
Exp.Cell Res. 299:128-136.
lieu, Z.Z., J.G. Lock, L.A. Hammond, N.L. La Gruta, J.L. Stow, and P.A. Gleeson. 2008. A trans-Golgi network 
golgin is required for the regulated secretion of TNF in activated macrophages in vivo. Proc.Natl.Acad.Sci.U.S.A. 
105:3351-3356.
linstedt, a.D., and H.P. Hauri. 1993. Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic 
domain of at least 350 kDa. Mol.Biol.Cell. 4:679-693.
lippincott-schwartz, J., N.B. Cole, A. Marotta, P.A. Conrad, and G.S. Bloom. 1995. Kinesin is the motor for 
microtubule-mediated Golgi-to-ER membrane traffic. J.Cell Biol. 128:293-306.
litvak, v., R. Argov, N. Dahan, S. Ramachandran, R. Amarilio, A. Shainskaya, and S. Lev. 2004. Mitotic 
phosphorylation of the peripheral Golgi protein Nir2 by Cdk1 provides a docking mechanism for Plk1 and 
affects cytokinesis completion. Mol.Cell. 14:319-330.
livingston, b.T., C.E. Killian, F. Wilt, A. Cameron, M.J. Landrum, O. Ermolaeva, V. Sapojnikov, D.R. Maglott, 
A.M. Buchanan, and C.A. Ettensohn. 2006. A genome-wide analysis of biomineralization-related proteins in 
the sea urchin Strongylocentrotus purpuratus. Dev.Biol. 300:335-348.
loomis, c.a., E. Harris, J. Michaud, W. Wurst, M. Hanks, and A.L. Joyner. 1996. The mouse Engrailed-1 gene and 
ventral limb patterning. Nature. 382:360-363.
losev, e., C.A. Reinke, J. Jellen, D.E. Strongin, B.J. Bevis, and B.S. Glick. 2006. Golgi maturation visualized in 
living yeast. Nature. 441:1002-1006.
lowe, m., and F.A. Barr. 2007. Inheritance and biogenesis of organelles in the secretory pathway. Nat.Rev.Mol.Cell 
Biol. 8:429-439.
lowe, m., and T.E. Kreis. 1996. In vivo assembly of coatomer, the COP-I coat precursor. J.Biol.Chem. 271:30725-
30730.
lowe, m., J.D. Lane, P.G. Woodman, and V.J. Allan. 2004. Caspase-mediated cleavage of syntaxin 5 and giantin 
accompanies inhibition of secretory traffic during apoptosis. J.Cell.Sci. 117:1139-1150.
lu, b., D.B. McClatchy, J.Y. Kim, and J.R. Yates 3rd. 2008a. Strategies for shotgun identification of integral 
membrane proteins by tandem mass spectrometry. Proteomics. 8:3947-3955.
lu, p., Y. Yu, Y. Perdue, and Z. Werb. 2008b. The apical ectodermal ridge is a timer for generating distal limb 
progenitors. Development. 135:1395-1405.
luan, x., Y. Ito, and T.G. Diekwisch. 2006. Evolution and development of Hertwig’s epithelial root sheath. Dev.Dyn. 
235:1167-1180.
maag, r.s., M. Mancini, A. Rosen, and C.E. Machamer. 2005. Caspase-resistant Golgin-160 disrupts apoptosis 
induced by secretory pathway stress and ligation of death receptors. Mol.Biol.Cell. 16:3019-3027.
macias, D., Y. Ganan, M.A. Ros, and J.M. Hurle. 1996. In vivo inhibition of programmed cell death by local 
administration of FGF-2 and FGF-4 in the interdigital areas of the embryonic chick leg bud. Anat.Embryol.
(Berl). 193:533-541.
macneil, r.l., J.E. Berry, C.L. Strayhorn, Y. Shigeyama, and M.J. Somerman. 1998. Expression of type I and XII 
collagen during development of the periodontal ligament in the mouse. Arch.Oral Biol. 43:779-787.
macsai, c.e., B.K. Foster, and C.J. Xian. 2008. Roles of Wnt signalling in bone growth, remodelling, skeletal 
disorders and fracture repair. J.Cell.Physiol. 215:578-587.
maeda, y., T. Ide, M. Koike, Y. Uchiyama, and T. Kinoshita. 2008. GPHR is a novel anion channel critical for 
acidification and functions of the Golgi apparatus. Nat.Cell Biol. 10:1135-1145.
mak, K.K., H.M. Kronenberg, P.T. Chuang, S. Mackem, and Y. Yang. 2008. Indian hedgehog signals independently 
of PTHrP to promote chondrocyte hypertrophy. Development. 135:1947-1956.
63
mallein-gerin, f., R.A. Kosher, W.B. Upholt, and M.L. Tanzer. 1988. Temporal and spatial analysis of cartilage 
proteoglycan core protein gene expression during limb development by in situ hybridization. Dev.Biol. 126:337-
345.
malsam, J., A. Satoh, L. Pelletier, and G. Warren. 2005. Golgin tethers define subpopulations of COPI vesicles. 
Science. 307:1095-1098.
mancini, m., C.E. Machamer, S. Roy, D.W. Nicholson, N.A. Thornberry, L.A. Casciola-Rosen, and A. Rosen. 2000. 
Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J.Cell Biol. 149:603-
612.
mansour, m., S.Y. Lee, and B. Pohajdak. 2002. The N-terminal coiled coil domain of the cytohesin/ARNO family 
of guanine nucleotide exchange factors interacts with the scaffolding protein CASP. J.Biol.Chem. 277:32302-
32309.
mariani, f.v., C.P. Ahn, and G.R. Martin. 2008. Genetic evidence that FGFs have an instructive role in limb 
proximal-distal patterning. Nature. 453:401-405.
mariani, f.v., and G.R. Martin. 2003. Deciphering skeletal patterning: clues from the limb. Nature. 423:319-325.
marks, s.c.,Jr. 1995. The basic and applied biology of tooth eruption. Connect.Tissue Res. 32:149-157.
marks, s.c.,Jr, and D.R. Cahill. 1987. Regional control by the dental follicle of alterations in alveolar bone 
metabolism during tooth eruption. J.Oral Pathol. 16:164-169.
marra, p., L. Salvatore, A. Mironov Jr, A. Di Campli, G. Di Tullio, A. Trucco, G. Beznoussenko, A. Mironov, and 
M.A. De Matteis. 2007. The biogenesis of the Golgi ribbon: the roles of membrane input from the ER and of 
GM130. Mol.Biol.Cell. 18:1595-1608.
marsh, b.J., D.N. Mastronarde, K.F. Buttle, K.E. Howell, and J.R. McIntosh. 2001. Organellar relationships in the 
Golgi region of the pancreatic beta cell line, HIT-T15, visualized by high resolution electron tomography. Proc.
Natl.Acad.Sci.U.S.A. 98:2399-2406.
marsh, b.J., N. Volkmann, J.R. McIntosh, and K.E. Howell. 2004. Direct continuities between cisternae at different 
levels of the Golgi complex in glucose-stimulated mouse islet beta cells. Proc.Natl.Acad.Sci.U.S.A. 101:5565-
5570.
matanis, T., A. Akhmanova, P. Wulf, E. Del Nery, T. Weide, T. Stepanova, N. Galjart, F. Grosveld, B. Goud, C.I. De 
Zeeuw, A. Barnekow, and C.C. Hoogenraad. 2002. Bicaudal-D regulates COPI-independent Golgi-ER transport 
by recruiting the dynein-dynactin motor complex. Nat.Cell Biol. 4:986-992.
matsuura-Tokita, K., M. Takeuchi, A. Ichihara, K. Mikuriya, and A. Nakano. 2006. Live imaging of yeast Golgi 
cisternal maturation. Nature. 441:1007-1010.
mcalinden, a., N. Havlioglu, L. Liang, S.R. Davies, and L.J. Sandell. 2005. Alternative Splicing of Type II 
Procollagen Exon 2 Is Regulated by the Combination of a Weak 5’ Splice Site and an Adjacent Intronic Stem-
loop Cis Element. J. Biol. Chem. 280:32700-32711.
miletich, i., and P.T. Sharpe. 2003. Normal and abnormal dental development. Hum.Mol.Genet. 12 Spec No 1:R69-
73.
miller, J.h., S. Jin, W.F. Morgan, A. Yang, Y. Wan, U. Aypar, J.S. Peters, and D.L. Springer. 2008. Profiling 
mitochondrial proteins in radiation-induced genome-unstable cell lines with persistent oxidative stress by mass 
spectrometry. Radiat.Res. 169:700-706.
minguillon, c., J. Del Buono, and M.P. Logan. 2005. Tbx5 and Tbx4 are not sufficient to determine limb-specific 
morphologies but have common roles in initiating limb outgrowth. Dev.Cell. 8:75-84.
minina, e., C. Kreschel, M.C. Naski, D.M. Ornitz, and A. Vortkamp. 2002. Interaction of FGF, Ihh/Pthlh, and BMP 
signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev.Cell. 3:439-449.
mironov, a.a., G.V. Beznoussenko, R.S. Polishchuk, and A. Trucco. 2005. Intra-Golgi transport: a way to a new 
paradigm? Biochim.Biophys.Acta. 1744:340-350.
montero, J.a., C.I. Lorda-Diez, Y. Ganan, D. Macias, and J.M. Hurle. 2008. Activin/TGFbeta and BMP crosstalk 
determines digit chondrogenesis. Dev.Biol. 321:343-356.
moon, a.m., and M.R. Capecchi. 2000. Fgf8 is required for outgrowth and patterning of the limbs. Nat.Genet. 
26:455-459.
morrow, e.m., S.Y. Yoo, S.W. Flavell, T.K. Kim, Y. Lin, R.S. Hill, N.M. Mukaddes, S. Balkhy, G. Gascon, A. 
Hashmi, S. Al-Saad, J. Ware, R.M. Joseph, R. Greenblatt, D. Gleason, J.A. Ertelt, K.A. Apse, A. Bodell, J.N. 
Partlow, B. Barry, H. Yao, K. Markianos, R.J. Ferland, M.E. Greenberg, and C.A. Walsh. 2008. Identifying 
autism loci and genes by tracing recent shared ancestry. Science. 321:218-223.
moyer, b.D., B.B. Allan, and W.E. Balch. 2001. Rab1 interaction with a GM130 effector complex regulates COPII 
vesicle cis--Golgi tethering. Traffic. 2:268-276.
Mukherjee, S., R. Chiu, S.M. Leung, and D. Shields. 2007. Fragmentation of the Golgi apparatus: an early apoptotic 
event independent of the cytoskeleton. Traffic. 8:369-378.
munro, s., and B.J. Nichols. 1999. The GRIP domain - a novel Golgi-targeting domain found in several coiled-coil 
proteins. Curr.Biol. 9:377-380.
myers, K.r., and J.E. Casanova. 2008. Regulation of actin cytoskeleton dynamics by Arf-family GTPases. Trends 
Cell Biol. 18:184-192.
Myllyharju, J. 2003. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol. 22:15-24.
Myllyharju, J., and K.I. Kivirikko. 2004. Collagens, modifying enzymes and their mutations in humans, flies and 
worms. Trends Genet. 20:33-43.
64
naiche, l.a., and V.E. Papaioannou. 2007. Tbx4 is not required for hindlimb identity or post-bud hindlimb outgrowth. 
Development. 134:93-103.
Nakajima, H., S. Yonemura, M. Murata, N. Nakamura, H. Piwnica-Worms, and E. Nishida. 2008. Myt1 protein 
kinase is essential for Golgi and ER assembly during mitotic exit. J.Cell Biol. 181:89-103.
nakamura, n., M. Lowe, T.P. Levine, C. Rabouille, and G. Warren. 1997. The vesicle docking protein p115 binds 
GM130, a cis-Golgi matrix protein, in a mitotically regulated manner. Cell. 89:445-455.
nakamura, n., C. Rabouille, R. Watson, T. Nilsson, N. Hui, P. Slusarewicz, T.E. Kreis, and G. Warren. 1995. 
Characterization of a cis-Golgi matrix protein, GM130. J.Cell Biol. 131:1715-1726.
nanci a, Sommerman M. 2003. The periodontium. In: Ten Cate’s oral histology: development, structure and function. 
Nanci A, ed. St. Louis: Harcourt heath sciences. 
nanci, a., and D.D. Bosshardt. 2006. Structure of periodontal tissues in health and disease. Periodontol.2000. 40:11-
28.
narita, T., S. Sasaoka, K. Udagawa, T. Ohyama, N. Wada, S. Nishimatsu, S. Takada, and T. Nohno. 2005. Wnt10a is 
involved in AER formation during chick limb development. Dev.Dyn. 233:282-287.
nichols, b.J., and J. Lippincott-Schwartz. 2001. Endocytosis without clathrin coats. Trends Cell Biol. 11:406-412.
niswander, l. 2003. Pattern formation: old models out on a limb. Nat.Rev.Genet. 4:133-143.
novick, p., C. Field, and R. Schekman. 1980. Identification of 23 complementation groups required for post-
translational events in the yeast secretory pathway. Cell. 21:205-215.
oh, c.D., S.H. Chang, Y.M. Yoon, S.J. Lee, Y.S. Lee, S.S. Kang, and J.S. Chun. 2000. Opposing role of mitogen-
activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J.Biol.
Chem. 275:5613-5619.
okamoto, c.T., J. McKinney, and Y.Y. Jeng. 2000. Clathrin in mitotic spindles. Am.J.Physiol.Cell.Physiol. 279:C369-
74.
olsen, b.r., A.M. Reginato, and W. Wang. 2000. Bone development. Annu.Rev.Cell Dev.Biol. 16:191-220.
orci, l., M. Stamnes, M. Ravazzola, M. Amherdt, A. Perrelet, T.H. Sollner, and J.E. Rothman. 1997. Bidirectional 
transport by distinct populations of COPI-coated vesicles. Cell. 90:335-349.
ostermann, J., L. Orci, K. Tani, M. Amherdt, M. Ravazzola, Z. Elazar, and J.E. Rothman. 1993. Stepwise assembly 
of functionally active transport vesicles. Cell. 75:1015-1025.
Pajni-Underwood, S., C.P. Wilson, C. Elder, Y. Mishina, and M. Lewandoski. 2007. BMP signals control limb bud 
interdigital programmed cell death by regulating FGF signaling. Development. 134:2359-2368.
palmer, D.J., J.B. Helms, C.J. Beckers, L. Orci, and J.E. Rothman. 1993. Binding of coatomer to Golgi membranes 
requires ADP-ribosylation factor. J.Biol.Chem. 268:12083-12089.
parr, b.a., and A.P. McMahon. 1995. Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes 
of mouse limb. Nature. 374:350-353.
pecot, m.y., and V. Malhotra. 2004. Golgi membranes remain segregated from the endoplasmic reticulum during 
mitosis in mammalian cells. Cell. 116:99-107.
pelham, h.r., and J.E. Rothman. 2000. The debate about transport in the Golgi--two sides of the same coin? Cell. 
102:713-719.
perkins, D.n., D.J. Pappin, D.M. Creasy, and J.S. Cottrell. 1999. Probability-based protein identification by searching 
sequence databases using mass spectrometry data. Electrophoresis. 20:3551-3567.
peters, h., B. Wilm, N. Sakai, K. Imai, R. Maas, and R. Balling. 1999. Pax1 and Pax9 synergistically regulate 
vertebral column development. Development. 126:5399-5408.
pittenger, m.f., A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, 
S. Craig, and D.R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science. 
284:143-147.
preisinger, c., R. Korner, M. Wind, W.D. Lehmann, R. Kopajtich, and F.A. Barr. 2005. Plk1 docking to GRASP65 
phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint signalling. EMBO J. 
preisinger, c., B. Short, V. De Corte, E. Bruyneel, A. Haas, R. Kopajtich, J. Gettemans, and F.A. Barr. 2004. YSK1 
is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-
3{zeta}. J.Cell Biol. 164:1009-1020.
pulvirenti, T., M. Giannotta, M. Capestrano, M. Capitani, A. Pisanu, R.S. Polishchuk, E. San Pietro, G.V. 
Beznoussenko, A.A. Mironov, G. Turacchio, V.W. Hsu, M. Sallese, and A. Luini. 2008. A traffic-activated 
Golgi-based signalling circuit coordinates the secretory pathway. Nat.Cell Biol. 10:912-922.
puntervoll, p., R. Linding, C. Gemund, S. Chabanis-Davidson, M. Mattingsdal, S. Cameron, D.M. Martin, G. 
Ausiello, B. Brannetti, A. Costantini, F. Ferre, V. Maselli, A. Via, G. Cesareni, F. Diella, G. Superti-Furga, L. 
Wyrwicz, C. Ramu, C. McGuigan, R. Gudavalli, I. Letunic, P. Bork, L. Rychlewski, B. Kuster, M. Helmer-
Citterich, W.N. Hunter, R. Aasland, and T.J. Gibson. 2003. ELM server: A new resource for investigating short 
functional sites in modular eukaryotic proteins. Nucleic Acids Res. 31:3625-3630.
puthenveedu, m.a., C. Bachert, S. Puri, F. Lanni, and A.D. Linstedt. 2006. GM130 and GRASP65-dependent lateral 
cisternal fusion allows uniform Golgi-enzyme distribution. Nat.Cell Biol. 8:238-248.
rabouille, c., N. Hui, F. Hunte, R. Kieckbusch, E.G. Berger, G. Warren, and T. Nilsson. 1995. Mapping the 
distribution of Golgi enzymes involved in the construction of complex oligosaccharides. J.Cell.Sci. 108 ( Pt 
4):1617-1627.
reilly, b.a., B.A. Kraynack, S.M. VanRheenen, and M.G. Waters. 2001. Golgi-to-endoplasmic reticulum (ER) 
65
retrograde traffic in yeast requires Dsl1p, a component of the ER target site that interacts with a COPI coat 
subunit. Mol.Biol.Cell. 12:3783-3796.
reinhard, c., M. Schweikert, F.T. Wieland, and W. Nickel. 2003. Functional reconstitution of COPI coat assembly 
and disassembly using chemically defined components. Proc.Natl.Acad.Sci.U.S.A. 100:8253-8257.
reitman, m.l., and S. Kornfeld. 1981. UDP-N-acetylglucosamine:glycoprotein N-acetylglucosamine-1-
phosphotransferase. Proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of 
lysosomal enzymes. J.Biol.Chem. 256:4275-4281.
rodriguez-boulan, e., and A. Musch. 2005. Protein sorting in the Golgi complex: shifting paradigms. Biochim.
Biophys.Acta. 1744:455-464.
roth, J., M. Ziak, and C. Zuber. 2003. The role of glucosidase II and endomannosidase in glucose trimming of 
asparagine-linked oligosaccharides. Biochimie. 85:287-294.
royle, s.J., N.A. Bright, and L. Lagnado. 2005. Clathrin is required for the function of the mitotic spindle. Nature. 
434:1152-1157.
ruan, Q., Q. Wang, S. Xie, Y. Fang, Z. Darzynkiewicz, K. Guan, M. Jhanwar-Uniyal, and W. Dai. 2004. Polo-like 
kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle. Exp.Cell Res. 
294:51-59.
salas-vidal, e., C. Valencia, and L. Covarrubias. 2001. Differential tissue growth and patterns of cell death in mouse 
limb autopod morphogenesis. Dev.Dyn. 220:295-306.
sandell, l.J., N. Morris, J.R. Robbins, and M.B. Goldring. 1991. Alternatively spliced type II procollagen mRNAs 
define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. 
J.Cell Biol. 114:1307-1319.
sandell, l.J., A.M. Nalin, and R.A. Reife. 1994. Alternative splice form of type II procollagen mRNA (IIA) is 
predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev.Dyn. 
199:129-140.
satoh, a., Y. Wang, J. Malsam, M.B. Beard, and G. Warren. 2003. Golgin-84 is a rab1 Binding Partner Involved in 
Golgi Structure. Traffic. 4:153-161.
scales, s.J., R. Pepperkok, and T.E. Kreis. 1997. Visualization of ER-to-Golgi transport in living cells reveals a 
sequential mode of action for COPII and COPI. Cell. 90:1137-1148.
schilling, T.f., T. Piotrowski, H. Grandel, M. Brand, C.P. Heisenberg, Y.J. Jiang, D. Beuchle, M. Hammerschmidt, 
D.A. Kane, M.C. Mullins, F.J. van Eeden, R.N. Kelsh, M. Furutani-Seiki, M. Granato, P. Haffter, J. Odenthal, 
R.M. Warga, T. Trowe, and C. Nusslein-Volhard. 1996. Jaw and branchial arch mutants in zebrafish I: branchial 
arches. Development. 123:329-344.
schipani, e., H.E. Ryan, S. Didrickson, T. Kobayashi, M. Knight, and R.S. Johnson. 2001. Hypoxia in cartilage: 
HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15:2865-2876.
seemann, J., M. Pypaert, T. Taguchi, J. Malsam, and G. Warren. 2002. Partitioning of the matrix fraction of the Golgi 
apparatus during mitosis in animal cells. Science. 295:848-851.
sekine, K., H. Ohuchi, M. Fujiwara, M. Yamasaki, T. Yoshizawa, T. Sato, N. Yagishita, D. Matsui, Y. Koga, N. Itoh, 
and S. Kato. 1999. Fgf10 is essential for limb and lung formation. Nat.Genet. 21:138-141.
shaul, y.D., and R. Seger. 2006. ERK1c regulates Golgi fragmentation during mitosis. J.Cell Biol. 172:885-897.
sheen, v.l., V.S. Ganesh, M. Topcu, G. Sebire, A. Bodell, R.S. Hill, P.E. Grant, Y.Y. Shugart, J. Imitola, S.J. Khoury, 
R. Guerrini, and C.A. Walsh. 2004. Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor 
proliferation and migration in the human cerebral cortex. Nat.Genet. 36:69-76.
short, b., A. Haas, and F.A. Barr. 2005. Golgins and GTPases, giving identity and structure to the Golgi apparatus. 
Biochim.Biophys.Acta. 1744:383-395.
shorter, J., R. Watson, M.E. Giannakou, M. Clarke, G. Warren, and F.A. Barr. 1999. GRASP55, a second mammalian 
GRASP protein involved in the stacking of Golgi cisternae in a cell-free system. EMBO J. 18:4949-4960.
smits, p., P. Li, J. Mandel, Z. Zhang, J.M. Deng, R.R. Behringer, B. de Crombrugghe, and V. Lefebvre. 2001. The 
transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev.Cell. 1:277-290.
sonnichsen, b., M. Lowe, T. Levine, E. Jamsa, B. Dirac-Svejstrup, and G. Warren. 1998. A role for giantin in 
docking COPI vesicles to Golgi membranes. J.Cell Biol. 140:1013-1021.
spang, a., K. Matsuoka, S. Hamamoto, R. Schekman, and L. Orci. 1998. Coatomer, Arf1p, and nucleotide are 
required to bud coat protein complex I-coated vesicles from large synthetic liposomes. Proc.Natl.Acad.
Sci.U.S.A. 95:11199-11204.
sprague, J., L. Bayraktaroglu, Y. Bradford, T. Conlin, N. Dunn, D. Fashena, K. Frazer, M. Haendel, D.G. Howe, J. 
Knight, P. Mani, S.A. Moxon, C. Pich, S. Ramachandran, K. Schaper, E. Segerdell, X. Shao, A. Singer, P. Song, 
B. Sprunger, C.E. Van Slyke, and M. Westerfield. 2008. The Zebrafish Information Network: the zebrafish model 
organism database provides expanded support for genotypes and phenotypes. Nucleic Acids Res. 36:D768-72.
stagg, s.m., C. Gurkan, D.M. Fowler, P. LaPointe, T.R. Foss, C.S. Potter, B. Carragher, and W.E. Balch. 2006. 
Structure of the Sec13/31 COPII coat cage. Nature. 439:234-238.
stanley p, Schachter H, Taniguchi N. 2009. Structure and Biosynthesis of N-Glycans. In: Essentials of Glycobiology, 
2nd edition. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, ed. 
Cold Spring Harbor Laboratory Press.
steele-perkins, g., K.G. Butz, G.E. Lyons, M. Zeichner-David, H.J. Kim, M.I. Cho, and R.M. Gronostajski. 2003. 
Essential role for NFI-C/CTF transcription-replication factor in tooth root development. Mol.Cell.Biol. 23:1075-
66
1084.
stevens, s.m.,Jr, R.S. Duncan, P. Koulen, and L. Prokai. 2008. Proteomic analysis of mouse brain microsomes: 
identification and bioinformatic characterization of endoplasmic reticulum proteins in the mammalian central 
nervous system. J.Proteome Res. 7:1046-1054.
stickens, D., D. Brown, and G.A. Evans. 2000. EXT genes are differentially expressed in bone and cartilage during 
mouse embryogenesis. Dev.Dyn. 218:452-464.
stickens, D., B.M. Zak, N. Rougier, J.D. Esko, and Z. Werb. 2005. Mice deficient in Ext2 lack heparan sulfate and 
develop exostoses. Development. 132:5055-5068.
styers, m.l., A.K. O’Connor, R. Grabski, E. Cormet-Boyaka, and E. Sztul. 2008. Depletion of beta-COP reveals a 
role for COP-I in compartmentalization of secretory compartments and in biosynthetic transport of caveolin-1. 
Am.J.Physiol.Cell.Physiol. 294:C1485-98.
sutterlin, c., R. Polishchuk, M. Pecot, and V. Malhotra. 2005. The Golgi-associated protein GRASP65 regulates 
spindle dynamics and is essential for cell division. Mol.Biol.Cell. 16:3211-3222.
Tabas, i., and S. Kornfeld. 1978. The synthesis of complex-type oligosaccharides. III. Identification of an alpha-D-
mannosidase activity involved in a late stage of processing of complex-type oligosaccharides. J.Biol.Chem. 
253:7779-7786.
Tamamura, y., T. Otani, N. Kanatani, E. Koyama, J. Kitagaki, T. Komori, Y. Yamada, F. Costantini, S. Wakisaka, 
M. Pacifici, M. Iwamoto, and M. Enomoto-Iwamoto. 2005. Developmental regulation of Wnt/beta-catenin 
signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J.Biol.Chem. 
280:19185-19195.
Tan, s., H.T. Tan, and M.C. Chung. 2008. Membrane proteins and membrane proteomics. Proteomics. 8:3924-
3932.
Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y and Yoshida T. 1988. Protein and Polymer Analyses up to m/z 100,000 
by Laser Ionization Time-of-flight Mass Spectrometry. Rapid Communications in Mass Spectrometry. 2 (8):151-
153.
Tanigawa, g., L. Orci, M. Amherdt, M. Ravazzola, J.B. Helms, and J.E. Rothman. 1993. Hydrolysis of bound GTP 
by ARF protein triggers uncoating of Golgi-derived COP-coated vesicles. J.Cell Biol. 123:1365-1371.
Taylor, r.s., C.C. Wu, L.G. Hays, J.K. Eng, J.R. Yates 3rd, and K.E. Howell. 2000. Proteomics of rat liver Golgi 
complex: minor proteins are identified through sequential fractionation. Electrophoresis. 21:3441-3459.
Taylor, T.D., H. Noguchi, Y. Totoki, A. Toyoda, Y. Kuroki, K. Dewar, C. Lloyd, T. Itoh, T. Takeda, D.W. Kim, X. 
She, K.F. Barlow, T. Bloom, E. Bruford, J.L. Chang, C.A. Cuomo, E. Eichler, M.G. FitzGerald, D.B. Jaffe, 
K. LaButti, R. Nicol, H.S. Park, C. Seaman, C. Sougnez, X. Yang, A.R. Zimmer, M.C. Zody, B.W. Birren, C. 
Nusbaum, A. Fujiyama, M. Hattori, J. Rogers, E.S. Lander, and Y. Sakaki. 2006. Human chromosome 11 DNA 
sequence and analysis including novel gene identification. Nature. 440:497-500.
te welscher, p., A. Zuniga, S. Kuijper, T. Drenth, H.J. Goedemans, F. Meijlink, and R. Zeller. 2002. Progression of 
vertebrate limb development through SHH-mediated counteraction of GLI3. Science. 298:827-830.
Ten cate, a.r. 1997. The development of the periodontium--a largely ectomesenchymally derived unit. 
Periodontol.2000. 13:9-19.
Thesleff, i. 2006. The genetic basis of tooth development and dental defects. Am.J.Med.Genet.A. 140:2530-2535.
Thesleff i, Nieminen P. 2006. Tooth Induction. In: ENCYCLOPEDIA OF LIFE SCIENCES. John Wiley & Sons, 
Ltd: Chichester http://www.els.net/ [doi: 10.1038/npg.els.0004183]
Thesleff, i., S. Keranen, and J. Jernvall. 2001. Enamel knots as signaling centers linking tooth morphogenesis and 
odontoblast differentiation. Adv.Dent.Res. 15:14-18.
Tickle, c. 2003. Patterning systems--from one end of the limb to the other. Dev.Cell. 4:449-458.
Topol, l., X. Jiang, H. Choi, L. Garrett-Beal, P.J. Carolan, and Y. Yang. 2003. Wnt-5a inhibits the canonical Wnt 
pathway by promoting GSK-3-independent beta-catenin degradation. J.Cell Biol. 162:899-908.
Townley, a.K., Y. Feng, K. Schmidt, D.A. Carter, R. Porter, P. Verkade, and D.J. Stephens. 2008. Efficient coupling of 
Sec23-Sec24 to Sec13-Sec31 drives COPII-dependent collagen secretion and is essential for normal craniofacial 
development. J.Cell.Sci. 121:3025-3034.
Trucco, a., R.S. Polishchuk, O. Martella, A. Di Pentima, A. Fusella, D. Di Giandomenico, E. San Pietro, G.V. 
Beznoussenko, E.V. Polishchuk, M. Baldassarre, R. Buccione, W.J. Geerts, A.J. Koster, K.N. Burger, A.A. 
Mironov, and A. Luini. 2004. Secretory traffic triggers the formation of tubular continuities across Golgi sub-
compartments. Nat.Cell Biol. 6:1071-1081.
Tucker, a.s., A. Al Khamis, and P.T. Sharpe. 1998a. Interactions between Bmp-4 and Msx-1 act to restrict gene 
expression to odontogenic mesenchyme. Dev.Dyn. 212:533-539.
Tucker, a.s., K.L. Matthews, and P.T. Sharpe. 1998b. Transformation of tooth type induced by inhibition of BMP 
signaling. Science. 282:1136-1138.
Turner, J.r., and A.M. Tartakoff. 1989. The response of the Golgi complex to microtubule alterations: the roles of 
metabolic energy and membrane traffic in Golgi complex organization. J.Cell Biol. 109:2081-2088.
uniprot consortium. 2008. The universal protein resource (UniProt). Nucleic Acids Res. 36:D190-5.
valsdottir, r., H. Hashimoto, K. Ashman, T. Koda, B. Storrie, and T. Nilsson. 2001. Identification of rabaptin-5, 
rabex-5, and GM130 as putative effectors of rab33b, a regulator of retrograde traffic between the Golgi apparatus 
and ER. FEBS Lett. 508:201-209.
van baelen, K., J. Vanoevelen, G. Callewaert, J.B. Parys, H. De Smedt, L. Raeymaekers, R. Rizzuto, L. Missiaen, and 
67
F. Wuytack. 2003. The contribution of the SPCA1 Ca2+ pump to the Ca2+ accumulation in the Golgi apparatus 
of HeLa cells assessed via RNA-mediated interference. Biochem.Biophys.Res.Commun. 306:430-436.
van der eerden, b.c., M. Karperien, and J.M. Wit. 2003. Systemic and local regulation of the growth plate. Endocr.
Rev. 24:782-801.
van meer, g., D.R. Voelker, and G.W. Feigenson. 2008. Membrane lipids: where they are and how they behave. Nat.
Rev.Mol.Cell Biol. 9:112-124.
van vliet, c., E.C. Thomas, A. Merino-Trigo, R.D. Teasdale, and P.A. Gleeson. 2003. Intracellular sorting and 
transport of proteins. Prog.Biophys.Mol.Biol. 83:1-45.
varki, a. 1998. Factors controlling the glycosylation potential of the Golgi apparatus. Trends Cell Biol. 8:34-40.
varki, a., and S. Kornfeld. 1980. Identification of a rat liver alpha-N-acetylglucosaminyl phosphodiesterase capable of 
removing “blocking” alpha-N-acetylglucosamine residues from phosphorylated high mannose oligosaccharides 
of lysosomal enzymes. J.Biol.Chem. 255:8398-8401.
vogel, a., C. Rodriguez, and J.C. Izpisua-Belmonte. 1996. Involvement of FGF-8 in initiation, outgrowth and 
patterning of the vertebrate limb. Development. 122:1737-1750.
volchuk, a., M. Ravazzola, A. Perrelet, W.S. Eng, M. Di Liberto, O. Varlamov, M. Fukasawa, T. Engel, T.H. Sollner, 
J.E. Rothman, and L. Orci. 2004. Countercurrent distribution of two distinct SNARE complexes mediating 
transport within the Golgi stack. Mol.Biol.Cell. 15:1506-1518.
vornehm, s.i., J. Dudhia, K. Von der Mark, and T. Aigner. 1996. Expression of collagen types IX and XI and other 
major cartilage matrix components by human fetal chondrocytes in vivo. Matrix Biol. 15:91-98.
vortkamp, a., K. Lee, B. Lanske, G.V. Segre, H.M. Kronenberg, and C.J. Tabin. 1996. Regulation of rate of cartilage 
differentiation by Indian hedgehog and PTH-related protein. Science. 273:613-622.
vu, T.h., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior, and Z. Werb. 
1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic 
chondrocytes. Cell. 93:411-422.
wang, x.p., M. Suomalainen, C.J. Jorgez, M.M. Matzuk, M. Wankell, S. Werner, and I. Thesleff. 2004a. Modulation 
of activin/bone morphogenetic protein signaling by follistatin is required for the morphogenesis of mouse molar 
teeth. Dev.Dyn. 231:98-108.
wang, x.p., M. Suomalainen, C.J. Jorgez, M.M. Matzuk, S. Werner, and I. Thesleff. 2004b. Follistatin regulates 
enamel patterning in mouse incisors by asymmetrically inhibiting BMP signaling and ameloblast differentiation. 
Dev.Cell. 7:719-730.
warren, g., C. Featherstone, G. Griffiths, and B. Burke. 1983. Newly synthesized G protein of vesicular stomatitis 
virus is not transported to the cell surface during mitosis. J.Cell Biol. 97:1623-1628.
wasinger, v.c., S.J. Cordwell, A. Cerpa-Poljak, J.X. Yan, A.A. Gooley, M.R. Wilkins, M.W. Duncan, R. Harris, K.L. 
Williams, and I. Humphery-Smith. 1995. Progress with gene-product mapping of the Mollicutes: Mycoplasma 
genitalium. Electrophoresis. 16:1090-1094.
watanabe, h., M.P. de Caestecker, and Y. Yamada. 2001. Transcriptional cross-talk between Smad, ERK1/2, and 
p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan 
gene expression in chondrogenic ATDC5 cells. J.Biol.Chem. 276:14466-14473.
waters, m.g., D.O. Clary, and J.E. Rothman. 1992. A novel 115-kD peripheral membrane protein is required for 
intercisternal transport in the Golgi stack. J.Cell Biol. 118:1015-1026.
watson, p., R. Forster, K.J. Palmer, R. Pepperkok, and D.J. Stephens. 2005. Coupling of ER exit to microtubules 
through direct interaction of COPII with dynactin. Nat.Cell Biol. 7:48-55.
weatherbee, s.D., R.R. Behringer, J.J. Rasweiler 4th, and L.A. Niswander. 2006. Interdigital webbing retention 
in bat wings illustrates genetic changes underlying amniote limb diversification. Proc.Natl.Acad.Sci.U.S.A. 
103:15103-15107.
wegmann, D., P. Hess, C. Baier, F.T. Wieland, and C. Reinhard. 2004. Novel isotypic gamma/zeta subunits reveal 
three coatomer complexes in mammals. Mol.Cell.Biol. 24:1070-1080.
wei, y., E. Shen, N. Zhao, Q. Liu, J. Fan, J. Marc, Y. Wang, L. Sun, and Q. Liang. 2008. Identification of a novel 
centrosomal protein CrpF46 involved in cell cycle progression and mitosis. Exp.Cell Res. 314:1693-1707.
wickner, w., and R. Schekman. 2008. Membrane fusion. Nat.Struct.Mol.Biol. 15:658-664.
wilson, D.w., M.J. Lewis, and H.R. Pelham. 1993. pH-dependent binding of KDEL to its receptor in vitro. J.Biol.
Chem. 268:7465-7468.
wolters, D.a., M.P. Washburn, and J.R. Yates 3rd. 2001. An automated multidimensional protein identification 
technology for shotgun proteomics. Anal.Chem. 73:5683-5690.
woods, A., G. Wang, H. Dupuis, Z. Shao, and F. Beier. 2007. Rac1 signaling stimulates N-cadherin expression, 
mesenchymal condensation and chondrogenesis. J.Biol.Chem. 
woods, i.G., P.D. Kelly, F. Chu, P. Ngo-Hazelett, Y.L. Yan, H. Huang, J.H. Postlethwait, and W.S. Talbot. 2000. A 
comparative map of the zebrafish genome. Genome Res. 10:1903-1914.
wu, c.c., M.J. MacCoss, G. Mardones, C. Finnigan, S. Mogelsvang, J.R. Yates 3rd, and K.E. Howell. 2004. 
Organellar proteomics reveals golgi arginine dimethylation. Mol.Biol.Cell. 15:2907-2919.
wu, c.c., J.R. Yates 3rd, M.C. Neville, and K.E. Howell. 2000. Proteomic analysis of two functional states of the 
Golgi complex in mammary epithelial cells. Traffic. 1:769-782.
wu, m.m., M. Grabe, S. Adams, R.Y. Tsien, H.P. Moore, and T.E. Machen. 2001. Mechanisms of pH regulation in 
the regulated secretory pathway. J.Biol.Chem. 276:33027-33035.
68
xu, y., S. Takeda, T. Nakata, Y. Noda, Y. Tanaka, and N. Hirokawa. 2002. Role of KIFC3 motor protein in Golgi 
positioning and integration. J.Cell Biol. 158:293-303.
yamada, s., M. Tomoeda, Y. Ozawa, S. Yoneda, Y. Terashima, K. Ikezawa, S. Ikegawa, M. Saito, S. Toyosawa, and 
S. Murakami. 2007. PLAP-1/asporin, a novel negative regulator of periodontal ligament mineralization. J.Biol.
Chem. 282:23070-23080.
yamashiro, T., M. Tummers, and I. Thesleff. 2003. Expression of bone morphogenetic proteins and Msx genes 
during root formation. J.Dent.Res. 82:172-176.
yang, J.s., H. Gad, S.Y. Lee, A. Mironov, L. Zhang, G.V. Beznoussenko, C. Valente, G. Turacchio, A.N. Bonsra, G. 
Du, G. Baldanzi, A. Graziani, S. Bourgoin, M.A. Frohman, A. Luini, and V.W. Hsu. 2008. A role for phosphatidic 
acid in COPI vesicle fission yields insights into Golgi maintenance. Nat.Cell Biol. 10:1146-1153.
yang, J.s., S.Y. Lee, S. Spano, H. Gad, L. Zhang, Z. Nie, M. Bonazzi, D. Corda, A. Luini, and V.W. Hsu. 2005. A role 
for BARS at the fission step of COPI vesicle formation from Golgi membrane. EMBO J. 24:4133-4143.
yang, y., L. Topol, H. Lee, and J. Wu. 2003. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte 
proliferation and differentiation. Development. 130:1003-1015.
yokohama-Tamaki, T., H. Ohshima, N. Fujiwara, Y. Takada, Y. Ichimori, S. Wakisaka, H. Ohuchi, and H. Harada. 
2006. Cessation of Fgf10 signaling, resulting in a defective dental epithelial stem cell compartment, leads to the 
transition from crown to root formation. Development. 133:1359-1366.
yonei-Tamura, s., T. Endo, H. Yajima, H. Ohuchi, H. Ide, and K. Tamura. 1999. FGF7 and FGF10 directly induce 
the apical ectodermal ridge in chick embryos. Dev.Biol. 211:133-143.
yoon, b.s., D.A. Ovchinnikov, I. Yoshii, Y. Mishina, R.R. Behringer, and K.M. Lyons. 2005. Bmpr1a and Bmpr1b 
have overlapping functions and are essential for chondrogenesis in vivo. Proc.Natl.Acad.Sci.U.S.A. 102:5062-
5067.
yoshihisa, T., C. Barlowe, and R. Schekman. 1993. Requirement for a GTPase-activating protein in vesicle budding 
from the endoplasmic reticulum. Science. 259:1466-1468.
yoshizawa, T., F. Takizawa, F. Iizawa, O. Ishibashi, H. Kawashima, A. Matsuda, N. Endo, and H. Kawashima. 
2004. Homeobox protein MSX2 acts as a molecular defense mechanism for preventing ossification in ligament 
fibroblasts. Mol.Cell.Biol. 24:3460-3472.
young, D.w., M.Q. Hassan, X.Q. Yang, M. Galindo, A. Javed, S.K. Zaidi, P. Furcinitti, D. Lapointe, M. Montecino, 
J.B. Lian, J.L. Stein, A.J. van Wijnen, and G.S. Stein. 2007. Mitotic retention of gene expression patterns by the 
cell fate-determining transcription factor Runx2. Proc.Natl.Acad.Sci.U.S.A. 104:3189-3194.
Zaal, K.J., C.L. Smith, R.S. Polishchuk, N. Altan, N.B. Cole, J. Ellenberg, K. Hirschberg, J.F. Presley, T.H. Roberts, 
E. Siggia, R.D. Phair, and J. Lippincott-Schwartz. 1999. Golgi membranes are absorbed into and reemerge from 
the ER during mitosis. Cell. 99:589-601.
Zelzer, e., D.J. Glotzer, C. Hartmann, D. Thomas, N. Fukai, S. Soker, and B.R. Olsen. 2001. Tissue specific regulation 
of VEGF expression during bone development requires Cbfa1/Runx2. Mech.Dev. 106:97-106.
Zhang, J., X. Li, M. Mueller, Y. Wang, C. Zong, N. Deng, T.M. Vondriska, D.A. Liem, J.I. Yang, P. Korge, H. Honda, 
J.N. Weiss, R. Apweiler, and P. Ping. 2008. Systematic characterization of the murine mitochondrial proteome 
using functionally validated cardiac mitochondria. Proteomics. 8:1564-1575.
Zhou, g., Q. Zheng, F. Engin, E. Munivez, Y. Chen, E. Sebald, D. Krakow, and B. Lee. 2006. Dominance of SOX9 
function over RUNX2 during skeletogenesis. Proc.Natl.Acad.Sci.U.S.A. 103:19004-19009.
Zhou, y., J.B. Atkins, S.B. Rompani, D.L. Bancescu, P.H. Petersen, H. Tang, K. Zou, S.B. Stewart, and W. Zhong. 
2007. The mammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during 
mitosis. Cell. 129:163-178.
Zuzarte-luis, v., and J.M. Hurle. 2005. Programmed cell death in the embryonic vertebrate limb. Semin.Cell Dev.
Biol. 16:261-269.
